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AB STRACT 
The expansion of pharmaceutical knowledge, coupled 
with consumer demand to participate in health care, has 
created a need for extension of the variety and quality of 
pharmacists' expertise in health maintenance. In response, 
some practitioners have diversified their practices into the 
provision of specialized health related services. 
The aims of the thesis were, firstly, to determine 
the nature and extent of services being provided from 
community pharmacies in Queensland, to identify practices 
providing specific services, and to examine relationships 
between service provision and demographic and business 
factors. Secondly, an area of innovative service provision 
(diabetic services) was selected as a case study into 
specialization within community pharmacy practice. The aims of 
the case study were to document the services being offered, 
the types of diabetic stock held, and the degree of 
counselling involvement with diabetic patients. Historical, 
educational and motivational aspects were also investigated. 
To aid understanding of the developmental process, active 
pharmacies were classified into levels of service provision. 
A "Survey of Services from Community Pharmacies in 
Queensland, 1984" confirmed that pharmacists were performing 
duties related to dispensing of prescription medications and 
to provision of primary health care, and that many were 
offering other health-related services of a specialized 
nature. The major health related services offered were hire of 
invalid or health care aids (53.2%), sports medicine services 
(37.3%), pregnancy testing (35.6%), diabetic services (15.2%), 
and hypertensive services (8.3%). Seventy percent of 
pharmacies were providing at least one of these services. 
The "Survey of Diabetic Services from Community 
Pharmacies in Queensland, 1986-87" found that activities were 
broadly divided into three groups: services, supply and 
counselling. Services included provision of information to 
diabetic patients, and blood glucose monitoring. All 
pharmacies reported keeping ranges of stock of a wide variety 
of constantly needed goods associated with diabetic care. Only 
about half of them kept less frequently demanded items. 
Pharmacists were involved in counselling diabetic patients 
about a diverse range of topics. The areas of major 
involvement were counselling purchasers of blood glucose 
monitors about their use, and counselling about oral 
hypoglycaemic therapy. 
Pharmacists involved mostly did not have 
qualifications beyond the basic requirements of Ph.C. or 
B.Pharm. They tended to be members of professional and 
merchandising groups. Over 70% of pharmacists reported regular 
readership of journals, and journal reading was identified as 
a major source of information about diabetes. Only about a 
quarter of the pharmacies appeared to have specific diabetes 
reference texts available. 
Presence of Diabetic Association Support Group did 
not appear to inhibit the development of diabetic services in 
community pharmacies. The trend was for higher proportions of 
city centre and regional shopping centre pharmacies to be 
providing diabetic services. The physical size of the pharmacy 
and the annual turnover also differed significantly between 
providers and nonproviders, with greater proportions of larger 
pharmacies with higher turnovers being involved. 
Professional and altruistic reasons were cited as 
the major influences on the decision to provide a diabetic 
service. Pharmacists saw the service as a way to increase 
professional satisfaction, had a personal interest in 
diabetes, had a number of diabetic customers, and recognized 
the need of their diabetic customers for assistance. The 
prospect of making a profit was a less important factor. 
Support from external sources was apparently minor. The great 
majority of pharmacies had begun their involvement since 1980, 
probably due to the advent of blood glucose monitoring and the 
sale of monitors through pharmacies. Provision of specialized 
diabetic services from community pharmacies in Queensland 
appears to have been the result of the efforts of motivated 
practitioners. 
Grouping of pharmacies specializing in diabetic 
services resulted in the formation of two clusters providing 
lower and higher levels of service. The features 
distinguishing between the groups were that higher service 
level providers were more likely to be providing information 
to patients by sophisticated means, more likely to be 
performing blood glucose monitoring, more likely to assist 
clients with alternative means of monitoring during repair 
times, and more involved in counselling on wider aspects of 
diabetic care. 
A plan was suggested for the controlled development 
of the trend towards specialization in community pharmacy. 
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Chapter 1. 
C O M M U N I T Y E » H A R M A C Y P R A C T I C E I N 
A U S T R A L I A 
1.1 HISTORICAL DEVELOPMENT 
1.1.1 The Early Nineteenth Century 
Just as the early history of Australia, or more 
correctly the Colony of New South Wales, is inexorably linked 
to that of England, so too the early direction of pharmacy in 
this country was influenced by events affecting pharmacy in 
England (1,2). Gregory Haines, in his book on the history of 
pharmacy in New South Wales (NSW) (1), cited the Apothecaries 
Act passed in England in 1815 as the critical point in the 
development of pharmacy as separate from medicine. Prior to 
this time, there existed several branches within the medical 
profession, each of which were permitted to dispense. Entry to 
the prestigious group known as the London Physicians was based 
on theoretical training and examination. Surgeons, having 
finally separated from barbers in 1800, qualified by serving 
an apprenticeship. They were permitted to prescribe external 
remedies, but medicines to be taken by mouth could only be 
prescribed by the physicians. The lowest rung of the medical 
ladder was occupied by the apothecaries, who had gained their 
independence from the London Company of Grocers in 1617. By 
the eighteenth century, their role was chiefly in caring for 
the sick, with dispensing being only a part-time occupation 
often performed by an assistant. They were not permitted to 
perform any type of surgery and could only charge their 
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patients for medicines, not for services. 
As the apothecaries' involvement with dispensing 
decreased, a group known as "chemists and druggists", also an 
offshoot of the Grocers' Guild (2) and having associations 
with alchemists and herbalists (1), began to compete with them 
in this area. Because members of this group were not 
specifically trained and had no traditional reputation to fall 
back on, their success depended on financial aspects and they 
were seen as businessmen rather than professionals. The Act of 
1815 resulted in the recognition of the London Apothecaries as 
medical practitioners, but did not grant them a monopoly on 
dispensing. The chemists and druggists attempted to take over 
this function, as they were free to deal in drugs, medicines 
and medicinal compounds. However, the giving of advice was 
interpreted as "practising medicine" and was therefore an 
illegal function for this group, who were thus forced to 
supply their professional advice free of charge (3). 
As the 1815 legislation was in force prior to the 
establishment of chemist shops in New South Wales, its effect 
there was to ensure a place for pharmacists as the settlement 
progressed, but also to have them seen not as members of a 
profession, but as retail traders earning their living from 
sales of goods rather than fees for service (1,4). 
The pharmacist's skills in the first half of the 
nineteenth century were concerned with discerning good 
specimens of plant materials and the preparation of galenicals 
from these materials, the preparation of family and veterinary 
remedies for a wide variety of household uses from these 
galenicals, the mixing of medicinals such as lotions, 
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draughts, powders, ointments and mixtures to relieve minor 
ailments, and the dispensing of doctors' prescriptions (1,2). 
There are numerous examples of involvement by pharmacists in 
Australia in other commercial activities at this time, such as 
"spice-dealer and grocer" (5), "purveyor of groceries and 
chemicals" (6), and importing and distributing of both 
pharmaceutical and other goods (6,7). 
Because transport of extemporaneous preparations 
was difficult, and patients could not be expected to travel 
long distances, a system of distribution from independent 
retail pharmacy businesses was established offering ready 
accessibility to the public in both urban and rural Australia. 
This accessibility led to pharmacists being used by the public 
as the first contact for advice in medical and health matters 
in general (4). In the country, pharmacy maintained even 
stronger links with grocery than in the city, but also had 
stronger links with medicine, with many country pharmacies 
also offering dental and veterinary services (5,7). 
By the middle of the nineteenth century, pharmacy 
had established itself in New South Wales as an occupation 
separate from medicine (5). 
1.1.2 The Late Nineteenth Century 
Manning (8) stated that "In Australia in the 
mid-nineteenth century, pharmacists prescribed and doctors 
dispensed". Both activities were accepted and considered 
"normal". He described the pharmacist's specialty, however, as 
being distinguished by three areas: drugs, treatment, and 
business. The pharmacist's drug expertise at this time 
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involved him in such activities as solving problems related to 
storage, safe-keeping, dosage, strength, stability, and 
adulteration of drugs by suppliers, or ensuring that drugs be 
extracted and prepared in such a way as to maximize their 
therapeutic properties. According to Manning, the pharmacist 
was not operating in his expert field when treating the sick, 
but he was operating in a field where he could provide a 
cheaper service than the expert. An important aspect of this 
role continued to be the treatment of minor ailments which 
could be cured by self-medication prescribed and provided by 
the pharmacist. 
Impressions from advertising, and evidence given at 
an inquiry held by the Pharmacy Board of Victoria in 1927 (6), 
showed that pharmacists in the 1860s and 1870s were involved 
in considerable prescribing for common ailments. At this time, 
dispensing from doctors' prescriptions was less common, as 
many doctors did their own dispensing. The findings of the 
Board from this inquiry were that the "rights and privileges 
hitherto enjoyed by chemists and druggists in their open 
shops" ie prior to the passing of the Poisons Act of 1876, 
were as follows (9,10): 
1. To attend and advise patients in their open 
shops or pharmacies in ailments of common 
occurrence and to judge of their complaints 
by the symptoms; 
2. To prescribe medical as distinquished from 
surgical treatment for such patients; 
3. To supply, and if necessary, compound the 
medicines so prescribed; 
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4. To administer an antidote in cases of acute 
poisoning and to apply first-aid in cases of 
accident or injury. 
These findings placed a strong emphasis on the counselling and 
prescribing role of the pharmacist in addition to his 
functions as a compounder and supplier. 
The proliferation of patent nonprescription 
medicines in the middle and late nineteenth century 
jeopardized the pharmacist's role in the compounding of 
medications for the treatment of minor ailments, as their 
availablity bypassed the need for his manipulative skills. As 
these remedies were able to be sold by any retailer and the 
formulae were not disclosed, there was also no place for a 
knowledge of doses or a judgement of efficacy (11). 
Pharmacists attempted to retaliate by concocting their own 
secret remedies (7,11). 
1.1.3 The Early Twentieth Century 
Archambault (12) has described the early phase in 
the history of American pharmacy, lasting from colonial days 
until about 1930, as the "compounding and dispensing period". 
The description applies equally to pharmacy practice in 
Australia at that time. Pharmacists up to the 1930s were 
trained in coping with physical, chemical, and physiological 
incompatabilities related to the items they dispensed. Their 
work involved the compounding of such dosage forms as tablet 
triturates, capsules, powders, pills, cachets, ointments, 
plasters, suppositories, solutions, mixtures, liniments, and 
syrups. The production of a "pharmaceutically elegant" product 
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was cause for professional pride. They were also called upon 
to supply raw materials and to advise on preparation of folk 
remedies, as well as to provide advice on health matters to 
the community (4,12). Early this century, simple inorganic 
medicines also began to be used, requiring pharmacists to be 
concerned with purity, strength, standards, and stability of 
these as well as the traditional plant materials (2). 
The continuing increase in ready-made galenicals 
and factory produced medicines resulted in a change in the 
front shop section of pharmacies from a service area to a 
sales area, and the movement of professional and ethical 
matters to the dispensary (13). As the variety of medicinal 
compounds increased, prescribing by chemists began to incur 
risks, as their education in this area had not kept pace with 
that of doctors (13). Rather than prevent people from 
consulting them for treatment of minor ailments, the solution 
proposed to the Commonwealth Royal Commission for Food and 
Drugs in 1913, and later passed, was to restrict some drugs 
for use only on doctors' prescription. Pharmacy bodies saw 
this as a way to reduce conflict between pharmacists and 
doctors (10). Concern was shown by Queensland (Qld.) 
pharmacists about this time that proposed amendments to the 
Health Act may have forced them to divulge the composition of 
their over-the counter preparations, or "nostrums" (9). Action 
by the Pharmaceutical Society of Queensland managed to 
circumvent such legislation in 1911. While such a policy was 
considered ethically correct at the time, it also provided 
obvious economic advantages to the pharmacist. Secrecy about 
the contents of medicines persisted until the 1960s, even in 
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relation to prescription medication (13). 
Concerns about the spread of venereal disease in 
the early years of the twentieth century gave rise to possibly 
the first instance of the use of the pharmacist as a community 
health educator. In 1912, the journal Chemist and Druggist 
published a series of articles to enable pharmacists to 
accurately inform the public of the seriousness of these 
conditions (13). 
After World War I, agreement was reached between 
pharmacists and the federal government Repatriation Department 
regarding provision of pharmaceutical benefits for returned 
servicemen (9,14). Haines (14) felt that this agreement 
established the precedent that doctors should prescribe and 
pharmacists dispense, and that pharmacists were entitled to a 
professional fee for dispensing. 
By the 1920s, the professional role and 
responsibilities of the pharmacist were being questioned, as 
demand for his expertise in compounding continued to abate. 
Pharmacists continued to consider their professional role to 
be that of a dispenser rather than an expert in drugs (13). 
However, they had shown concern for public health and safety 
by proffering suggestions for control of drug usage. 
Legislation for the control of dangerous drugs, however, in 
the form of the Police Offences (Amendment) Drug Act of 1927, 
implicitely defined the pharmacist as a distributor only (13). 
In contrast to the situation in Europe, where customs and 
consequent laws had distinguished pharmacy as a separate 
profession from medicine, the course of evolution of pharmacy 
in England, and therefore in Australia, left it without such 
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tradition to follow (15). Pharmacists were told that they must 
realize that pharmacy was "a business as well as a profession" 
(16) and editorials on the future of pharmacy published by the 
Australian Journal of Pharmacy (AJP) in 1927 predicted its 
possible division into two extreme groups, the professional 
and the commercial (16). 
In 1931, B.S.Berry of the Guild Committee commented 
on pharmacists' contributions to public health through the 
range of gratuitous services offered and their ability to 
refer serious complaints for medical attention. He cited the 
pharmacist as the most readily accessibile health-care 
professional (15). Because of the long-standing practice of 
making no charge for advice, and probably in response to their 
customers' expectations, pharmacists considered it prudent to 
recommend a product for purchase in conjunction with giving 
advice (15). 
Some pharmacists felt that their professional 
status could be protected by extending the range of community 
health services they offered and suggested such areas as child 
welfare, gas defence, air-raid precautions, dietetics, 
bacteriology, and urinology (15). While such areas would have 
expanded the pharmacist's role as a health educator, most were 
only remotely related to his drug expertise. Although there 
appeared to be agreement on the need to find job satisfaction, 
there was a division of opinion as to whether the emphasis 
should be placed on the financial aspects of exploiting the 
business potential of pharmacy, or on the personal and 
professional aspects of an expanded medical role (15). 
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1.1.4 The 1940s to the 1960s 
The major change to the face of pharmacy during 
these three decades was the continuing decline in 
extemporaneous compounding due to the proliferation of drugs 
which could only be prepared industrially. Changes to 
pharmaceutical education were essential to keep pace with the 
changing face of drug treatment. 
1.1.4.1 Dispensing 
In the 1940s, most prescriptions presented still 
required extemporaneous dispensing (17). During World War II, 
however, the drug manufacturing industry had increased in size 
and number as had the complexity and efficacy of products 
being marketed. The chemical entities and dosage forms being 
manufactured were such that they could not be duplicated in 
the dispensary (4,15,18). 
As research and development in the pharmaceutical 
industry continued at a remarkable pace in the 1950s and 
1960s, simple extemporaneously prepared medicines were 
increasingly replaced by new and potent drugs which advanced 
the prevention and treatment of disease (2,17,19,20). The 
pharmacist's role became centred on aspects of distribution of 
manufactured products, such as availability, repackaging, 
price, storage, stability, and forensic issues (16). This 
change in emphasis of the pharmacist's role towards commercial 
aspects led to both practitioners and the public losing sight 
of the professional role of the pharmacist (21,22). 
Archambault (12) defined the period of pharmacy 
history from the early 1930s through the 1960s in the United 
States as the "count and pour" period, during which 
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pharmacists activities were directed to repacking (counting or 
pouring) bulk stocks of prescription items into the quantities 
required by the patient. Such was also the case in Australia. 
Archambault described that time as a "wandering and 
floundering" period during which pharmacy was attempting to 
justify a place within the health care professions (12). 
Advances in drug technology also resulted in the removal of 
suspect nonprescription medicines from the United States 
market by the Food and Drug Administration (FDA), and the 
restriction of certain medications to physician control (12). 
Legislation in Canada in the 1950s also made the distinction 
between prescription and nonprescription drugs (24). 
Attempts had been made to establish a contributory 
National Health Service (NHS) in Australia in 1938, but due to 
the intervention of war, it was 1948 before a revised scheme 
was introduced (9,14). Pharmaceuticals were supplied through 
the Pharmaceutical Benefits Scheme (PBS) under a cost plus 
mark-up plus dispensing fee pricing structure. The list of 
drugs available under the scheme was substantially increased 
in 1953, although there was concern among pharmacists at the 
reduction by the Government in the number of compounded 
preparations (9,14). The overall effect, however, was to 
increase the number of prescriptions being written. The 
comprehensiveness of the range of drugs available on the PBS 
in the 1960s, including many over-the-counter medicines, 
forced pharmacists increasingly into prescription supply 
activities (9). However, Haines (14) felt that the economics 
of the PBS were a disincentive to the development of 
professional skills and thus prompted pharmacists to venture 
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into the development of more profitable commercial channels 
(9,14). 
1.1.4.2 Education 
The advances in new drug discoveries that have 
already been alluded to resulted in a reshaping of 
pharmaceutical education in the late 1950s. Until this time, 
the training of pharmacists in Australia had been carried out 
under an apprenticeship system in conjunction with part-time 
study (21). As the need for teaching technical compounding 
skills decreased, pharmacy schools, both in Australia and 
overseas, began to move into the scientific fields of 
pharmaceutical chemistry, pharmaceutics, pharmaceutical 
technology, and pharmacology (12,17,26). Expertise was needed 
in these fields to enable graduates to understand the advances 
in new drug discovery, including the site and mode of action 
of the new drugs and the best way to administer them to obtain 
the most efficient action with minimum hazards (15,27). 
In most Australian states, the early 1960s saw a 
change to full-time tertiary academic study for a period of 
three years, followed by a period of one year training under 
the supervision of a pharmacist prior to registration being 
granted (9,28). In Queensland, the Pharmacy Act was amended in 
1957 to provide for the training of all future pharmacists at 
the University from 1960 (9). The scientific education being 
provided to pharmacy students at this time was important to 
the understanding of new drug development, formulation, and 
pharmaceutical manufacturing, and was thus essential for those 
pharmacists taking up careers in the pharmaceutical industry. 
However, professional satisfaction was elusive to the highly 
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trained graduates entering community or hospital practice, who 
often felt disillusioned by the lack of opportunity to apply 
their considerable knowledge in the practice setting. This 
problem persisted into the 1970s (22,29,30). 
1.1.5 The 1970s to the Present Day 
Following the "compounding and dispensing period" 
and the "count and pour period", pharmacy entered the 
"clinical" era. 
1.1.5.1 The Need for a Clinical Role in Community 
Pharmacy 
Although the rate of influx of new drugs onto the 
market began to decrease in the late 1960s, the amount of 
knowledge about them continued to increase. With increasing 
knowledge came a growing awareness of the hazards involved 
with the use of these highly potent substances, especially 
adverse reactions and interactions with other drugs (2). 
Pharmacists began to question whether their role should be 
merely distributive, or clinically orientated (16,31). Reports 
and textbooks describing adverse reactions and interactions 
became available in the very late 1960s and early 1970s, and 
the need for experts in drug therapy began to be recognized. 
From this recognition, the concept of "patient orientated" 
pharmacy practice developed, widening the pharmacist's 
traditional concerns to include individual patients and their 
total drug therapy (2,32). 
By the 1980s it was estimated that fewer than 1% of 
prescriptions dispensed in the United States of America (USA) 
required compounding (23), and that the information needed by 
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patients to maximize the effectiveness of the new drugs, and 
to minimize their potential for adverse effects, was becoming 
more important than their mere supply. The British National 
Pharmaceutical Association (NPA) report to the Nuffield 
Inquiry committee pointed out that modern pharmacists were 
required for their "knowledge of the properties of the 
materials that are being supplied and the ability to ensure 
that patients receive the correct medicine, in the correct 
quantity, in the correct form and with sufficient information 
to enable them to use it with maximum benefit and minimum risk 
of harm" (33). Burnet (34) estimated that, even though the 
volume of extemporaneous dispensing in Australia had similarly 
decreased, the increased need for advice and counselling in 
relation to drugs required about 65 percent of the 
pharmacist's time to be spent in dispensing prescriptions and 
dealing with sales of nonprescription medication. He advocated 
fewer and larger pharmacies and the use of technology to allow 
pharmacists to increase the time spent with patients in 
counselling, and in co-operation with other health 
professionals. 
The Guidance Notes to the Pharmaceutical Society of 
Great Britain (PSGB) Code of Ethics (35) explained the 
interpretation of the term "professional services" to include 
dispensing of prescriptions; sale or supply of medicinal 
products, surgical dressings and appliances, poisons and 
chemicals, aids to mobility; response to symptoms described in 
pharmacies; facilities for sale or supply of hearing aids; 
pregnancy testing; and sale of goods, supply of services or 
provision of advice where the pharmacist uses his scienfific 
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and pharmaceutical knowledge. The clinical approach to 
community practice, thus, was not seen as being restricted to 
dispensed medicines, but also as applicable to such activities 
as the diagnosis and treatment or referral of minor ailments; 
early recognition and referral of other disease states; supply 
of devices for treatment or management of illness; provision 
of drug information and health education. Many of these 
activities are not dissimilar to those attributed to 
pharmacists of a century before, as evidenced by the statement 
of the Pharmacy Board of Victoria inquiry of 1927 regarding 
the "rights and privileges (of) chemists and druggists" prior 
to 1876, which has been quoted earlier in this chapter (1.1.2, 
9,10). 
In addition to the changing nature of medication, 
external factors have also altered the nature of the patient, 
increasing both the demand and the need for health care 
information. These factors include the trend towards 
individuals accepting the responsibility for their own health, 
and the aging population. 
Since the 1960s, consumerism has become a major 
influence in the market place, including the community 
pharmacy market (20,36-40). The effects of this movement have 
been to alert the increasingly educated population to the need 
for information not only on the use of prescribed drugs, but 
also about other areas of health care, to enable people to 
take the responsibility for management of their own health 
(26,36,38,41-45). This move towards "self care" involves 
management of chronic disease states, self-treatment of minor 
ailments, and health maintenance by disease prevention. The 
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general concept of the "self-help" society has been seen by 
Naisbitt (39) as among the major trends for the future. 
The marked increase in the birth rate after World 
War II, followed by the move towards zero population growth, 
has resulted in a steadily increasing proportion of population 
in the over-65 group in Western countries (44-51). This trend 
has been assisted by advances in medicine prolonging life 
expectancy. The correlation between age and illness is 
inescapable, however, so that the nett result will be an 
increasing proportion of the population requiring long term 
medication (37,46,47,50,52,53). Because of increasing patient 
numbers and increasing hospitalization costs, as well as the 
advances in patient care techniques, it has been predicted 
that many of these patients will remain ambulatory, or will be 
cared for at home rather than in institutions 
(37,44,45,48,51-56). Gosselin (37) stated in 1976 that about 
70 to 80 percent of the ill population in the USA, even then, 
were ambulatory, living at home, and being treated by drugs. 
By 1984, the proportion was estimated to be 90 percent (48). 
The need for counselling has been stated to be 
greater for elderly patients than for the general population. 
Individuals in this group are likely to be taking a larger 
number of medications and may become confused with their 
regimens because of this, and also because of deteriorating 
comprehension and memory (46). 
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1.1.5.2 The Development of a Community Pharmacy 
Clinical Role 
Hospital pharmacy in the USA began to attract 
graduates interested in patient care from about the mid-1960s 
(12). The 1965 report of the Commission on Pharmaceutical 
Services to Ambulant Patients by Hospitals and Related 
Facilities stated the main function of pharmacy as "clinical 
in nature drug-use control" (57). The inclusion of 
clinical components in pharmacy courses in the USA and later 
in Australia, encouraged the development of new roles for 
hospital pharmacists such as poisons adviser, ward pharmacist, 
clinical drug consultant, and duties including recording and 
reviewing patient drug histories, reviewing overall drug 
therapy patterns in the hospital, and collecting data on 
adverse drug reactions (21). 
Clinical involvement in the community setting was a 
more complicated matter, as patients were free to use more 
than one doctor and/or pharmacist (21), but during the 1970s 
there was evidence that community pharmacists were beginning 
to fulfil this role by use of patient medication records, 
additional labelling, explanatory leaflets, and provision of 
drug information services to local doctors (21,57,58). The 
term "patient counselling", discussing treatment with patients 
to ensure correct use of their medication, became part of the 
pharmacist's vocabulary around this time (21,58). Bloomfield, 
a past-president of PSGB, speaking at the NSW Pharmaceutical 
Society centenary in 1976 (58), expressed the opinion that "a 
clinical role is the only acceptable professional future for 
pharmacy". However, the "Professional Report 1978" 
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commissioned by the Australian Hospitals and Health Services 
Commission, found that the incidence of counter-prescribing, 
patient counselling, and patient medication records was, at 
that time, limited (59). 
Through the 1970s and into the 1980s, community 
pharmacists were constantly being reminded of their abilities 
and obligations to become involved in the clinical aspects of 
practice. Reminders came from leaders in the academic 
(48,60-63) and practice (22,23,26,55,56,64-69) areas of the 
profession, both in Australia and overseas. Leaders emphasized 
the application of clinical involvement to the major 
professional areas of prescription-related, primary care, and 
health promotion activities, and provision of drug information 
to other health professionals (10). In a review of the 
Australian literature, Berbatis (70) attempted to quantify the 
contribution of pharmacists within the health care system from 
the limited data available. He estimated that approximately 
4.8 million persons per fortnight (average 820 per pharmacy) 
were receiving health services in community pharmacies, 
two-thirds of which were prescription-related contacts and 
one-third other health-related activities. He emphasized the 
need for education and assessment to equip pharmacists to 
fulfil the clinical role effectively. 
Fevang (24) observed that, as society came to 
recognize that it is information dependent rather than 
industry dependent, a concept endorsed by Naisbitt (71), the 
social value of the pharmacist would be restored from that of 
the "pill counter" by clinical pharmacists providing 
information to patients. 
35 
1.1.5.3 The Nature of the Clinical Role 
The main purposes of involvement by pharmacists in 
clinical aspects of medical treatment have thus been shown to 
be ensuring correct use and therefore optimal effect of 
prescribed and nonprescribed medication with minimal adverse 
reactions, and assisting the public with health care 
decisions. In order to achieve this aim, pharmacists are 
required to provide information to both patients and 
prescribers. Verbal communication, "counselling", is the basic 
means of transferring this information, reinforced by written 
aids such as labelling, ancillary labelling, leaflets, and 
audio-visual programmes. 
While the merits of counselling have been extolled 
and encouragement frequently given to pharmacists to 
participate in this activity, few studies of counselling in 
Australian community pharmacies have been undertaken. The 
major study of patient counselling by community pharmacists in 
Australia was conducted by Ortiz in response to the lack of 
research data on the way in which counselling was being 
conducted, the range of counselling activities, and the time 
taken for counselling (72-77). Counselling in this study was 
considered to cover general heath matters as well as 
medication information. A 1982 mail survey of pharmacies in 
New South Wales (NSW) and the Australian Capital Territory 
(ACT) elicited a response rate of 68% (72). An average of 32 
customers per pharmacy per day were estimated to receive 
counselling by a pharmacist, but the estimates varied widely 
between pharmacies. The categories identified by pharmacists 
as being the most frequent targets for counselling were advice 
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about prescribed and nonprescribed medications. A second study 
using a random stratified sample of pharmacies (52% response) 
was carried out, using a se1f-reported diary method (75). This 
method found an average of 12.2 counselling episodes per 
pharmacy per day. Approximately 60% of interactions were 
reported to have been initiated by the patient. 
Written support to verbal counselling, in addition 
to labelling, has been disseminated to pharmacy patrons by 
means of leaflets and health education books. Systems have 
been developed to make advisory leaflets and health education 
books available for use by Australian pharmacists (78-80). 
Twenty-six per cent of respondents to the survey by Ortiz et 
al (72) indicated that they used aids to assist their 
counselling such as reference books, leaflets, advisory 
labels, charts, and demonstration units. 
In the USA, a national study was undertaken by the 
FDA in 1983 to determine the use of written materials in the 
pharmacy (81). Twenty-nine percent of the 241 pharmacies 
surveyed had some type of free leaflets relating to 
prescription medicines, 22% offered books about prescription 
drugs for sale, and 44% had drug information materials 
available for customers to consult without payment, either 
patient-orientated or professional sources of information. 
General suggestions have been made regarding the 
use of audio-visual programmes as educational aids in 
community pharmacies (82,83). Pharmaceutical manufacturers 
have used audio-visual programmes for both education of 
consumers and training of pharmacy staff (84). 
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Lloyd, addressing the Pharmacy Guild of Australia 
(PGA) Conference in 1978, predicted an increase in dedication 
of specific areas within Australian community pharmacies to be 
used for counselling, diagnosis and treatment of minor 
ailments, health education, and health screening in an 
atmosphere of relative seclusion (85). Bowden (86), addressing 
another conference in the same year, listed the advantages of 
counselling rooms as convenience, privacy, and facilitation 
for the charging of a counselling fee because of the changed 
environment. Johnston (87), outlining a programme for 
provision of health care services in pharmacy, recommended 
locating a counselling room of at least 60 sq.ft. in area 
adjacent to the dispensary and with easy access from both the 
dispensary and the front shop. 
In a paper delivered at the Federation 
Internationale Pharmaceutique conference in 1983, Bickle (88) 
described the usual counselling site in Australian pharmacies 
as being over-the-counter or near the dispensary, and said 
that less than 8% of NSW pharmacies had an area specifically 
for counselling although the concept had the support of the 
Pharmacy Guild. The figure quoted was a result of the survey 
conducted by Ortiz (72). The survey also noted that there was 
a significantly more positive attitude towards professionalism 
in pharmacies with a counselling area. This was reflected by 
the fact that 25% of pharmacies which kept patient medication 
records also had counselling areas. John Ware (89), Executive 
Councillor of the Pharmaceutical Society of Australia (PSA), 
supported the concept of adapting the pharmacy environment to 
provide counselling areas which maintained privacy within the 
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front shop rather than isolating counselling episodes in a 
separate room and risking the loss of accessibility of the 
pharmacist to the public. 
While by no means being the usual site for patient 
counselling, there have been reports of pharmacies 
incorporating counselling rooms or counselling areas allowing 
private or semi-private consultation (88,90-92). 
The British NPA planning department has for some 
time included a "consultation point" in its pharmacy designs 
(93). In its report to the Nuffield Inquiry Committee, the NPA 
stated that their market research and the results of other 
studies indicated that people felt more relaxed in the 
surroundings of the community pharmacy than the doctor's 
surgery (33). A consumer survey by Miller in South Africa (94) 
found that 54% of respondents felt that they would prefer to 
consult a pharmacist in a private consulting area rather than 
in the open pharmacy if a need arose to seek the pharmacist's 
advice. 
The Nuffield Report recommended the provision of 
accomodation for confidential counselling in pharmacies 
contracting to provide advisory services to consumers (95), 
but the NPA urged the interpretation of this recommendation to 
include counselling areas within the pharmacy ("consultation 
points") as well as isolated counselling rooms (96). Both the 
Nuffield Report and PSGB were in favour of financial 
encouragement for the setting up of confidential counselling 
facilities (97). 
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1.1.5.4 Reward for Involvement in the Clinical Role 
From the early 1970s, concern was expressed in 
Australia that pharmacists, as a result of the historical 
development of pharmacy practice, were not receiving direct 
remuneration for the provision of clinical professional 
services. While comment from within the profession was 
generally of the opinion that financial reward was appropriate 
(3,98), warnings were sounded regarding the increased prospect 
of liability unless advice was soundly based (99,100). 
Pharmacists were seen as the only health professionals not 
receiving a fee for their professional advice (3,101). 
Different approaches were suggested for 
establishing a system of payment. One school of thought was 
that payment for the services, either by the consumer or by 
the Government, would not be possible until the profession had 
demonstrated that members were indeed providing the service, 
and that the service was of benefit to the receivers 
(21,22,98,102-107). The opposing view was that these 
professional services would not be recognized as such by the 
public until a fee was charged (98,108,109). Johnston (87) 
noted that counselling would occur in conjunction with most 
health care services, with the cost usually included in the 
total cost of the service. To assist recognition of the 
professional role of the pharmacist, he recommended that the 
fee for counselling should be defined separately where 
possible, including counselling associated with dispensing 
services. He cautioned pharmacists that commitment to 
counselling was essential before attempting to charge a fee. 
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as otherwise clients would be unable to see value for their 
money (110). Manning and Feehan (98), in recommending that a 
fee be charged for all pharmaceutical consultations, stressed 
that for such a move to be accepted, it would have to be 
introduced nationwide following an educational campaign among 
pharmacists and a publicity campaign to consumers. Pharmacy 
leaders in the USA have also recommended educating the public 
to appreciate the value of pharmaceutical services and 
encouraging their willingness to pay (66,111), 
The opinion was expressed that, as the public has 
traditionally expected to receive free advice from pharmacist 
on a number of matters, it was questionnable how many would 
continue to seek those services if a fee was involved 
regardless of whether goods were supplied (21). Manning and 
Feehan (98) expressed the opinion that charging for advisory 
services would not be likely to result in greatly decreased 
demand. However, there appeared to have been no research into 
the opinion of Australian consumers regarding the 
acceptability of pharmacists charging for consultative 
services, or their willingness to pay, although the need for 
this knowledge was recognized within the profession 
(98,106,110). 
Several American studies have explored customers' 
willingness to pay for various specific professional services. 
A survey of 934 (32% response) pharmacy customers in Iowa by 
Gagnon (112) found that 47% of respondents would probably or 
definitely pay 25-50 cents more per prescription for 
pharmaceutical services they rated as important. When 
questionned specifically about medication profiles, 91% said 
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they would probably or definitely accept an offer by a 
pharmacist to maintain such records if there were no added 
costs involved, but only 21% would accept at a cost of 25 
cents per prescription. A national cross-sectional stratified 
telephone survey of consumers by the American Pharmaceutical 
Association (APhA) in 1983 (113) found the public to be 
"surprisingly receptive" to the idea of using the pharmacist 
for provision of clinical services, and also to paying for 
services. This preliminary survey covered five types of 
clinical services: private consultations about correct use of 
prescription drugs, maintenance of medication records and 
monitoring drug therapy, refusal to dispense inappropriate 
prescriptions, home consultations, and consultations about 
treatment of minor ailments. Willingness to pay for these 
specific services was expressed by 31% to 57% of consumers. 
Other more restricted surveys have been conducted 
into consumers' willingness to pay for particular services 
such as prescription counselling (114) and medication reminder 
systems (115). Schondelmeyer and Trinca (114) concluded that a 
"substantial proportion" of consumers were willing to pay for 
prescription counselling, and also that pricing the service 
too low may have the effect of making consumers question the 
quality and value of the service. Brown et al (115) found 40% 
of patients willing to pay for a service which incorporated a 
refill reminder system for long-term medications, specifically 
cardiovascular medications. 
Few examples of individual pharmacists charging 
specifically for counselling have been published (86,110,116). 
A community pharmacist in Texas (USA) reported acceptance by 
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both patients and doctors of a three-tiered system of fees for 
counselling which distinguished between evaluating single and 
multiple symptoms and making a recommendation for their 
treatment, and reviewing the patient's complete prescription 
and nonprescription medications (117). 
1.1.5.5 Statement of the Professional Role of the 
Pharmacist 
In addition to comment from pharmacy leaders, 
professional organizations in Australia and overseas during 
the 1970s and 1980s addressed themselves to the formulation of 
statements to define the emerging roles of pharmacists. 
AUSTRALIA 
A statement of the professional role of the 
pharmacist was unanimously adopted by the conference of 
Pharmacy Boards of Australia and New Zealand in March, 1973 
(118,119). The overall role of the pharmacist was described as 
"to ensure optimal drug therapy both by his actions in the 
supply of medicines and associated products, and by the 
information and advice he provides to those who prescribe or 
use drug products". The explanatory clauses related to all 
aspects of drug therapy: drug stability, storage, formulation, 
administration, actions, interactions, dosage, compounding, 
and information. According to Lloyd (2), the statement 
affirmed the role of the pharmacist as the "drug authority" in 
the provision of professional pharmacy services and not merely 
a distributor. He described the services as including the 
provision of all medical information about drugs; the 
monitoring, and advising on the safety and efficacy of that 
part of the treatment of a patient that is associated with the 
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use of drugs; and the provision of services to ensure that all 
medicines are administered properly and correctly. 
A "Think Tank" on professional development 
conducted by the Victorian Branch of PSA in 1982 agreed that 
the primary role of the pharmacist was that of drug manager in 
the community, including control of the distribution, use and 
information about drugs to the individual in particular and 
also to the community at large (120,121). Opportunites for 
professional development in accordance with this premise were 
seen as: 
1. Expansion of counselling, including 
counter-prescribing with further deregulation 
from prescription only to pharmacist 
supervised sale; pharmacist authorization of 
continuation of supply of prescribed 
medicines for chronic conditions; 
inter-professional involvement; sessional 
hospital practice and home visits to 
non-ambulatory patients; 
2. Preventive medicine including health advice; 
social counselling; well person screening; 
home nursing/invalid care; minor pathology 
tests ; 
3. Animal health; 
4. Sports and leisure medicines. 
In 1986, PSA adopted a definition of pharmacy 
practice which clearly illustrated professional health care 
activities as well as the supply function of pharmacists 
(122). The official statement defined pharmacy practice as: 
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The preparation and supply of medications and 
the provision of systems and information to 
optimize their use; 
The provision of primary health care services 
within the ambit of the pharmacists' 
competence. Such services include: 
a. supply of therapeutic goods and 
appllances , 
b. assisting the public with 
identification and treatment of 
minor ailments, 
c. referral to other health care 
practitioners where warranted, 
d. education to prevent illness, and 
e. promotion of good health. 
UNITED STATES 
The Millis Report (123) published in 1975, was 
commissioned by the American Association of Colleges of 
Pharmacy (AACP) to investigate the nature of current pharmacy 
practice in the USA, factors affecting its development, and 
educational needs for the pharmacists of the future. The 
Commission, in defining pharmacy as a health service, 
recognized it as a knowledge system. It recommended that, in 
order to fulfil the need for provision of adequate information 
about drugs to consumers and health professionals, pharmacy 
education should be aimed at producing practitioners capable 
of developing, organizing and distributing knowledge and 
information about drugs in addition to the more accepted 
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skills of developing, manufacturing and distributing drug 
products. 
The APhA Policy Committee on Professional Affairs 
recommended a definition of pharmacy practice as "a 
patient-oriented health service that applies a scientific body 
of knowledge to improve and promote health through assurances 
of safety and efficacy in drug use and drug-related therapy" 
(124). Other recommendations of that Committee included those 
related to pharmacists' roles in health care and drug 
information, and the establishment of criteria for the 
dispensing of both prescription and nonprescription drugs. In 
1979, APhA presented a comprehensive statement on standards of 
practice for pharmacy (125) covering responsibilities in 
general management and administration of the pharmacy, 
processing of prescriptions, patient care, and education of 
health care professionals and patients. 
UNITED KINGDOM 
In 1982, PSGB released a policy statement on 
clinical pharmacy in community practice which it defined as 
"the application of pharmaceutical knowledge directly to the 
care of individual patients" (126). The professional clinical 
activities highlighted were dispensing, including patient 
counselling; sale of medicines; sale of surgical appliances, 
medical aids and sick room requisites; family planning and 
pregnancy testing; and blood pressure monitoring. 
In 1984, the Pharmaceutical Services Negotiating 
Committee published a Charter which set out the professions' 
aims for pharmaceutical services under the National Health 
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Service (127). Among its recommendations were several relating 
to recognition of the clinical role: provision of information 
and advice to prescribers and patients, use of counselling 
areas and health education materials within community 
pharmacies, and provision of domiciliary services to the 
elderly, mentally ill, and physically disabled. 
The Nuffield Report (95) published in 1986, made a 
number of proposals for the future of pharmacy, many of which 
were in line with those of the Pharmacists' Charter (127). 
Specifically, the section of the Nuffield Report devoted to 
community pharmacy recommended the welcoming of new technology 
including computers, greater collaboration with other health 
care professionals, greater personal involvement with members 
of the public in giving advice on the taking of medicines, 
provision of domiciliary services to patients at home or in 
institutions, and the provision of health education 
(95,128,129). The Council of PSGB welcomed the recognition by 
the Nuffield Report of the indispensable role of the 
pharmacist in health care, the change of emphasis from supply 
of medicines to the provision of a wider range of services, 
and the potential for pharmacists to contribute further to the 
development of health services (129). The British Government 
document "Primary Health Care - An Agenda for Discussion" 
recommended a wider role for pharmacists in advising patients, 
and proposed that more professional time could be made 
available for dealing with the public by relaxing the 
requirements for supervision of dispensing (130). 
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1.2 APPLICATION OF THE CLINICAL ROLE 
Clinical involvement by pharmacists has been shown 
to have relevance in the areas of dispensing of prescription 
medications, primary care and recommendation of 
nonprescription medications, and health promotion. 
1.2.1 Prescription Related Activities 
1.2.1.1 Extent of Dispensing 
Drugs provided under the Commonwealth PBS have 
continued to comprise an ever increasing proportion of those 
dispensed in Australia. In summarizing aspects of prescription 
drug usage in Australia to mid-1980, Berbatis and Kailis (131) 
stated that expenditure on all drugs distributed through 
community pharmacy was $680 million or 52% of total turnover, 
and involved over 70% of pharmacists' working time. PBS items 
for 1979-80 accounted for 80% of expenditure on prescription 
drugs and 84% of all prescriptions. Figures compiled by Webb 
(132) show the decline in extemporaneously-prepared items 
dispensed. In the year 1960-61, approximately 8.3 million of 
the 31.2 million prescriptions dispensed under the PBS were 
for extemporaneous items. By 1975-76 the number had declined 
to 4.3 million of 101 million prescriptions, and by 1979-80 to 
only 2.5 million, 56.5% of which were for standard formulae 
preparations. However, Kerr et al (133) pointed out that, even 
as late as 1985, there was still considerable variety in the 
types of extemporaneous products pharmacists were required to 
prepare. 
Blythe and Armstrong (134) found that 41% of 
customers in the Western Australian (WA) pharmacies surveyed 
by them in 1977 purchased a prescription, and 35% made no 
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other purchases. Forty percent of pharmacy customers 
interviewed in a national study by Darby in 1981 (135) stated 
that their main reason for entering the pharmacy was to have a 
prescription dispensed. 
1.2.1.2 Nature of Dispensing 
In the Guide to the Self-Assessment of Professional 
Practice Activities, PSGB described dispensing as including 
"all of the activities which occur from the pharmacist's 
initial scrutiny of a prescription to the collection of the 
dispensed medicine by the patient or agent" (35). As in Great 
Britain (95), the growth of the PBS in Australia was seen as 
responsible for the role of the pharmacist remaining primarily 
that of a dispenser of doctors' prescriptions (14,136). Haines 
(14) felt that, despite continual expansion of the scheme, 
costs were controlled in such a way that there was no 
opportunity or encouragement for pharmacists to increase the 
quality of services provided to correspond with the increasing 
quantity of dispensing. Crothers (136) also commented that the 
pharmacist has been largely recognized as simply a distributor 
of drugs, financial reward under the PBS being the greatest to 
those who dispensed most frequently, in effect penalising 
those attempting to spend more time with patients. 
While the decline in average time for dispensing a 
prescription through the 1970s was seen by some as a measure 
of improved efficiency, others saw it as an indication of 
inadequate professional attention to aspects of the dispensing 
process other than supply (28,131). These aspects were 
described as prescription review (examination of prescriptions 
before dispensing to ensure that they conform with legal 
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requirements and are appropriate to the patient), patient 
counselling to ensure compliance and correct drug usage, and 
therapeutic drug monitoring (follow-up) of compliance and drug 
effects (131,137). 
Despite the apparent retardation of the development 
of the clinical role associated with dispensing in community 
practice due to lack of remuneration for such activities, 
practitioners and professional organizations have taken the 
initiative in encouraging its development. Recognising the 
public need for assistance in taking responsibility for their 
medication, methods for providing information and monitoring 
drug use began to be used, including descriptive labelling and 
patient medication records, in addition to counselling. 
1.2.1.3 Counselling 
Expectation of Australian consumers with regard to 
counselling in pharmacies does not appear to have been 
investigated. A 1980 survey of households in rural Mississippi 
(138), conducted by personal interview with a stratified 
random sample, found that 67% of respondents expected 
pharmacists to counsel them on side effects of prescription 
drugs, and 65% expected counselling related to the dosage 
regimen. However, only 29% reported ever having received 
information about side effects from a pharmacist, 
A survey of customer inquiries in 35 pharmacies in 
Sydney (NSW) in 1970 (139) found that 15.2% related to 
prescribed medication. Over one third of these were medical 
inquiries relating to the item being dispensed, about 30% were 
requests for information about medication currently being 
taken, 12% were seeking clarification of dosage instructions. 
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and 9% were reports of possible adverse reactions. A similar 
study in five pharmacies in the Canberra area (ACT) in 1978 
(140) found that 19% of all inquiries were related to 
prescriptions, mostly seeking further explanation of the 
directions, information about side effects or 
incompatibilities, or advice on storage and when to discard. 
In the USA, Kirking (141), surveying a random 
sample of community pharmacists in Ohio in 1982 (77% response 
rate), found that they provided counselling on approximately 
40% of new prescriptions, although there was large variation 
between respondents. The most common topics discussed were 
medication name and general purpose, timing and frequency of 
administration, and common side effects and precautions. About 
two-thirds of the episodes were estimated to be initiated by 
the pharmacists, and differences were found in frequency of 
counselling between classes of drugs and types of patients. In 
further analysis (142), Kirking found attitude to counselling 
to be the major explanatory variable in a model for explaining 
counselling activity, but also that situational and 
demographic variables were involved. 
Garde and Benrimoj (143) investigating prescription 
counselling in a selected sample of community pharmacies in 
Brisbane (Qld.) in 1982, reported that verbal counselling 
occurred in conjunction with about one third of prescriptions 
dispensed. The NSW counselling study by Ortiz in 1984 (72) 
found that 54% of all types of counselling episodes were in 
connection with PBS prescriptions. 
In a study by Olsen and Ortiz (144) of the impact 
of computers in community pharmacy in NSW, 89% of respondents 
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reported a decrease in the time devoted to filling 
prescriptions and 70% reported a decrease in the time required 
for clerical aspects. A consequent increase in time available 
to work in the front shop was reported by 84% of respondents. 
Thus, 82% reported an increase in the number of patients 
counselled after installation of a dispensing computer system 
and 92% claimed that the computer made patient consultation 
eas ier. 
1.2.1.4 Computerization 
Unboubtedly, the most obvious recent change to the 
nature of dispensing in community pharmacy practice has been 
the introduction of computerized dispensing techniques 
(47,144-146). The survey conducted by Olsen and Ortiz 
(144,145) in NSW found that over 15% of pharmacies were 
computerized prior to 1985. Although their sample was not 
random, they quoted computer marketing companies as estimating 
the proportion to be about 17% at that time. By late 1985, 
companies estimated penetration at over 30% (145,147). A 
national study conducted as part of an Australian Journal of 
Pharmacy (AJP) readership survey (response rate 13%) in late 
1986 found the figure to be about 60%, with wide interstate 
variations (146). Projections have been made estimating 80% 
computerization of Australian pharmacies by 1990 (148). 
Similar trends have been seen in the USA. American Druggist 
published estimates of 23% penetration in American pharmacies 
by the end of 1984, and a projection of 62% by the end of 1986 
(147). The United States National Association of Retail 
Druggists (NARD) has estimated penetration of computerization 
to 75% of its members by the end of the 1980s (47). 
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Respondents to the 1984 survey by Olsen and Ortiz 
(145) used their computer systems mainly for prescription 
processing, including the keeping of prescription records and 
patient medication profiles, and as a prompt for advisory 
label information. Drug interaction and contra-indication 
monitoring were claimed to be mostly used if available, but 
the authors were of the opinion that these facilities were 
also often ignored. A few pharmacies utilized foreign language 
labels or nursing home packages, and many expressed an 
intention to use patient advice leaflets, which were not 
routinely available at that time. 
Optimal use of such systems can allow more 
efficient drug surveillance through patient medication records 
and automatic alerting of possible drug interactions, as well 
as simplifying counselling by the provision of drug 
information reminders which can then be communicated to the 
patient verbally and/or by means of leaflets and labels 
(20,26,149-152). 
1.2.1.5 Labelling 
Laws requiring that dispensed medicines be labelled 
with the name of the active ingredients or the proprietary 
name, and instructions for use were introduced in Australia in 
the 1960s and 1970s. In Queensland, this legislation was 
embodied in The Poisons Regulations of 1973 (153). 
The concept of Australian pharmacists using 
ancillary cautionary instructions on dispensed medicines was 
broached by Lloyd in 1972 (154), and subsequently a list of 
suggested additional instructions was included as an Appendix 
to the Australian Pharmaceutical Formulary (APF) of 1974 
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(155). The list has been expanded in later editions (156). In 
a survey of the use of the APF conducted in 1984, community 
pharmacists in Western Australia (WA) ranked this section 
second highest, both as "Most Used" and "Most Useful" (157). 
Trevena (90) described a system of ancillary labelling which 
he developed to fulfil perceived needs in his practice. 
The organized use of advisory labels was introduced 
in South Australia (SA) in 1974 (158-160), and in WA in 1975 
(161), both with apparent success (162,163). A study of their 
use in Tasmania (Tas.) in 1979 showed at least 77% of 
pharmacies to be involved, assuming non-respondents to be 
non-users (164). The study of prescription counselling in 
Queensland by Garde and Benrimoj (143) observed the use of 
ancillary labels with about two thirds of prescriptions 
dispensed. In 1986, a mail survey of the use of ancillary 
labels and additional instructions sent to 457 pharmacies in 
WA achieved a response rate of 39% (165). The findings of the 
survey were that 91% used ancillary labels and additional 
instructions to some extent, both on original and repeat 
presciptions, but that the rate of use varied for specific 
labels. The response rate was not unusual for a mail survey, 
but precluded the drawing of reliable conclusions. Assuming 
non-respondents to be non-users in this study reduced the 
frequency of use to below 20%. 
In their study of the impact of computers in 
community pharmacy practice in 1985, Olsen and Ortiz (144) 
found that 53% of pharmacists surveyed claimed to have 
increased their use of ancillary labels as a result of 
prompting by computer software. 
54 
Personal interviews of of a stratified random 
sample of Newcastle (NSW) residents in a study by Ortiz et al 
(77) found that 96% of those interviewed thought that 
pharmacists should use advisory/precautionary labels. 
While the use of advisory labels has been 
encouraged in Australia by professional bodies (156,166), the 
first mandate for their use in Queensland has only recenly 
appeared (153). Cook et al (165) described similar limited 
mandates in NSW and WA in 1986. 
A USA national study by the FDA in 1983 found that 
almost all (97%) pharmacists questioned said they used 
auxiliary labels (81). Another American study around this time 
confirmed auxiliary labels to be effective in providing 
pertinent information (167). 
1.2.1.6 Patient Records 
Patient medication record card systems have been 
used in the USA since the early 1960s (116,149), and by 1973 
were reported to be in use by about 60% of pharmacies, with 
their use being mandatory on request in some States (168). In 
Australia, they were reported to be in use in a number of 
pharmacies in NSW, Victoria, SA and Tasmania by the early 
1970s (169,170). In 1979, Pharmacy Boards in Australia and New 
Zealand were asked to consider making the keeping of patient 
medication records by pharmacists compulsory, as the 
introduction of dispensing computers was seen to facilitate 
this activity, but such action has not been taken (171). 
The usefulness of these records in enabling 
detection of potential adverse reactions and drug interactions 
has been illustrated both in Australia and overseas 
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(169,170,172-174), and their use has been encouraged (26,175). 
PSGB, in its Guidance Notes to the Code of Ethics stated that 
"patient records...,are particularly helpful....in ensuring 
that the correct medication regimen is followed by the 
patient" (35). Arguments against their use have been centred 
on the time involved in maintaining and accessing the records 
and the difficulties associated with recording nonprescription 
medications (149,174,176), but these objections have been 
countered by practitioners successfully operating systems 
(90,149,173,177), and by computerization facilitating the 
clerical process of record keeping. 
Methods for establishing and operating patient 
record card systems have been suggested (173,178,179). To 
overcome some of their limitations. Hunt Sharp (149) suggested 
their use in conjunction with cautionary and advisory labels, 
shelf card reminders of interactions and side effects, and 
patient package inserts. The "Professional Report 1978" (59), 
based on a survey of fifty pharmacies in Victoria, found that 
although about 20% of country pharmacies surveyed had 
introduced patient records, the proportion of metropolitan 
pharmacies involved was much less. Lloyd (85) predicted in 
1978 that electronic data processing equipment would be used 
to maintain patient records. With the increasing penetration 
of dispensing computer systems into community pharmacies in 
Australia (144-146,148), this method of maintaining patient 
records seems capable of overcoming former objections to their 
use (26). Training may be required to ensure optimal 
application by pharmacists of computer generated information 
such as patient records and drug interactions. 
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Interviews with Newcastle (NSW) residents in 1982 
(77) showed them to be largely unaware of patient medication 
record systems, but about 75% believed they would be useful 
after having the system explained to them. No other Australian 
consumer data appears to be available. A survey conducted for 
APhA by the Dichter Institute for Motivational Research in 
1973 (180) showed that 70% of consumers felt that patient 
medication profiles should be maintained, but that only 30% 
believed that they were receiving the service. The survey by 
Banahan et al (138) in rural Mississippi found that 71% of 
respondents expected pharmacists to maintain and refer to 
patient medication profiles, but about one third of them did 
not know if their pharmacist kept such records. Of those who 
knew that their pharmacist offered the service, only 59% 
reported the service to be in use. A South African survey 
(181) showed that 51% of a large sample of pharmacy customers 
thought that the maintenance of individual patient medication 
records by pharmacists was very important, and a further 28% 
considered it reasonably important. As the same survey also 
found that only 15% of customers thought that their pharmacist 
was aware of all their allergies to medicines, the importance 
of keeping such records may have been underestimated. 
A suggestion in Great Britain that patients 
register with a particular pharmacy has been applauded, 
particularly for elderly patients, as keeping of complete 
patient records would be facilitated (152). 
An alternative to keeping patient medication 
records in the pharmacy has been trialed in France and the 
United Kingdom (UK), where the individual retains his own 
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medical record in a form similar to a credit card ("smart 
card"), allowing access by the medical practitioner to all 
information, and access by the pharmacist to medication 
records (127,152). 
Use of patient medication records by individual 
pharmacists has been reported (90,169,182,183), and has been 
encouraged (150,184). 
1.2.1.7 Remuneration 
As the Commonwealth Government has continued to be 
the major payer for prescribed medicines, action was taken by 
pharmacy organizations to have a counselling component 
included in the PBS dispensing fee. This is the only aspect of 
clinical service which has received any official attention in 
relation to remuneration. Haines (21) felt that the Government 
was likely to resist payment of a true professional fee. He 
saw the challenge as being to provide clinical services on a 
free basis until their worth was established, and then 
introduce a fee, but feared that this may act as a delaying 
tactic retarding development of such services. 
The National Health Act of 1953-1975 
(Pharmaceutical Benefits) included a "professional fee" 
component in the basis for payment of pharmaceutical benefits, 
but the fee was based only on the labour costs of dispensing a 
prescription, and included no specific payment for the 
provision of professional advisory services (3). A discussion 
paper produced by the professional development committee of 
PSA in 1979 (101) recommended payment by the Government to 
pharmacists for the supply of pharmaceutical benefits and also 
for the supply of associated professional pharmaceutical 
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services. Following the 1977/78 Pharmacy Enquiry (185), it was 
apparent that time involved in professional counselling was 
included in the dispensing time used for calculation of the 
professional fee. However, no specific proportion of the fee 
was allocated for counselling, as the Government took the 
position that payment for counselling would not be justified 
until there was sufficient proof that pharmacists generally 
were providing it, since their evidence showed that only 1% of 
time spent on PBS dispensing was involved in counselling 
(107). The first fee decision of the Pharmaceutical Benefits 
Remuneration Tribunal (186,187) deferred consideration of 
specific payment for counselling for consideration by the 
second enquiry. The second decision (188) continued to 
recognize counselling only within the dispensing fee, despite 
submissions from PSA, PGA and individual pharmacists 
advocating an across-the-board payment identified as being for 
counselling, or payment for specific counselling episodes. 
Subsequent enquiries by the Tribunal do not appear to have 
addressed the issue, as further studies have not been 
undertaken to provide evidence of an increased proportion of 
dispensing time being devoted to counselling. 
The British Pharmaceutical Services Negotiating 
Committee (127) recommended that payment to pharmacists under 
the United Kingdom NHS should be adapted to allow specific 
remuneration for certain professional activities. The 
suggested activities included provision of advice in response 
to symptoms, services to individual patients on long term or 
complicated medication regimens, domiciliary and clinic 
attendance, and health education. 
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1.2.2 Primary Health Care 
The involvement of pharmacists in primary health 
care activities has historically been a part of their role and 
thus is not generally disputed in pharmacy professional 
circles, although changes in its nature and extent have 
occurred over the years. Treatment with nonprescription 
medication has been shown to frequently be the first line of 
action taken in health care (189-194). The outcome of a 
primary health interaction between pharmacist and patient may 
be referral to another health care professional, sale of a 
nonprescription medication or other health care aid, and/or 
recommendation of other means for management of the condition 
in question. 
1.2.2.1 Extent of Primary Care 
Australian surveys have shown that about 12-15% of 
customers request advice in pharmacies (134,195), although 
other studies have reported levels of around only 3-5% 
(139,140), These anomalies may be attributable to 
methodological differences. The Australian Health Survey of 
1983 (196) revealed that 2.5% of the population had consulted 
a pharmacist for medical advice at least once during the four 
weeks prior to interview. Lord and Dewdney's 1971 NSW survey 
(139) showed that 30% of pharmacy customers purchased a 
nonprescription medicine, and that this was the only type of 
purchase for 24% of customers. Fourteen percent of customers 
in a later survey by Darby in Sydney (NSW) (135) stated the 
purchase of a nonprescription medicine as being their main 
reason for entering the pharmacy. Lord and Dewdney (139) found 
that nonprescription medicine sales were the result of 
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requests for advice in 38% of cases, (although they also 
stated that selection of products was made approximately 
equally by customers and by pharmacy staff), whereas a 1982 
Brisbane (Qld.) study showed that 28% of sales of 
nonprescription medicines were accompanied by advice from the 
pharmacy staff, initiated by either the staff or the customer 
(197). About 75% of patients presenting symptoms were 
apparently using the pharmacy as a primary health care source 
(134,198). A review of studies of self-treatment and primary 
care in Australia and overseas has been compiled by Berbatis 
and Sunderland (10), showing high usage of nonprescription 
medications, and considerable involvement by pharmacists in 
their selection. 
1.2.2.2 Recognition of the Primary Care Role 
A study by Darby (135) in which a stratified sample 
of 174 pharmacy customers was interviewed in 30 Sydney 
pharmacies, found that while 14% said that they had entered 
the pharmacy to buy a nonprescription medicine, only one 
respondent had entered with the intention of seeking advice of 
health matters. These figures contrast with those collected by 
self-reporting or observation of inquiries in pharmacies in 
Australia (134,139,197), New Zealand (NZ) (199), and the 
United Kingdom (200-202) which showed that between 15% and one 
third of customers purchasing nonprescription medications also 
received advice. A study in Dunedin (NZ) in which 24 
pharmacists (65% response rate) recorded patient-initiated 
inquiries over one week, found an average inquiry rate of 
5.5%, excluding those related to prescriptions (203). 
Interviews with a random sample of 100 women from the same 
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area found that, of the 86% who had visited a pharmacy in the 
previous month, 18% had done so to buy a nonprescription 
medicine, but only 1% mentioned the pharmacist as an 
alternative source of advice to the doctor for treatment of 
minor ailments (204). Although limited by methodological 
problems, this result exhibits the same trend as Darby's study 
(135). The study of households in rural Mississippi by Banahan 
et al (138) found that 64% of consumers expected counselling 
from their pharmacists about nonprescription medicines, but 
only 51% expected the pharmacist to answer questions about 
health matters other than drugs. When questioned about their 
behaviour, about one third said that they had asked their 
pharmacist about the use of nonprescription medicines, but 
only about one fifth had asked for other health information. 
From these results, it is apparent that customers 
perceive their motives as purchase of a product for self-care 
purposes rather than consultation of a health care 
professional for advice when entering the pharmacy. However, 
customers appeared to value the advice of pharmacists. 
Twenty-one percent of people interviewed by Christopher et al 
(205) in five pharmacies in Dundee, Scotland, said that they 
chose their nonprescription medicine as a result of advice 
received from the pharmacist. Darby (206), commenting that 
people did not appear to regard the pharmacist as directly 
relevant to their health activities, advocated the promotion 
of pharmacy in a way which would demonstrate the value of the 
pharmacist's skills. 
This approach has been adopted by PSA in promotion 
of the current "Self Care" Programme (207). The aim of the 
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programme is to provide community pharmacists with health 
information in a suitable form for the consumer. Publicity 
associated with the campaign has been prepared to alert 
members of the public to the availability and accessibility of 
the information and to inform them of the role of the 
pharmacist in assisting them to maintain optimum levels of 
health. The programme aims to help people achieve this by 
adoption of healthy life-styles, prevention of illness or 
minimization of severity when illness occurs, self-management 
of minor illness, participation in treatment of major illness, 
coping with chronic illness in the ambulatory setting, and 
assisting dependents such as the young and the elderly in 
these areas (80). Its applications are thus both to primary 
health care and to health promotion activities through 
community pharmacies. The pharmacists' role in the programme 
is to provide a source of information about health, to provide 
primary care for minor illness, to act as a referral agent to 
other health care resources when appropriate, and to 
supplement the advice given by other health care practitioners 
(79). The "Self Care Programme" was launched in NSW and the 
ACT in April 1986 (79) and the first year of operation was 
reported to have been highly successful (208). The scheme was 
launched in Tasmania in July 1987, and in Queensland, Victoria 
and South Australia in October 1987, and is planned to 
commence in Western Australia in early 1988 (207,209). 
1.2.2.3 Availability of Nonprescription Medications 
Regulation of supply of medication in Australia is 
governed by a system of scheduling in which Schedule 4 (S4) 
drugs are restricted to supply on prescription only. Schedule 
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3 (S3) drugs are restricted to sale through pharmacies by 
pharmacists only, and Schedule 2 (S2) drugs are restricted to 
sale through pharmacies by responsible persons under the 
supervision of a pharmacist (153). In addition, unscheduled 
items are available for unrestricted sale through pharmacies 
and other retail outlets. A similar situation exists in the 
United Kingdom, where drugs are supplied on prescription-only 
(POM), through pharmacies under the supervision of a 
pharmacist (P), or under an unrestricted General Sales List 
(GSL) (33). In Canada, some provinces have established a 
"third class" of drugs, in addition to prescription-only and 
over-the-counter groups, which are available only through 
pharmacies with pharmacist intervention in the sale (210). 
Despite efforts by pharmacists in the USA since 1868 to 
establish a similar "third class" of drugs (211-214), 
pharmacists in Florida are the only ones with access to 
prescribing a wider range of substances than those recommended 
by the FDA for general over-the-counter status (211). 
Products purchased by 263 Brisbane (Qld.) pharmacy 
customers in a survey by Stewart et al (198) were scheduled 
for sale in pharmacies only (ie S2 or S3) in 52% of cases. 
Forty-five percent of customers requesting products by name 
purchased S2 or S3 items, while 62% of products recommended by 
pharmacy staff were so scheduled. A similar distribution was 
found in a survey by Hardisty (202) in 225 pharmacies in the 
UK. The division of products between the GSL and the P lists 
was found to be such that 61.2% of the 2340 products demanded 
by customers were on the GSL, whereas only 40.0% of products 
recommended by pharmacy staff were on that list. A national 
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survey of 180 pharmacists in the UK in 1982 found that 90% of 
respondents agreed or strongly agreed that all 
over-the-counter medicines should be sold only through 
pharmacies, and 87% believed that pharmacists were 
sufficiently qualified to give advice to patients about minor 
conditions (215). 
The rationale behind having a group of drugs under 
the control of pharmacists is that such a scheme allows easier 
access by patients to a wider range of therapeutically active 
medications for treatment of minor ailments, whilst still 
affording them protection against the consequences of 
inappropriate or incorrect use by ensuring consultation with a 
health professional (206,211,216-218). If such a system is to 
operate effectively from the consumer's point of view, 
supervision of sales must be conscienciously provided by 
pharmacists trained in this area of practice (211,218). 
Advantages from the pharmacist's point of view are increased 
professional satisfaction by being able to recommend more 
effective treatments as well as economic benefits (206,211). 
Action by pharmacists and pharmacy bodies has been advocated 
in Australia to expand the range of substances available for 
prescribing by pharmacists (10,206,211,216) and also to 
protect the existence of the pharmacy-only group of drugs 
(219). 
1.2.2.4 Remuneration 
Scheduling changes in South Australia, which 
resulted in release of drugs from prescription-only (S4) to 
pharmacy-only (S3) status, were seen by some as providing an 
ideal opportunity for pharmacists to provide necessary 
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counselling to consumers at an appropriate price (220). These 
items had previously attracted a dispensing fee, and new S3 
legislations imposed similar requirements on pharmacists to 
those involved in dispensing. However, in SA, the transfer of 
items from S4 to S3 seemed to leave pharmacists apologetic 
about charging a fee for their sale, even though recording, 
labelling and counselling were required (28). 
Similar changes in Queensland in 1983 led to PGA 
Queensland Branch committee adopting a policy of adding a 
professional fee equal to the private dispensing fee to the 
retail price of S3 items which had previously only been 
available on prescription (221). Unfortunately, the changes of 
substances from S4 to S3 were also accompanied by changes of 
some products from S2 to S3. Although these products were then 
subject to the same restrictions and responsibilities, the 
Guild felt that it would have been difficult to expect 
patients to pay the professional fee for substances they could 
previously buy without prescription. The willingness of 
patients to pay for the extra professional services, however, 
was not investigated. Parker (210), quoting a consumer study 
conducted in Canada, claimed that 55% of Canadians desired 
private consultation with the pharmacist, and that only 45% of 
this group thought that the service should be free. The 
somewhat false distinction between products in S3 in 
Queensland according to the route by which they attained the 
classification, apparently caused some confusion among the 
public and pharmacists alike. As a result of this confusion, 
the professional role of the pharmacist in dealing with 
nonprescription medicines was unlikely to be able to be 
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clearly demonstrated to the public. It was again apparent that 
pharmacists were reluctant to take the initiative to charge 
for services related to the provision of nonprescription 
medicines, even though provision of services was mandatory, 
perhaps through fear of having to justify the level of the fee 
(222). 
Berbatis and Sunderland (10) made several 
recommendations for increasing the remuneration to pharmacists 
for primary health care activities. They suggested: 
1. Introduction of a consulting fee; 
2. Enlarging the range of pharmacist-only 
medicines and products; 
3. Incorporating a professional fee into each 
health care item; 
4. Increasing the market for established items. 
However, they felt that the introduction of a consulting fee 
would be too controversial in the 1980s. Such a move was 
thought to be unlikely to be accepted by the public or by 
pharmacists in the short term, and its achievement would 
require prolonged educational efforts by pharmacy bodies and 
educators. 
1.2.3 Health Promotion 
1.2.3.1 Nature of Health Promotion 
Health promotion has been defined by the 
Commonwealth Health Department as including "those methods by 
which individuals and populations can be influenced in the 
direction of preserving their health (and) involves informing 
people of the benefits and risks of lifestyles and practices. 
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and devising strategies to motivate them towards positive 
change in those practices" (223). Their report includes 
aspects of practice such as self-care and screening under the 
umbrella of health promotion as well as preventive medicine 
and health education (223). 
Fry (224) reminded pharmacists that hopes for 
better community health lie in promotion of health 
maintenance, and also in disease prevention and control by 
adoption of better life styles and early diagnosis of 
manageable diseases. Berbatis and Sunderland (10) outlined a 
rationale for pharmacists' involvement in health promotion, 
emphasizing the advantages to overall community health of such 
activities, and the advantages of siting the activities in the 
pharmacy, including cost savings, accessibility, and the 
knowledge base of the pharmacist. Gilbert (225) pointed out 
that, not only is the pharmacist accessible to members of the 
public seeking advice, but also the pharmacist is in regular 
contact with a number of sections of the community such as the 
elderly and young families and is therefore in a position to 
monitor community health. Similar advantages were listed by 
Smith and Gibson in the United States in 1975 (226) and Miller 
in South Africa in 1981 (94). 
1.2.3.2 Extent of Involvement 
The activities of Australian pharmacists in the 
field of health promotion have been historically much less 
obvious than their activities in the field of primary health 
care (10), and do not appear to have been specifically 
researched. 
In a survey of South African consumers. Miller (94) 
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found that nearly 40% of respondents said that they were 
afforded the opportunity to be counselled by their pharmacist 
in relation to daily personal health needs and general health 
education. A survey conducted by mail in the UK in 1980 was 
sent to a random sample of one in twenty registered premises 
and resulted in a 78% response (227). The results were 
validated by observation in a stratified sample of pharmacies. 
Seventy-nine percent of pharmacists agreed with the principle 
that health education should form part of the practice of 
community pharmacy. Respondents claimed that, on average, 
thirty-seven minutes per day were being spent on this task. 
Seventy-three percent felt that their customers expected to 
receive advice as part of normal pharmacy service, and 95% 
felt that the public had easy access to pharmacists. 
Sixty-seven percent thought that it would be possible to 
expand the health education activities in their pharmacy. A 
later survey of the general public (71% response) showed that 
consumers placed a relatively high degree of trust on health 
information received from pharmacists (184). 
1.2.3.3 Areas of Involvement 
A large number of health promotion areas 
appropriate for participation by pharmacists have been 
suggested, including limiting of drug abuse and drug misuse, 
safety of medicines, sexually transmitted disease control, 
family planning, child abuse and neglect prevention, screening 
and diagnostic testing, immunization, nutrition including 
areas such as low-fat and low-salt diets, automobile accident 
prevention, alcohol abuse, and smoking cessation 
(225,226,228-230). Jinks et al (228) saw the pharmacist's role 
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with individuals in primary disease prevention as providing 
education on behavioural topics such as smoking, alcohol use, 
nutrition, exercise and stress reduction. 
Using smoking as an example of the activity of 
pharmacists in health promotion, campaigns have been 
implemented through pharmacies in several countries to 
discourage smoking (231-234), and the ethics of selling 
tobacco through pharmacies discussed (235). Ninety-five 
percent of pharmacists questioned about participation in a 
campaign in Scotland in 1980 said that they would take part 
again if the exercise were repeated, and only 23% thought that 
the campaign had not been very effective in terms of changing 
the smoking habits of their customers (231). The success of a 
pilot programme in the West Midlands of England in 1982 (232) 
led to expansion of the programme in 1983 (234). Pharmacies 
were involved at one of three levels: displaying posters and 
leaflets; also showing a visual slide programme for children; 
and additionally emloying a carbon monoxide analyser to 
measure concentrations in expired air. Eighty-two percent of 
pharmacists and 69% of their staff counselled customers about 
giving up smoking during the campaign, and 60% of pharmacists 
considered the campaign to have been quite effective (234). A 
programme conducted in Winnipeg, Canada, in 1983 (233) 
involved 82% of pharmacies in the city. Of available smoking 
cessation booklets, 93.5% were distributed to the public from 
these pharmacy sources as a result of extensive media 
advertising about the programme. 
McKenney et al (236) listed instances of United 
States pharmacists' participation in health promotion at a 
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community level in their pharmacies or to school or community 
groups on such topics as poison prevention, drug abuse, 
venereal disease, family planning, diabetes, high blood 
pressure, cancer, mental illness, and dental health. A 
national study by the FDA (81) found that 22% of pharmacists 
questioned were engaged in speaking to community groups and 
21% gave time on a voluntary basis for health screening or 
participation in health fairs. 
Reports of individual Australian pharmacies 
involved in health promotion as such have not been found, but 
pharmacists were reported to have been involved with a NSW 
Health Commission project in Lismore in 1980, providing 
counselling on prescribed medicines and other health 
information (237). Gibson, in a submission to the Better 
Health Commission (195), expressed the view that pharmacists 
are in a key position to support the Commission's health 
promotion activities, but cautioned that there would be a 
limit to the extent to which community pharmacies could 
provide services free of charge. 
The diversity of topics suggested as being suitable 
for health promotion programmes through pharmacies would 
create difficulties if every pharmacy were to attempt to cover 
each topic with a high degree of expertise. Specialization may 
provide a solution. 
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Chapter 2 
SPECIALIZATION IN COMMUNITY 
PHARMACY PRACTICE 
2.1 SPECIALTY PRACTICE 
A major issue facing pharmacy in the 1980s and 
beyond, which has already occupied the attention of other 
health professions, is the development of practice specialties 
(1). With continued acceptance by individuals of the 
responsibility for their own health, including management of 
chronic conditions, a need is envisaged for increased variety 
and quality of expertise of pharmacists involved in health 
maintenance activities. A trend towards concentration on 
specialized areas of practice has been observed. 
2.1.1 Process of Specialization 
The economic theory of specialization has been 
discussed by Manning (2): constant practice at a specialized 
process results in increased dexterity and acquisition of 
greater skills, allowing savings of time and labour and 
stimulus of invention resulting from concentration on a single 
task. The division of labour into specialized areas is limited 
by the extent of the market. With a limited market, a firm is 
required to perform a number of functions, some subject to 
increasing returns, and others to diminishing returns. With 
expansion in the size of the market, some of the functions 
with increasing returns split off and their expansion in 
output allows a decrease in costs. This is the process of 
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specialization. In applying the theory to pharmacy, Manning 
explained that its development has been a slow and continuous 
process because the development of the market has also been 
slow and continuous, and that it has been influenced by 
economic growth because it is dependent not only on numbers 
but also on the affluence of the people. An early example of 
the specialization process in pharmacy was the "split off" of 
the dispensing function from the tasks of the doctor, and 
later the take-over of manufacturing by the industrial 
pharmacist and the multi-national drug companies. 
2.1.2 Criteria for Specialization 
In 1974, APhA, through a Task Force on Specialties 
in Pharmacy, recommended the creation of a Board of 
Pharmaceutical Specialties with authority to recognize, 
approve qualifications of, and certify specialists in 
pharmacy. In presenting the report of the Task Force to the 
membership of APhA, the Journal of the American Pharmaceutical 
Association urged pharmacists to review the development of 
specialties in the other health professions of medicine (3), 
dentistry (4) and nursing (5), and to consider whether 
pharmacy specialties should develop the degree of complexity 
of recognition and certification structure existing in 
medicine, should be allowed to develop with little control or 
input from the profession as in nursing, or should follow the 
example of dentistry in providing a limited number of 
well-defined specialties under the control of the profession 
(6). Seven criteria were established for specialty recognition 
(7): 
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Criterion 1 - The area of specialization in the 
practice of pharmacy rests on a specialized knowledge of 
pharmaceutical sciences, which have their basis in the 
biological, physical, and behavioural sciences, and not on the 
basis of managerial, procedural, or technical services, nor on 
the basis of the environment in which pharmacy is practised. 
Criterion 2 - The area of specialization shall be 
one for which specially trained practitioners are needed to 
fulfil the responsibilities of the profession of pharmacy in 
improving the health and welfare of the public, which 
responsibilities may not otherwise be effectively fulfilled. 
Criterion 3 - The area of specialization shall 
represent an identifiable and distinct field of practice that 
calls for special knowledge and skills acquired by education 
and training and/or experience beyond the basic pharmaceutical 
education and training. 
Criterion 4 - The area of specialization shall be 
one in which schools of pharmacy and/or other organizations 
offer recognized education training programs to those seeking 
advanced knowledge and skills in the area of specialty 
practice so that they may perform more competently. 
Criterion 5 - The area of specialization shall be 
one in which there is an adequate educational and scientific 
base to warrant transmission of knowledge through teaching 
clinics and scientific and technical publications immediately 
related to the specialty. 
Criterion 6 - The area of specialization shall be 
one in which there exists a significant and clear health care 
demand to provide the necessary public reason for 
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certification. 
Criterion 7 - The area of specialization shall be 
comprised of a reasonable number of individuals who devote 
most of the time of their practice to the specialty area. 
While the task force felt that specialization would provide 
professional and economic advantages to specific professional 
groups, it was aware of the potential ecomomic and health care 
risks to the public (8). 
The first area of pharmacy practice to achieve 
recognition via these criteria was Nuclear Pharmacy, which 
came into being as a specialty in 1978 (8,9), and came of age 
in 1982 with the certification by the Board of Pharmaceutical 
Specialties of 63 pharmacists who were successful in 
completing its examination and also provided evidence of at 
least 4,000 hours of experience in nuclear pharmacy practice 
(10). 
Other areas of practice which have beeen suggested 
as specialties include general clinical pharmacy, paediatric 
clinical pharmacy, geriatric clinical pharmacy, total 
parenteral nutrition pharmacy, family practice pharmacy, 
psychopharmacy, drug information, analytical pharmacy, 
manufacturing pharmacy, and research (10-13). 
Views on the recognition of Clinical Pharmacy as a 
specialty were discussed at the 1980 APhA meeting (14-16). 
Subsequently, a Committee on Clinical Pharmacy as a Specialty 
was established to compile a submission to the Board of 
Pharmaceutical Specialties. The Committee defined clinical 
pharmacy as "a pharmacy practice specialty, whose 
responsibility it is to assure the safe and appropriate use of 
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drugs in patients through the application of specialized 
knowledge and functions in patient care, and which 
necessitates specialized education and/or structured training. 
It requires use of judgment in the collection and 
interpretation of data, patient-specific involvement, and 
direct interprofessional interaction." (17). The petition 
requesting recognition, which detailed the claims of clinical 
pharmacy in each of the previously listed criteria, was 
submitted to the Board in mid-1986 (18,19). 
Opinions on the issue of specialization expressed 
in Drug Intelligence and Clinical Pharmacy (DICP) over a 
number of years were collected in the April 1986 edition 
(12,13,20-25). 
The Guidance Notes to the PSGB Code of Ethics (26) 
used the term "specialized services", explaining that the use 
of the term required provision of a "comprehensive service in 
that specialization". 
2.1.3 Specialization in Australia 
In Australia, where no certification processes have 
as yet been established, arguments have been put as to the 
validity of use of the term "specialist". A judgement in the 
High Court against a doctor claiming to be a specialist, while 
not bearing directly upon the pharmacy situation, was cited in 
1977 as implying that specialist status could not be claimed 
unless a practitioner had an academic qualification or had 
been granted fellowship or membership of a specialist society 
subsequent to passing certain examinations and fulfilling 
certain requirements (27). Despite this restriction, it was 
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considered that the development of specialties would be a 
positive step in the development of a sound professional 
structure for pharmacy (28). 
The fact that hospital pharmacists in particular 
were increasingly involved in specialized tasks such as 
clinical ward pharmacy, paediatric pharmacy, 
radio-pharmaceuticals, drug information, oncology, and 
parenteral services was recognized and interpreted as possibly 
being the beginning of a trend towards specialization (29-32). 
There are currently thirteen Committees of Specialty Practice 
operating within the Society of Hospital Pharmacists of 
Australia (SHPA) to develop standards of practice in the 
fields of oncology, drug information, radiopharmacy, clinical 
pharmacy, outpatients, parenteral services, drug distribution, 
pharmacokinetics, computerization, extended care, quality 
assurance, patient counselling, and poisons information (33). 
Jim Matthews of PGA thought it inevitable that 
specialists would appear in pharmacy as they had in all other 
professions, and that the increasing specialization of medical 
services would require parallel specialization in 
pharmaceutical services. He envisaged these services being 
provided by private practice pharmacists in health centres, 
and that these pharmacists would require further academic 
degrees in order to practice their specialties (34,35). 
Beresford Stock, then president of PSA, proposed a 
case for recognition of specialist or consultant pharmacists 
competent to provide therapeutic services in the area of 
symptomatic treatment (36). 
Frank Ryan, Advisor in Pharmacy to the Queensland 
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Government, speaking at a seminar on Pharmacy Education in 
1985, also raised the issue of specialization. He felt that 
there was a need for the profession of pharmacy to develop 
areas of specialty practice, and that the profession should be 
addressing itself to designing various subsets of specialty 
practice as has been done in medicine and dentistry and to 
some extent in nursing. He cited the success of such 
approaches overseas, particularly in the United States, and 
foresaw specialties paralleling many of the medical 
specialties, so that pharmacists would become integral parts 
of clinical teams directly associated with patient care and 
would function as the drug consultants to these teams (37). 
The development of initiatives such as minor 
pathology testing, disease screening, home parenteral 
nutrition, family planning, and private hospital and nursing 
home services in community pharmacy practice was encouraged by 
the president of the national Pharmaceutical Society of 
Australia in 1984, Nelson Hunt Sharp (38), He emphasized that 
the provision of such services through pharmacies would help 
people to identify pharmacists as part of the health care 
team, but he cautioned practitioners against claiming 
specialist status for providing these services without having 
obtained appropriate post-graduate qualifications, believing 
that many of them could be adequately provided by pharmacists 
as a result of their basic training without the need to claim 
specialist status (38), 
Although there have as yet been no structured moves 
towards specialization in community pharmacy practice in 
Australia, there are numerous examples of practitioners 
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developing specialized services in a wide variety of areas. 
Professional specialization has been described as a response 
to the needs of clients, and its development and official 
recognition in pharmacy seen as likely to have a positive 
effect on the strength and relevance of the profession in the 
provision of total health care (32,39). 
2.2 SPECIALIZED HEALTH SERVICES 
Specialized health services in community pharmacy, 
both in Australia and overseas, have developed in several 
major areas. They have been established to cater for the needs 
of specific groups within the pharmacy clientele such as the 
young and the elderly, for those suffering from particular 
disease states such as diabetes, cancer, or hypertension, and 
as an adjunct to the sale of particular stock ranges such as 
family planning and sports medicine needs. 
2.2.1 Classification 
No generally accepted means of classification of 
services has been developed, but for ease of discussion they 
have here been grouped as: 
Services for Specific Patient Groups 
Geriatric Patients 
Domiciliary Care Patients 
Paediatric Patients 
Services Related to Specific Conditions 
Asthma and Allergy 
Diabetes 
Hypertension 
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Oncology 
Ophthalmology 
Ostomy 
Pregnancy Testing 
Services Related to Product Ranges 
Alternative Medicine 
Dent is try 
Family Planning 
Home Health Care Equipment 
Nutrition 
Sports Medicine 
Veterinary Medicine. 
In addition, some initiatives for general clinical involvement 
through community pharmacies will be discussed, including 
biological testing, pharmacokinetic evaluation, and 
office-based practice. 
The volume of information should not necessarily be 
taken as an indicator of the importance of an area or of the 
extent of specialization, but merely reflects the amount of 
international literature available on the topic. Similarly, no 
attempt has been made to rank the services under each heading. 
They have been arranged alphabetically. 
2.2.2 Services for Specific Patient Groups 
2.2.2.1 Geriatric Patients 
The increasing numbers and proportion of elderly 
people in the community have been identified as among the 
major current influences on the provision of health care 
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services. Patients in this group are more likely to suffer 
multiple disease states and thus be on multiple medication 
regimens (40-42). Special problems of the elderly associated 
with their medications include difficulties in opening 
containers, in reading labels and package inserts, in hearing 
verbal instructions, and in comprehending and remembering 
administration details, especially for multiple therapy 
(40,43-49). In addition, multiple therapy (prescribed and 
nonprescribed) may increase the risk of side effects and drug 
interactions, and body changes due to aging may result in a 
different response to medication than in other age groups 
(40,41,47-52). Shimp et al (52) in a study of fifty-three 
elderly patients with multiple chronic disease states and 
multiple drug therapy, found that the number of prescription 
medications taken by a patient was a strong predictor of the 
number of potential medication-related problems. 
Socio-economic factors have also been implicated in 
contributing to noncompliance with medication regimens 
(40,42). Studies of medication compliance by the elderly have 
reported administration errors ranging from 25-59% 
(40,44,49). 
Functions for the pharmacist in the care of the 
elderly in various settings were suggested by Lamy (49). 
Primary care functions to the well, ambulatory elderly were 
described as provision of drugs, education, monitoring, 
preventive services, nutritional advice, and referrals. 
Long-term care functions to the chronic patient with multiple 
diseases and disabilities were described as provision of home 
health care services including total parenteral nutrition and 
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oxygen, and provision of pharmacotherapeutic consultant 
services to the physician, patient, and family. For 
institutionalized long-term care patients, similiar services 
would be provided to the patient and to the institution. Some 
of these functions are considered as specialized services in 
their own right (49). 
A survey of 432 American pharmacists associated 
with geriatric practice (response rate 64.4%) (50) identified 
the most difficult areas as inadequate geriatric knowledge, 
patient compliance, overprescribing, communication with the 
elderly, and lack of professional and/or financial 
recognition. Interviews with 300 elderly persons in a 
Mississippi county revealed limited communication between them 
and their pharmacists about prescription and nonprescription 
drugs (47). 
While papers have been published offering 
information to pharmacists for effective communication with 
geriatric patients (40,44,45,50,54,55), prescription and 
nonprescription drug monitoring (40,56), and improvement of 
compliance (40,51), little evidence was found of individual 
community pharmacists concentrating on this area of practice. 
Pharmacies employing paramedical personnel, such as a 
chiropodist (57), and a nurse to administer free 'flu 
vaccinations to elderly patients (58), have been reported. 
However, many nursing homes and other institutions 
not having a pharmacist on staff are serviced by community 
pharmacists in Australia, either through their pharmacies or 
on a "sessional practice" basis at the institution concerned. 
The provision of otherwise unavailable clinical services has 
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been cited as advantageous to both the institutions and the 
pharmacists involved (59,60). These services are, of course, 
not restricted to geriatric patients. In 1984, PSA (Qld. 
Branch) established guidelines for practitioners providing 
services to nursing homes and private hospitals to ensure the 
quality of those services. The statement of professional 
practice covered dispensing, drug therapy monitoring, quality 
control, counselling, clinical and drug administration 
services (61). 
2.2.2.2 Domiciliary Care Patients 
Care of patients in the home setting has been 
recognized as an acceptable alternative to hospitalization 
(62). The increasing costs of medical care, the aging 
population, and public demand for health care have been cited 
as major factors in this trend (63). Advantages listed have 
included less disruption and more convenience to the patient, 
a closer to normal lifestyle, and cost savings. Because of the 
trend towards domiciliary care for ambulatory patients, both 
the elderly and the handicapped, predictions have been made of 
the need for greater involvement by pharmacists in helping 
patients manage their medication (64-67). The 1984 President 
of PSA (Qld. Branch) foresaw an extension of in-home services 
beyond delivery of medication to include counselling, removal 
of out-of-date or no longer used medicines, and advice on diet 
and patient aids (60,68). Domiciliary care services from 
hospital pharmacies in Australia have concentrated mainly on 
haemodialysis and peritoneal dialysis until recently, but are 
likely to be expanded to include parenteral nutrition. 
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cytotoxic therapy, intravenous antibiotic treatment, and 
continuous infusion of analgesics, and to involve community 
pharmacists in provision of services (69). 
Although the trend may be only in its infancy in 
Australia, various agents including home care companies, 
manufacturers of parenteral nutrition fluids, district nurses, 
and both hospital and community pharmacists have been involved 
in the provision of both therapy and equipment in the United 
States and Great Britain (63,70). British pharmacists have 
been providing domiciliary oxygen services for some time (71). 
Discussion of the home health care role has been proceeding in 
the United States since the early 1970s, initially through 
hospital-based pharmacists, and later through home health 
agencies (72-76). Additional aspects suggested by Wertheimer 
(72) included monitoring drug therapy, documenting allergies, 
reviewing contraindications to newly prescribed drugs, and 
educating the patient's family as well as the patient. Zage 
(63) listed potential areas for involvement as including 
antibiotic therapy, chronic ambulatory peritoneal dialysis, 
continuous infusion diabetes therapy, chronic pain therapy, 
and cardiac monitoring. The Academy of Pharmacy Practice 
within APhA adopted a Statement on Pharmaceutical Service in 
Home Health Care in 1979 to clarify their role (77). 
A survey of Canadian consumers, reported by Parker 
(62), found that 23% of respondents thought that pharmacists 
should provide private consultations and services in the home. 
Of those desiring such a service, 56% were prepared to pay a 
separate fee for its receipt. 
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2.2.2.3 Paediatric Patients 
Although community pharmacies serve as a source of 
baby care needs and trade magazines have been involved in the 
promotion of baby products, little attention has been given to 
the possibility of pharmacists concentrating their attention 
on child health. Suggestions have been made regarding roles 
for the pharmacist in encouraging compliance with medication 
regimens, especially for children with chronic conditions 
(78); in paediatric health education in areas such as 
nutrition, fluoridation, immunization, and poisoning (79); and 
in specific disease states (80). Thirty-three percent of 
respondents interviewed in pharmacies by Darby (81) supported 
the concept of a baby care section in pharmacies, with a 
trained clinic sister in attendance. Use of a professionally 
orientated counselling area for a visiting clinic sister has 
been reported (57). 
An example of an American pharmacist establishing a 
practice focussed on paediatrics has been reported (82). The 
services offered by the practice were a 24-hour emergency 
prescription and consultation service, counselling of parents 
and children, and supply of equipment such as compressors, 
nebulizers, and bed-wetting alarms. Another pharmacy, while 
not concentrating so specifically on the paediatric area, was 
reported to supply a folder of useful paediatric information 
to pregnant women and new parents entering the pharmacy as a 
means of making them aware of the availability of paediatric 
advice (83). Information supplied included paediatric drug 
dosing, immunization schedules, and suggested items for a 
paediatric medicine cabinet. 
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2.2.3 Services Related to Specific Conditions 
2.2.3.1 Asthma and Allergy 
Pharmacists have become involved in the alleviation 
of asthma and allergies through the marketing of aids such as 
impermeable mattress casings and anti-dust surface sprays 
(85,86), sale or hire of nebulizers (87,88), and through 
counselling patients on the use of inhalation devices for the 
administration of medications. The importance of counselling 
on the use of these devices has been illustrated by research 
studies (89-92) which showed the effectiveness of personal or 
videotape demonstration in promoting correct technique. 
A possible growth area has been seen as the sale of 
peak flow meters (93), or in performing peak flow measurements 
in the pharmacy, as this technique of measuring lung function 
has been predicted to become as much a part of asthmatic 
control as blood glucose monitoring is in diabetic control 
(94). In 1977, some pharmacies in the USA expressed their 
intention of offering lung testing using carbon dioxide 
measurements (95). A report from California described an 
elective course within the pharmacy curriculum which provided 
training in physical assessment, one aspect of which was 
asthma monitoring (96). An American survey, quoted by Huston 
(97) in 1985, found 4% of pharmacies to be involved in allergy 
screening programmes, and 5% in lung function testing. 
Individual Australian pharmacists have been 
reported as having special involvement in the treatment of 
asthma and allergy patients (86,87,98). A newspaper. Breathing 
leaxe^, distributed to the public through pharmacies, aimed to 
assist in the education of asthma sufferers (94,99). 
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2.2.3.2 Diabetes 
UNITED STATES 
Encouragement was given to American community 
pharmacists to participate in Diabetes Week efforts to detect 
undiagnosed diabetics, using blood glucose testing techniques, 
as early as 1969 (100,101). However, mass screening programmes 
relying on less precise urine testing were still being 
conducted and evaluated as late as 1977 (102). Prior to 
Diabetes Week in 1971, Pharmacy Times (103) published a list 
of suggestions as to how pharmacists could help diabetic 
patients. The list was compiled from responses to a letter 
sent to a random sample of pharmacists and included ideas such 
as maintaining lists of diabetic patients for informational 
purposes, maintaining patient profiles, advising on aspects of 
care including use of equipment and mixing of insulins, and 
establishing a diabetic department in the pharmacy. 
The ready accessibility of the pharmacist to 
patients, coupled with the facts that diabetic patients are 
frequent visitors to the pharmacy for insulin and other needs 
and could benefit from extra support, have frequently been 
cited as an important reasons for improving the services to 
diabetics from this source (104-108). Suggestions for ways to 
augment the supply role of pharmacies to diabetic patients 
with a service component, including patient education, have 
been documented (106,109-114). A study by Zelnio et al (105) 
showed that both diabetic patients and physicians were 
favourably disposed to pharmacy based diabetes informational 
services, but less so to screening and monitoring activities. 
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Pharmacists have been urged to advise diabetic 
patients in the areas of insulin use (104,108,110,115,116), 
choice and care of syringes (110), oral hypoglycaemics 
(108,110,115), hypoglycaemia (108,115), urine glucose 
monitoring (104,110,115,117), blood glucose monitoring 
(104,110,116,118), diet (110,115), foot care (110,115,116), 
eye care (119), general hygiene (115), and choice of 
nonprescription medication (120). Maintenance of detailed 
patient profiles for diabetic patients has been advocated 
(104,110). A range of special aids for visually impaired 
diabetic patients has been described (119). Campbell described 
the pharmacist's health education role in diabetes as being 
mainly supportive of that of other health professionals, and 
aimed at helping patients to accept responsibility for 
self-care by their availability for consultation and their 
knowledge of nonprescription drugs (108,110). Leichter (118) 
also described the pharmacist's role as being part of the 
health care team. 
The American Pharmaceutical Association (APhA), in 
co-operation with various pharmaceutical companies, has 
developed a self-study continuing education programme to 
motivate and educate pharmacists to take greater 
responsibility in assisting diabetic patients with management 
of their condition (114,121-123). APhA has also developed aids 
for counselling including a drug monitoring checklist (124) 
and a self-assessment programme for pharmacists (125). The 
importance of tailoring education to the needs of the specific 
patient has been addressed by Torre and Sause (126), who 
prepared a questionnaire to assess the needs of patients. 
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Individual pharmacies in America active in diabetes 
have been profiled (95,96,106,127). "Medicine Shoppe" 
pharmacies expressed their intention of offering a foot 
pathology screening service, which would be of particular 
benefit to diabetic patients (95). George (128) reported that 
some pharmacists provided training in blood glucose monitoring 
technique without charge when patients purchased meters from 
them, while others charged $15 - $20 per half hour for the 
time taken in training. Some pharmacists also charged for 
blood glucose measurements performed in the pharmacy (127). A 
survey quoted by Huston (97) in 1985 found that 30% of 
pharmacies were involved in diabetes screening programmes, and 
a 1984 Drug Topics survey showed that 87% of pharmacies 
stocked diabetes diagnostic aids, but only 4% stocked 
glucometers (97). No methodological details of either survey 
were provided. It was estimated in 1986 that about 5% of 
Californian pharmacies performed blood glucose measurements 
(66). A survey of a nationwide sample of pharmacists in 1986 
showed that 59% of pharmacists believed that they played an 
active or very active role in advising patients about insulin 
therapy, and that 75% would like their role in advising 
patients with diabetes to increase (129). 
CANADA 
Roles suggested to Canadian pharmacists for 
participation in diabetic services have included assisting 
diabetic patients with their choice of nonprescription 
medications and with dietary advice, and alerting physicians 
to medications that may alter blood sugar levels (130). 
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UNITED KINGDOM 
Pharmacists in the UK have been reminded of the 
needs of diabetics for advice regarding insulin (131), syringe 
care (132), oral hypoglycaemic drugs (131), hypoglycaemia 
(132), monitoring (131,132), diet (132,133), foot care 
(131,132), eye care (134), and giving up smoking (131,132). 
Cantrill and Wright (132) found that, although all 
patients obtained their repeat prescriptions from their 
general practitioners, only about one third of them saw the 
doctor at this time. As contact with the pharmacist was likely 
to be more frequent, they advocated the pharmacy as the 
appropriate site for diabetic health education. 
Despite the demonstrated superiority of blood 
glucose measurements over urine glucose tests, the consequent 
improvement in control, and the resultant likelihood of 
decreased incidence of long-term complications, economic 
debate continues in the UK over the inclusion of blood glucose 
monitoring strips in the Drug Tariff (135,136). 
SOUTH AFRICA 
Miller (137) reminded South African pharmacists of 
their responsibilities to diabetic patients and to the 
community, encouraging participation in advising, educating, 
screening and monitoring. He felt that the assistance of 
pharmacists would be beneficial to patients responsible for 
control of their disease state, especially in the areas of 
urine and blood glucose monitoring. Blood glucose levels as 
referral criteria were suggested. 
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AUSTRALIA 
The potential for increased involvement by 
pharmacists in the management of diabetic patients was 
recognized in the 1970s in conjunction with their developing 
clinical role (138). Reporting on a Scottish study of urine 
glucose testing by patients, Thomas (138) observed that, in 
view of the poor results of patient measurements, pharmacists 
could assist by instructing patients in correct assay 
techniques or by offering an assay service. Later studies 
elsewhere continued to highlight problems with patient urine 
testing techniques (117). 
The introduction of U-100 insulins into the PBS in 
1980 required extra counselling of insulin dependent diabetic 
patients during the changeover period (139). It was observed 
at that time that diabetics could also be expected to play an 
increasing part in self-management of their condition by 
regular blood glucose monitoring and home treatment of 
diabetic emergencies, and would benefit by assistance from 
pharmacists taking an interest in diabetes (140). 
Pharmaceutical companies have played a large part 
in encouraging the development of diabetic centres in 
community pharmacies in Australia (141-144). The Ames Division 
of Miles Laboratories set up a system of diabetes self-care 
centres in selected community pharmacies which was based on a 
scheme developed in the United States, but modified as a 
result of research into the needs of Australian diabetics. A 
major aspect of the centres was the provision of advice on the 
use of blood glucose monitors at the point of sale, in line 
with the growing use of blood glucose monitoring techniques by 
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Australian diabetics. Ames reported the existence of 100 such 
centres throughout Australia in 1983 (142) and 200 in 1984 
(143). In 1984, they announced plans for a major expansion of 
the scheme to assist all interested pharmacists by introducing 
special services, product sections, counselling routines and 
educational programmes for both pharmacists and patients, and 
by promotion of the centres (143-145). Follow-up services and 
advertising assistance were provided to participating 
pharmacies (146). Pharmaceutical companies have also assisted 
in the education of diabetics and health practitioners through 
the production of booklets and video tapes (147,148). 
Anecdotal accounts have been published of diabetic 
activities, including blood glucose measurement, in individual 
pharmacies in Australia (146,149-154). A survey conducted in 
NSW and ACT in 1982 by Ortiz et al (155) found 0.6% of 
pharmacies to be involved in blood sugar testing and 0.7% in 
urine testing. Sissian (154) reported an average of 3% 
abnormal glucose readings during a period of four years of 
screening in his pharmacy. A company marketing various health 
care machines reported about twenty pharmacies in Australia 
using their equipment for diabetic screening in 1983 (156). 
Approval of provision of diabetic services through 
community pharmacies has been expressed (157,158), but Gibson 
(66) felt that greater emphasis should be placed on diabetic 
screening and monitoring in Australian pharmacies. 
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2.2.3.3 Hypertension 
UNITED STATES 
In the USA, the impetus for pharmacist involvement 
with hypertensive patients was provided by the Task Force 
Report for the National High Blood Pressure Education Program 
in 1973 (159). Pharmacists were encouraged to participate in 
National High Blood Pressure Month in May 1974 and provided 
with the information to assist them to do so by a series of 
articles published in J.Am.Pharm.Assoc. which covered such 
topics as counselling, screening, and monitoring (160-166). A 
National Pharmacy Symposium on High Blood Pressure held at 
that time formulated recommendations on the role of the 
pharmacist in hypertension and on education of pharmacy 
students, pharmacists, patients and the public (167). Pharmacy 
continued to be involved in the National High Blood Pressure 
Education Program in later years (168-171). 
Evaluation of a twelve pharmacy screening programme 
in the New Orleans area, published in 1978, showed a 24% 
referral to physicians due to readings above 160/95. Follow-up 
of this group (52% response) showed that 84% of them had 
visited their physicians, who confirmed 70% of those to be 
hypertensive, but only 6% were newly-diagnosed. Encouragingly, 
97.5% of respondents felt that the screening programme had 
been beneficial and would participate in later pharmacy 
screening programmes (172). Another study, published in 1976, 
using one pharmacy drawing on the population of a Virginia 
county, showed the advantage of recalling patients for 
repeated measurements in the pharmacy prior to referral. By 
recording blood pressure on three visits, 5% of those screened 
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were referred for medical assessment due to readings above 
160/95, whereas 16% would have been referred on the initial 
reading. All of the referred patients were subsequently 
confirmed as hypertensive, A disadvantage of this approach was 
identified as the time involvement required by the pharmacist 
(173). These studies confirm the effectiveness of pharmacy 
screening programmes in detecting hypertensive patients. A 
1976 study by Zelnio and Gagnon (174) attempted to evaluate 
consumer attitudes towards blood pressure screening by 
pharmacists, but failed to produce conclusive results. 
McKenney et al (175) demonstrated the success of 
pharmacists in improving blood pressure control by medication 
monitoring and patient education. They felt that the 
improvement observed could be primarily attributed to improved 
medication compliance. 
A 1985 survey quoted by Huston (97) found 64% of 
pharmacies to be involved in blood pressure screening, and a 
Drug Topics survey was quoted as finding that 90% of 
pharmacies stocked home blood pressure monitoring devices 
(97). No details of either survey were provided. It has been 
estimated (66) that 8-10% of pharmacies in California were 
involved in blood pressure measurement in 1986, a level 
similar to that found in NSW and ACT by Ortiz et al (155). 
Monitoring of blood pressure and medication 
compliance by individual pharmacies in the United States have 
been reported (58,84,95,176-178). In at least one instance, 
the monitoring service was only offered at certain times 
during the week, Patients could make appointments or report 
during the designated hours (58). Baker (176) found that 
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charging a small service fee was acceptable to his patients. 
George (128) also reported charges of 50c to $5 being applied. 
A discussion of the liability aspects of blood pressure 
monitoring by pharmacists concluded that legal issues should 
not deter pharmacists from offering extended professional 
services, as long as those performing them were adequately 
trained, and that charging a fee did not imply a greater need 
for care than would have otherwise existed (179). 
Advice on setting up monitoring services, including 
guidelines for physician referral, has been provided 
(84,173,176), as have suggestions for effective counselling on 
medication (180,181) and home monitoring (182). APhA has a 
source book on hypertension for the use of pharmacists (183). 
UNITED KINGDOM 
An examination of the feasibility of blood pressure 
measurement by community pharmacists in the UK, carried out in 
nine pharmacies in 1981, showed that pharmacists were capable 
of measuring blood pressure within acceptable limits, that 5% 
of people screened were later confirmed as being hypertensive, 
and that 98% of the lay public sampled approved of pharmacist 
in such a role (184). It was concluded that, in collaboration 
with medical practitioners, pharmacists could provide a 
valuable community service in this field. 
A pilot study aimed at promotion of health 
education in pharmacies was conducted in the West Midlands in 
1982, and included blood pressure monitoring (185). Public 
acceptance was encouraging. In a national survey of 180 
pharmacies in the UK in 1982, blood pressure testing in 
pharmacies was suggested as an appropriate activity by 11% of 
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respondents (186). Teeling Smith (187) advocated extension of 
the availability of the service in community pharmacies. 
Former President of PSGB, David Sharpe (188), saw blood 
pressure measurement as a purely technical manipulative skill 
well within the ability of the pharmacist to perform, and 
recommended that if automatic equipment were used it should be 
sited near the dispensary to ensure that the pharmacist would 
be on hand for interpretation and counselling. 
The Pharmaceutical Society of Great Britain 
formulated guidelines in 1979 for the measurement of blood 
pressure in pharmacies (189). 
Individual providers have been reported (190). 
SOUTH AFRICA 
The need for pharmacists to become involved in 
hypertensive screening has also been raised in South Africa 
(137). Pharmacists were advised that, to give an effective 
service, they would need knowledge of the disease state and 
its symptoms, rationale for the use of antihypertensive drugs, 
dietary measures, treatment of hypertensive emergencies, and 
techniques of blood pressure measurement. They were also 
advised to set criteria for referral purposes. 
NEW ZEALAND 
A survey of 101 pharmacies (72% response) in 
Wellington, New Zealand, found only two pharmacies offering 
blood pressure testing (191). 
AUSTRALIA 
Recognition of the potential of the pharmacist to 
assist in the monitoring of chronic conditions, specifically 
hypertension, apparently occurred in Australia in the 
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mid-1970s. Thomas (192) suggested that measurement of blood 
pressure by pharmacists could encourage patients to have more 
regular checks without the responsibility of home measurement, 
enable better supervision of both prescribed and nonprescribed 
medicine use, and alleviate the load of general practitioners. 
In a subsequent article (193), he reported on two American 
studies which appeared to support his premise, showing 
improvement in the patients' knowledge, compliance and control 
as a result of pharmacist involvement, and the detection of 
adverse drug reactions and potential interactions with 
nonprescription medications. 
Pharmaceutical companies also appeared to recognize 
the potential of pharmacists to encourage compliance with 
medication regimens (194). Manufacturers of blood pressure 
monitors and pulse rate measuring machines have encouraged 
their installation in pharmacies (156,195-197), but cautions 
have been issued regarding use of patient-operated machines 
(198). For patients electing to monitor their own blood 
pressure, concern was expressed that professional advice 
should be given on the correct use of home monitors to ensure 
accurate readings, and that pharmacy was thus a suitable 
outlet for sale of such devices (199). 
A pilot study of hypertensive screening in seven 
Sydney pharmacies during three months in 1977 showed a 13% 
referral for medical assessment, and an increase in use of the 
service with increasing public awareness of its availability 
(200,201). Although Robertson concluded that pharmacists would 
be justified in charging a fee for blood pressure measurement, 
doubts were expressed about the legal position (202). A later 
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more comprehensive study of 45 pharmacies by Robertson in 1983 
(203) found that the use of automated blood pressure 
monitoring machines in pharmacies contributed to the detection 
of undiagnosed hypertensives in the community, and to 
hypertensive management in conjunction with physicians. 
Interviews with pharmacy customers by Darby (82) in 1982 found 
that 43% of respondents supported the provision of heart and 
blood pressure testing by pharmacists. Ortiz et al (155) 
reported 11% of pharmacies to be performing blood pressure 
measurement and 2% to be performing pulse rate measurement in 
a 1982 survey of pharmacies in NSW and ACT. Sissian (154), in 
1987, reported an average of 16% abnormal readings over a 
period of three years screening in a community pharmacy. 
Activity by individual Australian community 
pharmacists in hypertensive screening and monitoring has been 
reported (149,153,154,195,197,204-207). The assessment of 
blood pressure in pharmacies has been encouraged (157), and 
guidelines for measurement formulated by PSA (208). 
2.2.3.4 Oncology 
The main role of the community pharmacist with 
regard to cancer is an educative one. Pharmacists as a group 
have participated in specific programmes about breast 
self-examination (209), skin cancer prevention (210), smoking 
cessation (211-214), and in general education on prevention 
and early detection of cancer (215-217). 
Home test kits for detection of colorectal cancer 
have been made available to the public through pharmacies 
(218,219). Such tests could also be performed in the pharmacy 
(157). Aa American survey quoted by Huston (97) found 17% of 
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pharmacies to be involved in colorectal cancer screening 
programmes, and a 1984 Drug Topics survey found that 29% 
stocked home detection kits (97). No methodological details of 
either survey were provided. "Medicine Shoppe" pharmacies in 
the USA expressed their intention of offering oral cancer 
screening (95). 
The importance of the counselling role, not only in 
respect to medication, has been stressed (220,221) and 
pharmacists encouraged not to avoid interaction with patients 
in difficult situations. A pharmacist in California was 
reported to have employed a psychologist to counsel patients 
on the many problems presented in the pharmacy which he felt 
unable to deal with (128). Better communication between 
patient, pharmacist and oncology team has also been advocated, 
especially in relation to pain control (222). 
Other suggested ways for community pharmacists to 
help cancer patients have included monitoring toxic effects of 
chemotherapy, supplying appropriate nonprescription medication 
or referral advice, supplying narcotics, encougaging 
compliance, and offering support (223). A possible role for 
pharmacists in drug monitoring for cancer patients has been 
noted (128). 
Ong (224) outlined a potential role for community 
pharmacists involving prevention, detection and care aspects: 
A. Prevention 
(i) Improve the impact of public health education, 
(ii) Encourage practice of avoiding cancer causing 
agents. 
(ill) Modification of behaviour. 
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(iv) Participation in cancer screening programmes. 
B. Detection 
(i) Screen for early warning symptoms, 
(ii) Encourage regular medical examinations. 
C Care 
(i) Supply medications and allied products, 
(ii) Patient counselling, 
(iii) Psychological support. 
At least one medical centre pharmacy in the USA has 
established a practice almost exclusively dealing in cancer 
chemotherapy, even to the extent of dispensing investigational 
new drugs (225), and the supply of home health care aids and 
special nutritional needs to cancer patients (220). While the 
role of hospital pharmacists has been recognized (226), 
Australian community pharmacists having special involvement 
with cancer patients have not been reported. 
2.2.3.5 Ophthalmology 
Participation by pharmacists in aspects of eye care 
has been mainly directed towards the care of contact lenses. 
The increasing popularity of contact lenses has led to 
increased sales of after-care products through pharmacies. 
Educational articles have attempted to provide pharmacists 
with the necessary information to offer advice in this area 
(227,228). Increased co-operation between optometrists and 
pharmacists has been advocated, especially in regard to 
contact lens care (229). 
Some pharmacies in the USA, particularly a number 
of larger pharmacy chains, have expanded their optical 
departments to include supply of spectacles since 1976 (230). 
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APhA, in conjunction with the National Society to 
Prevent Blindness, launched a pharmacy Glaucoma Alert Program 
in 1980 to help pharmacists train patients to protect their 
eyes. The programme drew attention to the early warning signs 
of glaucoma, the leading cause of irreversible blindness, and 
encouraged biennial testing. Pharmacies were used as sites for 
screening as well as education (231). A survey quoted by 
Huston (97) in 1985 showed 5% of pharmacies to be involved in 
eyesight screening programmes. Also, 8% were involved in 
hearing testing. No details of the survey were available. A 
group of small pharmacies, "Medicine Shoppes", were reported 
as offering both vision and hearing tests, and expressed their 
intention of offering glaucoma screening (95). 
Pharmacists in the United Kingdom were also asked 
to encourage testing, especially of relatives of known 
glaucoma sufferers, and to be alert to the possibility of 
glaucoma when counselling patients with eye complaints (232). 
2.2.3.6 Ostomy 
Considerable distribution of ostomy aids through 
pharmacies has been reported in the United States (77,96,233). 
The market for ostomy products in the USA was estimated in 
1982 to be growing at 4-5% annually (234), and to include 
pouches, skin products, adhesives, barriers, deodorants, and 
items for irrigation and night drainage. A study quoted in 
NARD Journal (234) found that successful pharmacies involved 
in ostomy care committed at least twelve feet of floor space 
to ostomy products, and stocked a range consisting of at least 
fifteen lines. However, White (233) warned that the field was 
not one to be entered lightly, as considerable knowledge and 
1 16 
training would be required in order to provide counselling in 
ostomy management. In California, some pharmacists received 
training through companies suppying equipment, and some 
pharmacies employed qualified enterostomal therapists 
(96,234). Advice for pharmacists on colostomy management has 
been offered (235), 
The British NPA has encouraged pharmacists' 
attendance at its courses on stoma care (236). 
Although a number of items are available to ostomy 
patients on the PBS, the major means of supply in Australia is 
through ostomy support groups (237). The scope for involvement 
by pharmacists in this field has therefore been limited, 
although advice for helping these patients has been offered to 
Australian pharmacists (158,238). 
2.2.3.7 Pregnancy Testing 
Conducting of pregnancy tests by pharmacists began 
in Australia in the early 1970s (239), but not in all States 
(240). Although such an activity was seen by some as 
appropriate for pharmacists, it was approached with caution by 
others (239,241), and caused varied reactions from medical 
practitioners (241-244) and consumer groups (245). Despite the 
introduction of home test kits, and later improved home test 
kits (246), there appears to have been a continued demand for 
in-pharmacy testing services. 
The trend in Australia appeared to follow that of 
Canada, where most pregnancy testing was also done in 
pharmacies rather than at home, and not that of the United 
States and Europe, where pharmacy pregnancy testing was less 
usual (247). An American survey quoted by Huston (97) in 1985 
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showed that 95% of pharmacies stocked home pregnancy test 
kits. No details of the survey were provided. An indication of 
the acceptability of the service in the United Kingdom may be 
gauged by the inclusion in a 1970 PSGB Statement upon Matters 
of Professional Conduct of a clause allowing "a discreet 
notice relating to Pregnancy Testing Services" to be displayed 
in any pharmacy (248), and by its specific mention in the 
Society's 1982 policy statement on Clinical Pharmacy in 
Community Practice (249). At that time it was estimated that 
about one third of British pharmacies were offering a 
pregnancy testing service (188). A national survey of 180 UK 
pharmacies in 1982 found 61% to be in favour of playing a 
greater role in conducting pregnancy tests (186). 
Provision of pregnancy testing services in 
Australian pharmacies was recommended in 1982 by a visiting 
British physician (157) and supported by 26% of consumers 
interviewed in Sydney (NSW) pharmacies by Darby around that 
time (82). In 1983, 27% of pharmacies in New South Wales and 
13% of pharmacies in Victoria were said to be involved in 
pregnancy testing on the premises (246), although a 1982 study 
by Ortiz et al (155) had found the figure to be much higher -
64% of pharmacies in NSW and ACT. In 1984, about half of all 
in-pharmacy pregnancy testing in Australia was being performed 
in NSW, 10% in Western Australia and 4% in Queensland, but 
virtually none in South Australia (250). 
A centre for pregnancy testing, established by a 
pharmacist and a nursing sister, was reported (251) as an 
offshoot of pharmacy testing services. 
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2.2.4 Services Related to Product Ranges 
2.2.4.1 Alternative Medicine 
The growing scepticism by the public of the 
infallibility of conventional medicine and concern about the 
toxicity of modern medications have resulted in an increasing 
interest in holistic medicine, nutrition, herbalism, 
acupuncture, and alternative medical services such as 
homeopathy, osteopathy, naturopathy and chiropracty (252). 
Wiesner (252) felt that the scientific background of 
pharmacists should enable them to evaluate the claims being 
made for unconventional forms of medicine and to provide 
advice to the public on vitamins, dietary supplements, and 
orthomolecular nutrition, especially if post-graduate courses 
were made available to them. Advantages would be apparent in 
both professional and commercial aspects. However, PSA (253) 
cautioned that, until clinical trials have demonstrated the 
efficacy of alternative treatments in man, pharmacists should 
adopt a "defensible" position, and "not one based purely on 
financial considerations". 
Pharmacists in the USA have also expressed 
differing opinions as to the appropriate position for 
pharmacists to take in this regard (254,255). In 1984, Gardner 
(256) reviewed a number of alternative therapy methods 
including naturopathy, homeopathy, herbalism and 
orthomolecular medicine, in an attempt to provide an insight 
into the legal position of both the practices and the products 
involved. Definitive conclusions were not able to be drawn. 
Reports of individual pharmacists venturing into 
fields of alternative medicine have included homoepathy 
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(190,257,258), and suggestions for employing therapists, such 
as a naturopath (149), within the pharmacy. 
2.2.4.2 Dentistry 
Community pharmacy was formerly the usual place to 
buy tooth brushes and tooth paste. Although this distribution 
was largely transferred to supermarkets, many dental products 
for prevention of caries and for treatment of sensitivity 
problems have continued to be sold through pharmacies 
(259,260), A case has been put forward for increased 
inter-professional contact between dentists and pharmacists 
(260-264) in these areas, and for participation by pharmacists 
in counselling on the importance of fluoride (265) and on the 
correct use of dental products (260-262,266). 
Courses in aspects of dentistry have been offered 
by various pharmacy colleges in the USA (266,267), and a 
dental formulary has been prepared by the Memphis Chapter of 
the National Pharmaceutical Association in order to help 
practitioners to provide optimal dental care (268). 
Suggestions have been made for the establishment of an oral 
hygeine centre in the pharmacy (266). 
In the UK, a call for better dental education of 
pharmacists was sounded as the result of a survey indicating 
that pharmacists' knowledge of dental health education was 
weak, and that they were keen to improve it (269). 
2.2.4.3 Family Planning 
UNITED STATES 
Surveys of pharmacists in Washington (270) and 
Pennsylvania (271) in the early 1970s found that pharmacists 
were rarely asked for contraceptive advice, that spermicidal 
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preparations were openly displayed for sale, but condoms and 
diaphragms much less frequently as this had previously been 
illegal. Nearly one third of the Pennyslvania respondents felt 
that contraceptives should be restricted to pharmacy sale 
only. A review by Smith et al (272) noted that the New York 
State Pharmaceutical Association also approved of this 
approach, citing the pharmacist's counselling role as the 
reason. However, such restriction did not occur. Other studies 
around this time, reported by Smith et al (272), were 
conducted in Hawaii, Utah and Maryland where there also 
appeared to be limited use of the pharmacist as a source of 
information on contraception. Pharmacists in these studies 
generally appeared to feel that family planning would be an 
appropriate part of their practice, but that they would 
require further education for effective involvement. A study 
of pharmacists in Mississippi in 1978, with a 97% response 
rate, found that 92% thought involvement in family planning 
counselling to be appropriate for pharmacists. A need was 
recognized by 82% for more of these services in their 
community, but one third felt that they were not adequately 
prepared to provide such counselling. A willingness to expand 
their role was expressed by 84%, with 90% willing to 
participate in continuing education programmes (272). 
By the late 1970s, advice on counselling and 
display of condoms and other contraceptives was being provided 
to American pharmacists via journals and film (273,274). A 
potential role was also seen for pharmacists to educate the 
public about sexually transmitted diseases as well as 
contraception (275,276). The use of condoms as a preventive 
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measure had been promoted by Californian pharmacists for some 
time (272). 
CANADA 
In Canada, from the 1970s, family planning groups 
and others were active in educating pharmacists as counsellors 
(277-279) and advising on display of contraceptives, which was 
legalized in 1969 (279,280). A 1975 study of Canadian 
pharmacists revealed that 54% were involved in the provision 
of family planning information to patients, but that 96% would 
have liked to have been involved (272), 
UNITED KINGDOM 
PSGB wished to encourage the involvement of 
pharmacists in family planning, and also attempted to 
encourage the public to regard pharmacies as the logical 
source of such advice (281). In conjunction with the Family 
Planning Association (FPA), the Society surveyed pharmacies in 
1981 about their role in the provision of family planning 
information and advice, and their opinions on its future 
development. The survey, with an 89% response rate, found that 
over 99% of pharmacies stocked contraceptives, about half of 
the pharmacists had been asked for advice on contraception in 
the previous year, and three quarters of the respondents were 
keen to increase their role in this sphere (282,283). 
Following a pilot scheme in 1983, aimed at extending the 
pharmacists' role (284), PSGB and FPA recommended the 
establishment of a national family planning service through 
pharmacies ( 285 ) . 
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AUSTRALIA 
The introduction of the oral contraceptive appeared 
to prompt comment in the 1970s on the appropriateness of the 
pharmacist as a counsellor on the use of other family planning 
methods as well as the pill. The President of FPA said in 1974 
that "pharmacists had a tremendous responsibility to be well 
informed about contraception and to dispel ignorance on the 
subject wherever possible" (286). A contraceptive 
manufacturer, observing that the pharmacy was the logical and 
most frequent place to obtain contraceptives, prepared a 
teaching kit about this time to aid pharmacists in accepting a 
counselling role (287). PSA began to examine the potential for 
participation by pharmacists, and the professional and ethical 
aspects in 1976 (288), and by October 1977, the South 
Australian Branch had established a training course in 
conjunction with the FPA of South Australia (289). Porter 
encouraged the education of both pharmacists and assistants to 
enable them to provide accurate contraceptive information in a 
non-threatening way (290), and support was expressed for 
family planning services in pharmacies (60). 
A 1983 survey conducted in Western Australia by the 
Department of Social and Preventive Medicine, University of 
Western Australia, found that community pharmacists were 
active in giving family planning advice, and that the range, 
display and accessibility of contraceptives were good. 
However, the survey, which attracted an 80% response rate, 
found deficiencies in several aspects of the pharmacists 
knowledge, and 80% of pharmacists said they had gained their 
knowledge in contraception from sources other than formal 
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pharmacy or continuing education courses (291). 
Experiences in several countries since the early 
1970s indicate that, as most contraceptives are obtained from 
pharmacies, and since the pharmacist is easily accessible to 
the public, community pharmacy is an appropriate source of 
family planning advice. The need for adequate education of 
pharmacists to fulfil this role has been emphasized. The 
potential for action by pharmacists in educating the public 
about sexually transmitted diseases is sure to be increased by 
the current anxiety about A.I.D.S. and publicity about the use 
of condoms (292,293). 
2.2.4.4 Home Health Care Equipment 
A wide variety of equipment has been suggested as 
suitable for hire and/or sale through pharmacies: walking 
canes, crutches, walking frames, wheelchairs and appliances, 
air cushions, commodes, elevated toilet seats, bath seats, 
bath safety rails, Sitz baths, bedpans, urinals, waterproof 
sheets, nocturnal enuresis alarms, incontinence pads and 
liners, catheters, supports such as elastic bandages, elastic 
hosiery, braces, belts etc., cervical collars, traction kits, 
heat lamps, mastectomy prostheses, hospital beds and 
accessories (72,97,294-302). 
As the tendency towards home care rather than 
hospital care has expanded, the need for ready availability of 
home health care equipment, also referred to as durable 
medical equipment, has expanded (77). By 1981, an affiliation 
of independent pharmacies had established a network known as 
"Sickroom Services", covering 175 cities in 35 states of the 
USA, which specialized in hire and sales of home health care 
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equipment (296). Supply of surgical appliances, invalid aids, 
and sick room requisites was described as a clinical activity 
in the policy statement of PSGB regarding clinical pharmacy in 
community practice (249). A 1982 study of Australian pharmacy 
patrons by Darby (82) found that 19% of interviewees felt that 
surgical supplies should be available in pharmacies. A survey 
conducted by American Druggist in 1983 found that 63% of chain 
pharmacies and 60% of independents had departments primarily 
devoted to home health care needs (303). 
Eigen, president of "Sickroom Services", offered 
suggestions regarding choice of equipment, establishment of 
good inter-professional relations to encourage referral, and 
taking advantage of educational opportunities for pharmacists 
intending to enter or build up this area of their practices. 
He stressed that success was dependent on efficiency, 
expertise and commitment (296). The importance of expertise 
was well recognized, and a number of pharmacists have taken 
the initiative to become certified as orthotic fitters 
(297,304), or have employed orthotic fitters or protheses 
specialists in their businesses (96). Burroughs (305) 
described the essentials of a suitable fitting room. Spenlau 
(306) saw the requirements for running a successful health 
care practice as a desire to help people, product knowledge, 
an intelligent approach to business, and carefully chosen and 
trained staff. Other authors have also proffered advice to 
practitioners, including the importance of analysing and 
assessing the needs of the patient, and not relying solely on 
a prepackaged display of goods from one manufacturer to 
establish a successful business in this field (297,306-308). 
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Huston (97) saw space limitations and capital investment 
commitment as the greatest problems in setting up a home 
health care needs centre. The necessity to develop selling and 
publicity skills to assist sales has also been discussed 
(309,310). 
Because many reusable pieces of durable medical 
equipment may only be needed for short periods, or larger 
equipment may be too expensive for patients to buy, hire 
services have been offered in addition to sale of such items 
(300,306). Requirements for success have been listed as 
willingness to commit the necesssary capital, appropriate 
physical facilities for its storage and display, adequate 
product range, marketing knowledge, and trained staff (300). 
For a well-established department, a guideline of 50% of 
business from rental has been suggested, with a monthly rental 
rate of 10% of the list price, or an aim to recoup the 
wholesale cost after eight months of rental (306). 
Individual pharmacies or pharmacists involved in 
the home health equipment field have been profiled in the 
United States (297,308,311,312), Canada (313), and Australia 
(294,314,315). A 1987 survey showed a 30% increase over two 
years in the number of Western Australian pharmacies hiring 
health care equipment (302). 
Suggestions have been given to Australian 
pharmacists interested in becoming involved, with emphasis on 
the importance of displaying goods in a separate department, 
use of adequate space, effective marketing, and knowledgeable 
staff (295,301,315-317). Predictions have been expressed that 
Australian pharmacists may eventually fit convalescent 
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supplies and health supports, and may charge consultation fees 
for these health care services (295). Pharmacists have been 
advised to make preparations for future demand in this area, 
and the development of separate, pharmacy-owned patient aid 
outlets has been seen as likely (67). This trend has already 
occurred in the United States, with stores owned by pharmacy 
chains and by manufacturing companies (97,303,318). 
2.2.4.5 Nutrition 
The positive emphasis placed on health as being 
more than just the absence of disease has contributed to the 
increasing use of nutritional supplements and so called health 
foods. To enable pharmacies to compete with health food shops 
for the sale of these items, pharmacists have been encouraged 
to seek specialist knowledge to assist customers with their 
choice of appropriate nutrients through consultation 
(158,137,319-323). In a 1982 statement on health foods and 
herbal remedies, the Pharmaceutical Society of New Zealand 
emphasized that the stocking of a medicine or health-related 
product in a pharmacy conferred on it special status in the 
eye of the public, and that pharmacists had an obligation to 
employ knowledge and judgement in their selection and 
recommendation of products (322). 
As well as the supply of nutritional supplements, 
pharmacists may be called upon for advice on specialized diets 
such as diabetic, low sodium, low fat/low cholesterol, low 
kilojoule, high bulk/high fibre, and prenatal diets (137). 
Twenty-nine per cent of respondents interviewed in pharmacies 
in a study by Darby (82) felt that diet supplements and advice 
should be available in pharmacies. 
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In the USA, some community pharmacists have 
extended their interest in nutrition into the of provision of 
hyperalimentation, or total parenteral nutrition (TPN), and 
enteral nutrition supplies for home management, and 
suggestions have been offered for the benefit of those wishing 
to establish such services (324-327). Graves (325) outlined 
the pharmacist's responsibilities as preparation, delivery and 
administration of the TPN solutions, and counselling the 
patient in catheter care and equipment operation. As a result 
of this type of involvement, the sales of nutritional products 
in community pharmacies was quoted to have increased by 20% 
during 1983 (63). A Drug Topics survey in 1984 found that 4% 
of pharmacies stocked nutritional feeding systems (97). 
Many individual pharmacists have expressed special 
interest in the various fields of nutrition 
(58,96,206,258,321,324,327-329). Wallace (206) recommended the 
use of a computerized system for dietary analysis in 
pharmacies. Pharmacists in a Sydney business were reported to 
be considering employing a dietician in the pharmacy (149). 
2.2.4.6 Sports Medicine 
Since the early 1980s, companies marketing ranges 
of sports medicine goods have encouraged the setting-up of 
specific areas in pharmacies to cater for the therapeutic and 
prophyllactic needs of the ever increasing number of people 
involved in participatory sports (141,330-334). Suggestions of 
product categories required for a sports medicine supply 
centre have included: foot products, hot and cold packs, knee, 
ankle and elbow elastic supports, bandages, antiseptics, 
liniments, and vitamins (335). 
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Evidence of involvement by pharmacists in the field 
of sports medicine in Australia has largely been limited to 
discussion of the supply of articles and advice for treatment 
or prevention of minor sports injuries. No published reports 
were found of the provision of services such as pre-game 
strapping for sporting teams, although pharmacists in 
partnership in a Sydney business were reported to be 
considering employing an exercise physiologist on the premises 
(149). 
2.2.4.7 Veterinary Medicine 
While almost all Australian community pharmacies 
would be expected to stock some items for veterinary use, the 
extent of involvement, both in terms of product variety and 
advice, is likely to vary considerably. No reports of 
individual specialization by Australian pharmacists in this 
field have been found. The "Professional Report 1978" (336) 
reported sales of veterinary medicines to be less than 1% of 
the total medication sales in pharmacy, and considered this to 
be considerably below the potential level, even in country 
areas. An increased involvement in animal health by Australian 
community pharmacists has been encouraged (158). 
Fillingim (337), while discussing the role of 
specialist pharmacists in veterinary teaching hospitals in the 
USA, also recognized the potential for community pharmacists 
to take a greater part in animal care, and encouraged the 
building of professional relationships with veterinarians. 
APhA and the American Veterinary Medicine Association 
developed a Code of Interprofessional Relations in 1966 which 
recommended rules of conduct consistent with the ethics and 
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practice of the two professions (338). 
In 1980, PSGB established a post-graduate diploma 
course in veterinary and agricultural pharmacy to assist 
practitioners in those areas (339). The results of a pilot 
survey of pet owners in England in 1984 suggested that 
community pharmacists, because of their ready accessibility 
and because they could supply anthelmintics and insecticides, 
could play a role in educating pet owners about control of 
parasites such as worms and fleas (340). 
2.2.5 General Clinical Involvement 
2.2.5.1 Biological Testing 
Predictions were made in 1973 that the range of 
biological tests in pharmacies would expand beyond the 
pregnancy testing then being performed, to include screening 
for such conditions as kidney and liver ailments, as well as 
diabetes (242). 
A computerized, automated health screening service 
installed in a Sydney pharmacy was reported in 1983 to have 
the ability to measure not only blood pressure and blood 
glucose levels, but also to read routine urine tests using 
reagent strips, providing measurements of pH, blood protein, 
ketone, bilirubin nitrite and urobilinogen levels (149). 
Gibson (66) commented on the use of machines for in-pharmacy 
testing for glucose, uric acid, cholesterol, bilirubin, 
haemoglobin, creatinine, blood urea, nitrogen, and 
triglycerides. Sissian (154), reporting on six months of 
screening for cholesterol in a Sydney pharmacy, using a 
capillary testing meter, disclosed that 57% of males and 63% 
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of females tested had readings higher than the National Heart 
Foundation acceptable level of 5.5 mmol/1. 
It has also been suggested that pharmacists could 
be authorized to take throat cultures from self-medicating 
patients to assist in determining need for referral (341). 
In addition to in-pharmacy testing, home kits for 
pregnancy testing, detection of occult blood in the stools, 
and monitors for measurement of blood pressure and blood 
glucose have already been mentioned as being available through 
pharmacies. Gibson (66) noted the likelihood of other in vitro 
kits appearing on the Australian market to test for ovulation, 
urinary tract infection. Streptococcal throat, and venereal 
disease. Reports from the USA have listed the availability of 
home testing kits for pregnancy; blood and urine glucose 
levels; colorectal cancer; high blood pressure; gonorrhoea; 
sodium, calcium and vitamin C levels; urinary tract 
infections; vision; breast diseases; cellulite; and ovulation 
(342,343). Pharmacies have been recommended as the best place 
to market the test kits because of the availability of the 
pharmacist to make recommendations, explain how to use the 
tests, and interpret the results (342). 
2.2.5.2 Pharmacokinetic Evaluation 
A study by Edwards (344), reported in 1984, looked 
at the effect of a pharmacy-based pharmacokinetic service in 
the primary care of epileptic patients and concluded that 
there was potential for pharmacists to be involved with 
monitoring of blood levels for chronic therapy and advising on 
consequent changes to dosage levels. However, it was admitted 
that such an activity would not be possible in every community 
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pharmacy. Gibson (66) saw a future for the use of machines in 
the pharmacy which could provide rapid determination of drug 
levels for long-term patients such as epileptics 
(phenobarbitone, phenytoin) and asthmatics (theophylline). 
2.2.5.3 Office-Based Practice 
In pursuit of the goal of satisfying professional 
practice, some pharmacists have attempted to restrict their 
businesses to dispensing only, or dispensing combined with 
sale of health related items only. Early reports of 
establishment of such practices in Australia appeared in 1971 
with the setting up of pharmacies within private medical 
centres in South Australia (345) and Western Australia (346). 
The South Australian pharmacy was reported to include a 
laminar flow unit for the preparation of sterile products 
(345). 
A more recent practice reported in England has 
preserved the expected appearance of a pharmacy, but has 
restricted its merchandise to health related products (347). 
The services offered in the pharmacy were described as 
dispensing and a general health care service, both with an 
emphasis on patient counselling. The design of the pharmacy 
incorporated a private area to be used for surgical fittings, 
and counselling if needed. 
"Office-based" practices have been described in the 
United States (17 7,348-351). Office practices attempted to 
eliminate commercialism by removing all merchandise from 
display, even though nonprescription drugs and other health 
related items were available for purchase. The atmosphere was 
designed to be professional, yet warm and inviting. 
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The history of the development of this practice 
alternative has been explored by Catizone and Mrtek (349). 
Eugene White developed his office practice setting in Virginia 
in the early 1960s, although he had been advocating the 
patient-oriented role for some years before (348,349). He 
described the principle of office practice simply as "a 
patient and pharmaco-therapy orientated pharmacist practising 
in a private office setting". The emphasis was on educating 
patients and monitoring their continuing therapy regimens. 
Family prescription records were an important basis for 
success of this service. The other major departure from 
traditional pharmacy practice advocated by White was the 
principle of fee for service, similar to the system of 
charging used by other professions. He also advocated 
extension of the pharmacist's responsibilities to include 
prescribing (352), A former associate of White, Carl 
Emswiller, also established an office practice in Virginia in 
the early 1970s (353), His premises comprised waiting area, 
consulting room, private office/library, administrative 
office, and laboratory. Emil Baker's practice was begun in 
Kentucky in 1972 and was described by Dolan (177) as 
consisting of dispensing, including a nursing home contract, 
and the provision of selected medical services such as high 
blood pressure screening, hypertension and diabetes 
monitoring, and parenteral medicine administration by a 
registered nurse on the premises. Fees were charged for these 
services. It has been estimated that about 1000 
office-practice pharmacies were in existence in the United 
States by 1984 (349). 
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A comparative study of patrons expectation for and 
satisfaction with pharmaceutical services from office practice 
and traditional pharmacy was conducted in 1980 (350). The mail 
survey, using a controlled research design, was administered 
to 25% of households in a small rural city serviced by one 
pharmacy of each type, with comparable prescription volumes. A 
useable response of 62% was achieved. The most significant 
findings were that patrons of the office practice had higher 
expectation and satisfaction scores than patrons of the 
traditional pharmacy, and that they also consulted with a 
pharmacist more frequently about drugs and health matters. The 
researchers speculated from these findings that pharmacists 
may be able to create a demand for clinical services by 
offering them on a consistent long-term basis. 
2.3 STATEMENT OF THE PROBLEM 
The preceding review of the international 
literature relating to community pharmacy services has shown 
that marked changes in practice have occurred and are 
continuing to occur in response to the clinical needs of 
patients. The development of clinical approaches has been 
particularly evident over the past two decades in relation to 
dispensing of prescriptions and to establishment of 
specialized health-related services for specific patient 
groups. Much of the information about community pharmacy 
services, however, has been in the form of isolated anecdotal 
accounts. Comprehensive surveys of the nature and extent of 
services do not appear to have been conducted in Australia or 
ove r seas . 
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In an attempt to redress this lack, it was decided 
to collect information on the nature and extent of services 
being provided by community pharmacies in Queensland, and to 
select one area thus identified for further investigation as a 
case study into development of innovative specialized 
practice. 
2.4 AIMS OF THE RESEARCH 
The specific aims of the study were: 
PART ONE 
1. To determine the nature and extent of services 
being provided through community pharmacies in Queensland. 
2. To collect demographic data about pharmacists 
engaged in community pharmacy practice in Queensland. 
3. To collect business characteristic data about 
community pharmacies in Queensland. 
4. To determine the relationships between 
demographic and business factors and the provision of 
innovative specialized services. 
5. To select an area for in depth investigation of 
the development of innovative specialized practice. 
PART TWO 
The aims of the study into specialized service 
provision in Queensland were: 
1. To document the services offered to patients by 
pharmacies involved in the selected area of specialized 
pract ice. 
2. To document the types of stock held by community 
pharmacies relevant to the selected area of practice. 
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3. To estimate the degree of counselling 
involvement which community pharmacists perceive themselves to 
have with patients in the selected area of practice. 
4. To document the historical development of 
provision of the selected service from community pharmacies in 
Queensland. 
5. To document the educational background of 
service providers. 
6. To determine the motivation for practitioners to 
become involved in the field. 
7. To classify pharmacies involved in the selected 
area of specialized practice into levels of service 
provision. 
8. To describe the services provided at each level 
of specialization. 
9. To describe the characteristics of pharmacists 
and pharmacies at each level of specialization. 
OVERALL 
10. To develop a methodology suitable for 
application to future studies. 
11. To suggest a plan to aid the controlled 
development of specialized services in community pharmacy 
practice. 
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Chapter 3 
SURVEY OF SERVICES PROVIDED 
FROM COMMUNITY PHARMACIES IN 
QUEENSLAND, 1 9 8 ^^ 
3.1 AIMS 
1 . To determine the nature and extent of services 
being provided through community pharmacies in Queensland. 
2. To document demographic details of pharmacists 
engaged in community pharmacy practice in Queensland. 
3. To document business characteristics of 
community pharmacies in Queensland. 
4. To determine the relationships between 
demographic and business factors and the provision of 
innovative specialized services. 
5. To select an area of practice and identify 
pharmacies involved, to allow an in depth investigation of the 
development of specialized pharmaceutical service. 
3.2 METHODOLOGY 
3.2. 1 The Sample 
3.2.1.1 Sample Tvpe 
Review of the contemporary literature revealed 
limited surveys only of specific services offered by 
Australian community pharmacies eg aspects of dispensing, 
counselling, and over-the-counter consultation. Many of these 
surveys were performed using restricted samples, and none 
examined the spectrum of pharmaceutical services. In view of 
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the shortcomings of the available comparative information, a 
census was deemed to be the appropriate sampling approach to 
ensure accuracy (1-3), Other important considerations in 
choosing to take a census are cost, time, and destruction or 
alteration of the sample by measurement (1-5). As the 
population of community pharmacies in Queensland was known to 
be about 1000 at the time of planning the survey, cost and 
time factors were not prohibitive. Measurement by means of a 
questionnaire would not be destructive to the sample, and the 
nature of the proposed questions were considered unlikely to 
produce a change in the respondents. 
3.2.1.2 Sampling Frame 
An element list (6) of names and addresses of 
Queensland pharmacies approved by the Commonwealth Health 
Department to dispense prescriptions under the Pharmaceutical 
Benefits Scheme was obtained by application to the Deputy 
Director (Pharmaceutical Benefits) of the Commonwealth Health 
Department's Queensland Office (7). Although this information 
is not freely available, an explanation of the proposed use of 
the list for research purposes and an assurance of 
confidentiality of information resulted in its release. The 
success of a census is dependent upon the accuracy and 
completeness of listing of the population (8-13). While use of 
the above list does not guarantee completeness of the census, 
it is unlikely that community pharmacies exist outside the 
list apart from subsequent new approvals. The information 
supplied included amendments to August 1984, and listed 955 
pharmacies. The Guild Digest 1985 (14) quotes the number of 
approved pharmacies in Queensland at 30 June 1984 as 952. 
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3.2.1.3 Respondents 
To determine the nature and extent of 
pharmaceutical services and document business characteristics 
of community pharmacies, the respondent was defined as the 
pharmacist usually in charge of the day to day operation of 
each community pharmacy in Queensland (Appendix 4). 
To document demographic details about community 
pharmacists, the respondent population was defined as 
full-time registered pharmacists and pre-registration trainees 
employed in community pharmacies in Queensland (Appendices 
4&5). 
3.2.2 Survey Type 
A mail questionnaire was chosen as the most 
suitable means of performing a survey of the length needed to 
fulfil the objectives outlined, and of reaching the selected 
population, which was widely scattered geographically (15). 
The mail survey method offered advantages in both 
administrative and manpower costs over personal interview or 
telephone survey methods (9,12,15-17). As the survey 
instrument was necessarily lengthy, personal approach may have 
resulted in a higher refusal rate due to respondents having to 
be contacted during working hours, whereas the mail technique 
allowed respondents the flexibility of completing the 
questionnaire at a time or times convenient to themselves. 
Opportunity to consult other sources of information such as 
business records, bestowed a further advantage in improving 
validity of responses (12,15). The absence of an interviewer 
and assurance of confidentiality may have proved less 
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inhibitory to the answering of questions dealing with personal 
or business details (12,13,15,16). The population being 
surveyed was unlikely to encounter difficulties of language or 
interpretation which can otherwise hamper response to 
self-administered questionnaires (12,13,15,16). 
Completion rates for mail surveys are generally low 
in comparison to personal or telephone interviews 
(9,13,15,16,18). Also, lag time in receipt of responses not 
only increases completion time of the survey, but also may 
introduce extraneous variables into measurements (12). 
Response has been shown to be improved by intrinsic interest 
of subject matter to respondents (16), as would be the case in 
this study, but surveys of more specific populations than the 
general public have still shown wide variation in response 
(13). Attention to detail in aspects of the construction and 
administration of the survey instrument has been shown to 
improve response rates (12,16). 
3.2.3 Survey Instrument 
The questionnaire was developed comprising six 
sections to collect information relevant to the stated aims: 
Pharmacist Information (46 variables). Pharmacy Information 
(34 variables). Dispensing Services (73 variables). Other 
Health-Related Services (36 variables), Over-the-Counter 
Services (8 variables) and Commercial Services (24 variables). 
See Appendix 4. 
3.2.3.1 Length 
The length of the questionnaire (six pages 
comprising 220 items) and the time required for completion 
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(about half an hour) were recognized as possible inhibitory 
factors to obtaining a high response rate. Dillman (9) 
reported no difference in response rates up to 125 items or 
twelve pages, but observed declining response rates for 
questionnaires beyond twelve pages in length. However, other 
research has shown length to have less influence on response 
rates than the image created by the questionnaire or the 
respondents' interest in the research topic (12). 
As this survey was considered to be instrumental in 
providing baseline data on provision of services from 
community pharmacy in Queensland, it was decided not to 
compromise the content but to concentrate on design aspects 
and follow-up techniques to encourage response. 
3.2.3.2 Appearance 
Appearance of the questionnaire has been shown to 
affect response rates (12,19,20), The survey instrument can be 
presented to appear professional, important, or serious, and 
suggestions for presentation have included booklet format, 
white or coloured paper, photoreduction and offset printing 
(12,16,19,20). However, resulting differences in response were 
doubtful (12). 
The questionnaire was designed to be business-like 
and attractive in appearance, with an easily followed format 
(16,19). Preparation was by computerized type-setting using a 
Compugraphic 8400 Typesetter. Size of type was selected to 
minimize the physical length of the questionnaire while 
maintaining legibility (19). Setting out was arranged so that 
sections began on a new page without leaving large spaces 
(19). 
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3.2.3.3 Confidentiality 
The individual respondent's right to privacy must 
be protected by assurance of confidentiality (21). 
As one purpose of the questionnaire was to identify 
pharmacies providing specific services of interest for 
follow-up studies, a code number was added to the upper left 
hand corner of the front page of each form, using a hand 
numbering machine (22). A code was used rather than the name 
of the pharmacy to allow confidentiality to be maintained, 
even though workers other than the main researcher had access 
to the completed forms (16,21). The code list was stored 
separately from the completed questionnaires, and was accessed 
only by the chief researcher. As visible codes have been shown 
to reduce response rates (12), a post-script to the survey 
form advised respondents of the purpose of the code number and 
assured confidentiality. An option was offered for removal of 
the code number by those respondents desiring anonymity. This 
could be easily done without risking loss of answers (22). 
Although removal of the code precluded tracing of these 
respondents, the measure was a compromise between exclusion of 
some pharmacies from follow-up studies and reduction of 
validity of this survey by inhibition of response (21). An 
explanation of the reason for the code number was given to 
discourage removal (20). 
The code was also used to account for returned 
questionnaires, thereby excluding identified respondents from 
reminder and follow-up mailings for cost saving purposes and 
so as not to intrude upon respondents unnecessarily. 
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3.2.3.4 Question Sequence 
Question sequence has been shown to affect response 
rates and the validity and quality of responses (Zelnio). It 
has been suggested that early questions should be either be 
general and easy to answer or of importance to the respondent, 
and that potentially objectionable questions be placed later 
in the questionnaire (12,16,19,20,23). Demographic questions 
have usually been placed towards the end as they may be seen 
as personal or sensitive (19), but other research has shown 
that their location does not affect response (12). As the 
respondent has access to all questions in a mail questionnaire 
and can answer at random, the researcher has no control over 
the order of answering. This could create validity problems if 
later posed questions affect responses to earlier questions 
(9,15,16), 
The questionnaire consisted of two distinct 
sections seeking information about pharmacists and about 
pharmacies. Within each section, questions of similar content 
were grouped together (19) and ordered in a logical 
progression (16,23). Because the pharmacist section was 
required to be answered by all full-time pharmacists, it was 
decided to place this section first in the overall survey 
instrument (Appendix 4) to encourage the chief respondent to 
distribute the extra copies (Appendix 5) to other relevant 
pharmacists. As the personal information required was not 
thought likely to be considered sensitive by the respondent 
population, it was placed first as being easy to answer 
without requiring reference to other sources. 
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Because of the length of the pharmacy section, the 
business demographic questions were placed at the beginning in 
case questionnaires were not followed through to the end. 
Items of topical interest to the responents were included in 
the appropriate subject areas to maintain interest and thus 
encourage response (15,20). 
Respondents were thanked for their co-operation at 
the end of the questionnaire (19,20). 
3.2.3.5 Question Structure 
In contrast to interviews, there is no opportunity 
to clarify questions or answers in a mail questionnaire (16). 
Standardization of questions and response categories provides 
ease of interpretation by respondents and facilitates data 
entry and tabulation of results in mail questionnaires 
(12,17,20). The closed question format is also easier to 
provide written answers to than are open ended questions (17). 
Closed-ended questions require response categories to be 
exhaustive and mutually exclusive (12,23). 
To simplify completion, questions were restricted 
to three main types: closed-ended questions seeking attribute 
information eg year of qualification, place of qualification; 
closed-ended questions requiring circling of a number for 
choice of answer eg 1 or 2 for "Yes" or "No" or one number 
from a list of mutually exclusive answers; and closed-ended 
questions allowing the respondent to provide information 
outside the set framework eg membership of professional 
organizations not listed (12,16,20,24). Questions of the third 
type, being more difficult to process, were kept to a minimum 
but were included where necessary to ensure completeness of 
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lists or to allow respondents to clarify or expand on listed 
options. The option to comment may not only allow for more 
accurate interpretation of answers when coding but also 
encourage responses which may otherwise be inhibited by too 
rigid a structure. 
Some open-ended "Comment" questions allowing free 
response (12,16) were included specifically at the request of 
professional pharmacy organizations whose presidents were 
consulted during the preparation of the questionnaire. These 
discussions were undertaken to inform the organizations of the 
existence of the survey and to offer them an opportunity to 
seek information related to the aims of the survey but of more 
specific application to their own purposes eg comments on 
provision of continuing education programmes. While attitude 
questions were not required for fulfilment of the main aims of 
the survey, Likert scales were used to assess pharmacist 
opinion in some areas of interest to the professional 
organizations (16,20). 
Clear, concise instructions for answering questions 
were frequently repeated in parenthesis throughout the 
questionnaire, with use of bold type for emphasis (19,20). 
Consistency of answering procedures was maintained (19). 
Wording of questions was chosen to avoid leading, 
loaded or double questions and to be non-objectionable 
(12,16,20). When attribute information requiring measurement 
was sought, the question was posed in units appropriate to the 
knowledge of the respondent eg options of sq.ft. or sq.m. were 
provided for quotation of shop areas (12). 
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3.2.4 Pilot Studies 
The Australian Bureau of Statistics recommends that 
at least two pilot studies be performed when conducting a 
survey, a preliminary pilot in the early planning stages, and 
a formal pilot study to confirm sample size requirements, test 
the survey instrument, and test field work procedures (13). 
The preliminary pilot was conducted by informal 
discussions with community pharmacists (16,25). In an attempt 
to locate pharmacists involved in innovative services to take 
part in these discussions, a press release was sent in March 
1984 to PSA (Qld.Branch), PGA (Qld.Branch) and the Australian 
Journal of Pharmacy. seeking input from progressive 
pharmacists (Appendix 1). 
After development of the survey instrument, the 
questionnaire was administered to ten pharmacies (1% of the 
population) by hand delivery and collection. Respondents were 
interviewed at the time of collection to ascertain any 
problems (12,16,19,20,23). As only minor clerical difficulties 
were enountered at this juncture, the pilot was extended to 
cover 5% of the population, choosing pharmacies in different 
site categories and pharmacists of both sexes and a variety of 
ages. No major changes were required. 
3.2.5 Administration and Collection 
3.2.5.1 Preliminary Contact 
Precontact advising participants of a forthcoming 
questionnaire has been shown to be effective in producing 
higher and faster response (12). Telephone has been shown to 
be better than mail contact (12), but both methods were 
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considered too expensive for the probable benefits to this 
study, 
A second press release was sent to PSA (Qld.Branch) 
and PGA (Qld.Branch) in September 1984 for distribution to 
members via their regular mailings (Supplement to Introspect. 
Sept.1984; Guild Bulletin. Sept.1984). The notice advised that 
all pharmacies would soon be receiving a questionnaire, 
outlined the purpose of the survey and its benefits to the 
profession, and encouraged response (Appendix 2). 
3.2.5.2 Covering Letter 
Letter, visit or telephone have been suggested as 
methods of initial contact with respondents to convince them 
to participate in surveys, any being suitable as long as the 
approach is uniform (12,21). 
A covering letter included with the questionnaire 
was chosen because of cost advantages (Appendix 3). The letter 
introduced the researcher, the educational institution, and 
the topic of the survey; explained its importance to the 
future of pharmacy and the importance of the individual 
respondent to its success; and offered a guarantee of 
confidentiallity (12,15,18,21,22). Personalization was 
conveyed by use of letterhead stationery and by signing the 
letter (12,16,22). The letterhead also provided an address and 
telephone number to allow contact for information or 
assistance (18). Mention was made of consultation with both 
PSA and PGA, as sponsorship of surveys by official bodies 
recognized by the proposed respondents has been shown to 
improve response rates (15,16). The letter was kept short to 
avoid introducing bias by provision of too much detail (20). 
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3.2.5.3 Distribution 
The survey (Appendices 4&5) was released on 26th 
October 1984, accompanied by the covering letter (Appendix 3) 
and postage-paid pre-addressed return envelope to improve 
response (16,22). Timing of the survey was planned so that 
collection would be largely completed by early December, as 
December was not thought to be conducive to achievement of 
high response rates (12,22). 
3.2.5.4 Follow-Up 
Use of postcard, letter or telephone reminders, and 
remailing of questionnaires have been shown to improve 
response (12,15,16,17,21). It has been suggested that the 
reminder be sent two weeks after the initial mailing or when 
the return rate begins to slacken (18). Alternative 
recommendations have included sending a reminder letter after 
one week, and another copy of the survey after two weeks (15). 
Dillman (22) recommended the sending of a reminder/thank-you 
after one week, a reminder letter with replacement 
questionnaire after three weeks, and a further replacement 
questionnaire after seven weeks. A reminder card (Appendix 6) 
was sent on 12th November 1984 to all pharmacies which could 
not be identified by code number as having replied to the 
original mailing (15,18). The card was a brief reminder of the 
survey questionnaire, and encouraged prompt reply (18,22). 
Finally, a follow-up mailing of similar content to the 
original was distributed to non-responding pharmacies on 27th 
November 1984 (Appendix 7). Timing of both the reminder card 
and the follow-up mailing was based on slackening of response 
(Figure 1). A response rate of 61% was achieved. 
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GRAPH 1 
Response Rate to "Survey of Services Provided from Community 
Pharmacies in Queensland. 1984". 
peAjsoey sendey jueo jed 
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3.2.6 Data Management and Analysis 
3.2.6.1 Data Coding 
Numerical codes were used for both numerical and 
categorical data. Consistency across codes was established by 
use of "." for missing numerical values, " " for missing 
categorical values, "0" for not applicables, "8" for unknowns 
and "9" for refusals (19,26-28). Where possible, codes were 
included on the right hand side of the columns of the 
questionnaire to reduce intermediate coding steps and 
consequent chances of error (28). Codes not built into the 
survey instrument were later written directly onto the right 
hand side of the columns of the questionnaire forms to ease 
data entry and avoid transcription errors (27,28). Open-ended 
questions were assessed and coded by the chief researcher to 
maintain consistency (28). 
The data coding key was set up as a library using 
the software package Statistical Analysis System (29) to 
allowing output to be readily checked and interpreted (28). 
3.2.6.2 Data Entry 
The data were entered onto the computer as five 
separate data bases, divided in accordance with the sections 
of the survey instrument: Pharmacist Information, Pharmacy 
Information, Dispensing Services, Other Health-Related 
Services, and Over-the-Counter and Commercial Services. 
3.2.6.3 Data Cleaning 
Each data base was entered in duplicate using fixed 
format, and the computer used to cross check for 
discrepancies, including field length (27,28). Corrections 
were made after reference to the original questionnaires. 
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On completion of each data base, frequency tables 
were computed and checked for inconsistencies such as 
uniqueness of record identifiers, and values outside the range 
for each variable (27,28). The data coding key was arranged to 
designate miscodes outside the allowable ranges. 
3.2.6.4 Analysis 
Analysis of the results was performed using the 
University of Queensland Prentice Computer Centre mainframe 
IBM 3083 E24 computer with VMS/CMS operating system, and the 
Statistical Analysis System, SAS (29). 
Nonparametric statistical procedures were employed, 
as data for most variables were of the nominal type (30-32). 
Chi square tests were used to test hypotheses, using a 
critical significance level of P=0.05 (31-33). The chi square 
statistic was accepted as reliable if the expected cell count 
was not below five for at least 80% of cells (29,33). 
The specialized services identified were correlated 
with demographic and business characteristics for hypothesis 
testing. Demographic details were those of the "pharmacist in 
charge" only. It must be emphasized that the questions about 
Health-Related Services were aimed at identifying services and 
the pharmacies involved, and not at establishing the causative 
factors for participation in such activities. 
3.3 VALIDATION OF RESPONSE 
Survey results may be biased due to nonresponse 
(9,12,17,34), although it has been stated that most biases 
tend to disappear when a response rate of 70% or more is 
achieved (12). Approaches to minimize the effect of 
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nonresponse have been suggested, including estimation of the 
extent of bias from this source, and methods of construction 
and administration of questionnaires to encourage response 
(9,12,15,19,22). The aim is to elicit a response from most of 
the sample and show that those who do not respond are not 
significantly different from those who do (13,17), One way of 
doing this is by comparison of respondents' answers with data 
from other sources, although such comparisons may not be 
related to the comparability of the variables being studied 
(9,15,35,36). 
Opinions on the acceptable levels of response for 
different types of surveys vary. Response rates to mail 
surveys of the general public have been quoted to be generally 
accepted at 20-40%, but ranging from 10-90% (13). Dillman (9) 
has stated that a response between 60-75% may be expected from 
a carefully constructed survey, even if it is lengthy. 
However, a population with an interest in the subject matter 
would be expected to produce a greater response (16,37). Forty 
or fifty percent response may be considered acceptable for 
mail surveys, with sixty percent rated as high (16,35), 
whereas 75% may be the minimum acceptable response for 
interview methods (16). Kerlinger (35) has recommended that, 
if the response is less than 80-90%, an attempt should be made 
to learn something of the characteristics of nonresponders eg 
by comparison with other evidence. 
From a population of 955 pharmacies in Queensland, 
582 useable replies were received (Response rate = 60.9%). 
Pharmacist Information was provided by 764 pharmacists working 
in Queensland community pharmacies at the time of survey. 
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3.3.1 Check for Nonresponse Bias by Response Time 
Receipt time of responses was coded according to 
return after the initial mailing, after prompting by reminder 
card, or after the second mailing of the survey material. 
Non-response bias was tested by comparing demographic and 
business variables for "initial", "reminder" and "remail" 
respondents and found not to be significant, except that 
higher proportions of PSA members had answered before the 
second mailing than had nonmembers (Table 1). 
TABLE 1 
CHECK FOR NON-RESPONSE BIAS 
by RESPONSE TIME 
Total number of responses = 582 
VARIABLE 
PHARMACISTS IN CHARGE 
Sex 
Year of Birth 
Pharmacy Qualification 
Year of Qualification 
Place of Qualification 
Pharmacist Status 
PSA Membership 
PGA Membership 
ACPP Membership 
SQUARE 
1.517 
6.885 
3.000 
5.544 
4.466 
6.151 
6.865 
1 .703 
5.940 
DEGREES OF 
FREEDOM 
2 
8 
2 
6 
4 
6 
2 
2 
2 
PROBABILITY 
0.468 
0. 549 
0.223 
0.476 
0.347 
0.407 
0.032* 
0.427 
0.051 
PHARMACIES 
Site 
Location 
Hours 
Size 
Group Membership 
3.836 
5.951 
1 .001 
22.028 
1.157 
8 
2 
4 
18 
2 
0 . 8 7 2 
0 . 0 5 1 
0 . 9 1 0 
0 . 2 3 1 
0 . 5 6 1 
*Significantly different at the 95% confidence level 
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Higher proportions of ACPP members than nonmembers 
and higher proportions of country than Brisbane respondents 
also had answered after the initial mailing, but these 
differences were just beyond the 95% significance level 
chosen. Of the population of 955 pharmacies in Queensland, 
48.3% (461) were located in the Brisbane metropolitan area. 
Responses received were 47.5% from Brisbane pharmacies. 
If the assumption were made that respondents to the 
second mailing were a random sample of nonrespondents to the 
first mailing, then, if there are no differences between the 
characteristics of these groups, it may be assumed that there 
are no differences between the characteristics of respondents 
and the remaining nonrespondents (15). However, Moser and 
Kalton (15) have stated that it is likely that nonrespondents 
would be closer in characteristics to those responding to 
follow-ups than those responding to the initial mailing. 
As the characteristics of pharmacists and 
pharmacies were consistent regardless of the response time, it 
was concluded that the characteristics of nonrespondents would 
also be likely not to differ greatly. 
3.3.2 Check for Nonresponse Bias of Pharmacist Sample 
Data collected from 733 (excluding 31 
pre-registration trainees from 764 respondents) registered 
pharmacists working in community pharmacies in Queensland were 
compared with data collected from registered pharmacists by 
the Division of Research and Planning of the Queensland 
Department of Health via the 1985 Pharmacy Manpower Statistics 
Return (38). The Manpower questionnaire was distributed by the 
175 
Pharmacy Board of Queensland in conjunction with annual 
registration renewal notices, and responses were collected 
between 1 January and 30 April 1985. Nonresponse to the 1985 
Manpower survey was 15%. Comparison was made with Manpower 
information from pharmacists working in Queensland only, which 
increased the nonresponse rate to 28% of pharmacists 
registered in Queensland, since a further 15% of respondents 
did not answer the work status question. 
Statistical tests could not be performed on these 
comparisons as the samples have been differently defined. 
However, evident close similarities indicated that respondents 
were most likely to be an unbiased subset of the population 
(Table 2). 
TABLE 2 
CHECK FOR NONRESPONSE BIAS of PHARMACIST SAMPLE 
by COMPARISON with MANPOWER SURVEY. 1985 
Total number of responses = 733 
VARIABLE VALUE SURVEY MANPOWER 
% % 
Sex Male 74.6 64.4 
Female 25.4 35.6 
Age 20-29 25.5 19.9 
30-39 22.7 21.9 
40-49 31.7 32.4 
50-59 16.3 20.5 
60 & over 3.8 5.3 
Place of Queensland 80.5 81.9 
Qualif'n. Interstate 14.0 13.1 
Overseas 5.5 5.0 
Pharmacist Owner/Partner 64.8 66.0 
Status Manag/Assist 35.3 34.0 
Location Brisbane 47.3 45.8 
of Work Country 52.7 38.4 
Not Stated - 15.9 
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3.3.3 Check for Nonresponse Bias of Pharmacy Sample 
Data collected from 582 community pharmacies in 
Queensland were compared with information for the financial 
year 1984-85 reported in the Guild Digest, 1986 (39). Response 
to the Digest survey was received from 99 Queensland 
pharmacies, representing 13.0% of PGA membership and 10.2% of 
the 974 approved pharmacies in Queensland listed by the 
Commonwealth Health Department at 30 June 1985. This response 
rate limits the reliability of the data presented. Owing to 
different methods of collecting and presenting the data, 
results for many variables cannot be directly compared between 
the two surveys. Some comparisons are shown in Table 3. 
The Guild Digest (39) reported an average of 53 
hours open per week for Queensland pharmacies. This result 
appears consistent with the finding of the 1984 survey that 
69.4% of pharmacies were open five days per week plus Saturday 
mornings or five days per week plus Saturday mornings and once 
a week for late-night shopping ie 48-54 hours per week. 
Tabulated results also show comparability within the 
methodological limitations. 
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TABLE 3 
CHECK FOR NONRESPONSE BIAS of PHARMACY SAMPLE 
by COMPARISON with GUILD DIGEST, 1986 
Total number of responses = 582 
VARIABLE VALUE SURVEY GUILD DIGEST 
% % or Av. 
Site Regional Centre 8.0 
Non-regional 92.0 
Location Brisbane 47.5 
(Sample) Country 52.2 
Location Brisbane 
(Total Country 
population) 
Merch. Member 53.1 
Group Non-member 46.9 
Size Less than 700 24.5 
(Sq.Ft.) 700-1099 31.4 
1100-1499 20.2 
1500 or more 24.0 
Turnover Less than 200 28.6 
($x1000) 200-299 23.6 
300-399 18.6 $406 543 
400-599 17.8 
600 or more 11.4 
Prescript. Less than 25% 14,3 
Proportion 25-34% 23.5 
35-54% 35.6 46% 
55-74% 23.6 
7 5 % o r m o r e 5.1 
Prescript. Less than 1000 14.7 28,526/yr 
per Month 1000-1999 42.5 or 
2000-2999 26.6 2377/month 
3000 or more 16.2 
19, 
80 , 
35 , 
64 , 
4 9 , 
50 , 
55 , 
4 4 , 
1 19 
.2 
. 8 
.4 
,6 
, 1 
,9 
,6 
,4 
Sq, 
or 
1280 Sq, 
.M . 
. F t 
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3.4 RESULTS 
3.4.1 Pharmacist Characteristics 
Replies to the Pharmacist Information section of 
the survey were received from 764 pharmacists working in 582 
community pharmacies in Queensland. Replies were received from 
two pharmacists in 129 of the pharmacies, from three in 
twenty-two pharmacies, and from four in three pharmacies. 
Demographic details of the sample, collected by Questions 3-45 
(Appendices 4&5) are shown in Table 4. 
In Queensland, where 81.4% of respondents had 
received their pharmacy qualification, the degree of Bachelor 
of Pharmacy (B.Pharm.) was first awarded in 1962. The previous 
qualification of Pharmaceutical Chemist (Ph.C.) was phased out 
around the same time. Changeovers in other Australian States 
occurred similarly in the early 1960s. 
A total of thirty-nine respondents had 
qualifications in addition to Ph.C. or B.Pharm. Thirteen had 
post-graduate pharmacy qualifications such as Honours or 
Masters degrees; twelve had degrees in other disciplines; nine 
had diplomas; three had other types of qualifications; two had 
more than one extra qualification. 
Although the supplementary Pharmacist Information 
questionnaire (Appendix 5) requested information from 
full-time pharmacists and pre-registration trainees, 3.6% of 
respondents were employed for an average of less than twenty 
hours per week. These respondents were not excluded from the 
sample, as some pharmacists responding as "pharmacist in 
charge" (Appendix 4) were also working below twenty hours in 
the pharmacies for which they provided information. 
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TABLE 4 
PHARMACIST INFORMATION for TOTAL SAMPLE 
Total number of responses = 764 
Results not tabulated if valid responses below 50% 
VARIABLE 
Sex 
Year of 
Birth 
Pharmacy 
Qualif icat ion 
Year of 
Qualification 
Place of 
Qualification 
Average 
Hours/Week 
Years in 
This Pharmacy 
NUMBER OF 
VALID 
RESPONSES 
759 
741 
761 
739 
598 
752 
729 
VALUE 
Male 
Female 
Before 1920 
1920-1929 
1930-1939 
1940-1949 
1950-1959 
1960s 
Ph.C. 
B.Pharm. 
Before 1940 
1940-1949 
1950-195 
1960-1969 
1970-1979 
1980s 
Qld. 
NSW 
Vic. 
Tas . 
SA 
WA 
NZ 
UK 
Other 
Less than 20 
20-39 
40-49 
5 0-59 
60 or more 
Up to 1 
>1 to 5 
>5 to 10 
>10 to 20 
More than 2 0 
NUMBER OF 
POSITIVE 
RESPONSES 
556 
203 
10 
62 
197 
197 
176 
99 
337 
424 
8 
29 
158 
228 
186 
130 
487 
40 
26 
3 
7 
4 
14 
12 
5 
27 
88 
343 
251 
43 
178 
190 
131 
128 
102 
PERCENT 
73.3 
26. 7 
1 .4 
8.4 
26.6 
26.6 
23.8 
13.4 
44. 3 
55.7 
1 . 1 
3.9 
21.4 
30.9 
25.2 
17.6 
81 .4 
6.7 
4.4 
0.5 
1 .2 
0. 7 
2. 3 
2.0 
0.8 
3.6 
11.7 
45.6 
33.4 
5.7 
24.4 
26. 1 
18.0 
17.6 
14.0 
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VARIABLE 
Pharmacis t 
Status 
NUMBER OF 
VALID 
RESPONSES 
760 
VALUE NUMBER OF 
POSITIVE 
RESPONSES 
PSA Member 
PGA Member 
714 
618 
CE Attendance: 
Evening Lect. 655 
W-end Seminars 622 
Conferences 579 
Reader of: 
AJP 722 
Aust.P'cist. 543 
Introspect 642 
Pharm.Review 492 
Pharm.Trade 675 
Aust.Prescr ib. 581 
ADRAC Bulletin 454 
Curr.Therapeut.469 
Patient Manag. 384 
Education: 
Hospitals 671 
Illness Gps. 664 
C'ty. Groups 691 
Schools 675 
Other 567 
Willing to 
Educate 701 
Personal Special 
Interests 725 
Sole owner 305 
Partner 167 
Manager 174 
Ass is tant 83 
Pre-registrant 31 
599 
441 
359 
379 
PERCENT 
40. 1 
22.0 
22.9 
10.9 
4. 1 
83.9 
71 .4 
279 
192 
1 15 
668 
363 
561 
298 
598 
447 
264 
206 
48 
29 
2 2 
73 
36 
17 
42.6 
30.9 
19.9 
92. 5 
66.9 
8 7.4 
60.6 
88.6 
76.9 
58.2 
43. 9 
12.5 
4. 3 
3.3 
10.6 
5.3 
3.0 
51 .2 
52.3 
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Although not tabulated due to a low response rate 
to the question (324 valid replies), 28 respondents stated 
that they were members of the Australian College of Pharmacy 
Practice (ACCP). 
Personal special interest areas related to pharmacy 
practice were claimed by 379 (52.3%) respondents. While some 
named more than one area of interest, others did not 
elaborate. Interests nominated included nutrition (72.3%), 
diabetes (19.4%) and sports medicine (7.4%). 
Demographics for the group identifying themselves 
as pharmacists in charge of the usual day to day operation of 
the pharmacy are shown in Table 5. 
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TABLE 5 
PHARMACIST INFORMATION for PHARMACISTS IN CHARGE 
Total number of responses = 582 
Results not tabulated if valid responses below 50% 
VARIABLE 
Sex 
Year of 
Birth 
Pharmacy 
Qualification 
Year of 
Qualification 
Place of 
Qualification 
Average 
Hours/Week 
Years in 
This Pharmacy 
NUMBER OF 
VALID 
RESPONSES 
578 
560 
580 
561 
454 
574 
566 
VALUE 
Male 
Female 
Before 1920 
1920-1929 
1930-1939 
1940-1949 
1950-1959 
1960s 
Ph.C. 
B.Pharm. 
Before 1940 
1940-1949 
1950-1959 
1960-1969 
1970-1979 
1980s 
Qld. 
NSW 
Vic. 
Tas . 
SA 
WA 
NZ 
UK 
Other 
Less than 
20-39 
40-49 
50-59 
60 or more 
Up to 1 
>1 to 5 
>5 to 10 
>10 to 20 
More than 
20 
20 
NUMBER OF 
POSITIVE 
RESPONSES 
481 
97 
7 
51 
172 
171 
121 
38 
288 
292 
6 
22 
137 
202 
134 
60 
363 
28 
23 
3 
7 
4 
12 
9 
5 
8 
46 
243 
236 
41 
105 
144 
1 10 
1 15 
92 
PERCENT 
83.2 
16.8 
1 .3 
9. 1 
30. 7 
30. 5 
21 .6 
6.8 
49.7 
50. 3 
1 . 1 
3.9 
24.4 
36.0 
23.9 
10.7 
80.0 
6.2 
5. 1 
0. 7 
1 . 5 
0.9 
2.6 
2.0 
1 . 1 
1 .4 
8.0 
42. 3 
41 . 1 
7. 1 
18.6 
25.4 
19.4 
20. 3 
16. 3 
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VARIABLE 
Pharmacist 
Status 
PSA Member 
PGA Member 
NUMBER OF 
VALID 
RESPONSES 
580 
545 
497 
CE Attendance: 
Evening Lect. 497 
W-end Seminars 480 
Conferences 449 
Reader of: 
AJP 546 
Aust.P'cist 40 5 
Introspect 483 
Pharm.Review 369 
Pharm.Trade 516 
Aust.Prescrib. 437 
ADRAC Bulletin 340 
Curr.Therapeut.342 
Education: 
Hospitals 509 
Illness Gps. 502 
C'ty. Groups 526 
Schools 512 
Other 432 
Willing to 
Educate 535 
Personal Special 
Interests 551 
VALUE 
Sole owner 
Partner 
Manager 
As s is tant 
NUMBER OF 
POSITIVE 
RESPONSES 
302 
129 
146 
3 
474 
396 
198 
152 
98 
508 
275 
421 
237 
470 
335 
202 
146 
22 
15 
62 
31 
15 
274 
296 
PERCENT 
52. 1 
22.2 
25.2 
0. 5 
87.0 
79.7 
39.8 
31 . 7 
21 .8 
93.0 
68. 0 
87. 2 
64.2 
91 . 1 
76. 7 
59.4 
42. 7 
4.3 
3.0 
11.8 
6. 1 
3.5 
51 .2 
53.7 
184 
3.4.2 Pharmacy Characteristics 
Replies to the Pharmacy Information section were 
received for 582 community pharmacies in Queensland (60.9% 
response). information about the businesses, collected by 
Questions 46-79 (Appendix 4) is shown in Table 6. 
Pharmacy site was defined for respondents by the 
survey instrument (Question 46, Appendix 4). Pharmacies 
classified as "Other" included those described by respondents 
as being within medical centies or private hospitals. 
Location was tabulated broadly as "Brisbane" or 
"Country". The data were entered as Postcodes, to allow 
receding into other groups eg regional, by Postcode Division. 
A wide variety of normal weekly trading hours was 
described by respondents, the most common (45.7%) being five 
week days (up to 6pm) and Saturday morning (up to 12 noon). 
For coding purposes, night trading was defined as any open 
hours beyond 6pm on week days, and week-end trading as open 
hours after 12 noon on Saturday and/or any open hours on 
Sunday. In the summarized results (Table 6) "Day and Night" 
included all pharmacies which were regularly open any night 
and week-end hours in addition to five week days and Saturday 
morning. Pharmacies classified as "Other" were mostly country 
pharmacies which were occasionally open at week-ends on a 
roster or on-call basis only. 
The questionnaire provided the option to express 
the pharmacy size in either square feet or square metres. 
Results have been tabulated in square feet, the units chosen 
by the majority of respondents, even though square metres were 
the official Australian units at the time of the survey. 
185 
Merchandising groups are groups of pharmacies which 
voluntarily integrate to enjoy the advantages of bulk buying 
and corporate image promotion. Chain pharmacies are virtually 
non-existent in Queensland, as pharmacy owners must be 
registered pharmacists, and pecuniary interest is limited to a 
maximum of four pharmacies (40). 
Pre-registration trainees were employed in 45 of 
the responding pharmacies, 38 of them for forty or more hours 
per week. 
In addition to registered pharmacists working forty 
hours or more, 63 pharmacies employed one pharmacist for 
between twenty and forty hours per week, eleven employed two, 
and three employed three. Pharmacists working less than twenty 
hours per week were employed by 162 pharmacies, 124 employing 
one, twenty employing two, ten employing three, and eight 
employing four or more. 
Pharmacy assistants working between twenty and 
forty hours per week were employed by 206 pharmacies, 113 
employing one, 53 employing two, 29 employing three, and 
eleven employing four or more. Assistants working less than 
twenty hours per week were employed by 263 pharmacies, 142 
employing one, 65 employing two, thirty employing three, and 
26 employing four or more. 
Reference books required to be held on the premises 
of Queensland pharmacies in 1984 in accordance with the 
Dispensary Regulations of 1973 (41) were current copies of the 
British Pharmaceutical Codex, the APF, Martindale's Extra 
Pharmacopoeia and the Poisons Regulations. Legal obligations 
were well adhered to, with each of the mandatory books being 
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held in over 90% of pharmacies, and all but the Codex being 
held by about 99%. Amendments to the Regulations in early 1985 
(42) dropped the Codex from the mandated schedule and added 
either the Prescription Proprietaries Guide (PP Guide) or the 
Monthly Index of Medical Specialties Annual (MIMS Annual), and 
the Handbook for Patient Medication Counselling (HPMC). 
TABLE 6 
PHARMACY INFORMATION 
Total number of responses = 582 
Results not tabulated if valid responses below 50% 
VARIABLE 
Site 
NUMBER OF 
VALID 
RESPONSES 
572 
VALUE 
Location 
Years of 
Trading 
575 
Trading Hours 5 7 3 
Years under 548 
Present Owner 
546 
NUMBER OF 
POSITIVE 
RESPONSES 
City Centre 176 
Regional Centre 46 
Suburban Centre 98 
Suburban Strip 220 
Other 32 
Br i sbane 2 7 3 
Country 302 
F ive Days 12 
Five Days/Sat. 262 
Five Days/Sat. 
am/Night(s) 136 
Five Days/Sat. 
am/Week-end 
Day and Night 
Other 
Less than 10 
10-19 
20-29 
30 or more 
Less than 10 
10-19 
20-29 
30-49 
50 or more 
44 
63 
56 
314 
124 
79 
31 
167 
124 
104 
61 
90 
PERCENT 
30.8 
8.0 
17.1 
38.5 
5.6 
47. 5 
52. 5 
2. 1 
45. 7 
23. 7 
7.7 
11.0 
9. 8 
57. 3 
22.6 
14.4 
5. 7 
30.6 
22.7 
19. 1 
11.2 
16.5 
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VARIABLE NUMBER OF 
VALID 
RESPONSES 
VALUE NUMBER OF 
POSITIVE 
RESPONSES 
PERCENT 
Size (Sq.Ft.) 502 
Merch. Group 572 
Turnover 
($ x 1000) 
500 
Prescr iption 
Proportion (%) 
533 
Staff: 
Full-Time 545 
Pharmacists 
(40 hrs or more) 
Full-Time 468 
Assistants 
(40 hrs or more) 
Less than 500 46 
500- 699 77 
700- 899 71 
900-1099 87 
1100-1299 66 
1300-1499 35 
1500-1699 32 
1700-1999 30 
2000 or more 58 
Nogroup 268 
Amcal 43 
Green Spot 71 
Pharmacare 29 
Soul Pattinson 15 
Sunshine 39 
Tri-Pharm 40 
Chemway 23 
Other/multiple 44 
Less than 200 143 
200-299 118 
300-399 93 
400-499 52 
500-599 37 
600-799 28 
800-999 12 
1000 or more 17 
Less than 25 76 
25-34 125 
35-44 86 
45-54 93 
55-64 80 
65-74 46 
75 or more 27 
None 5 
One 463 
Two 69 
Three 5 
Four 3 
None 23 
One 157 
Two 126 
Three 79 
Four 33 
Five 22 
Sixormore 28 
9 
15 
14 
17 
13 
7 
6 
6 
1 1 
46 
7 
12 
5 
2 
6 
7 
4 
7, 
28, 
23 , 
18. 
10, 
7, 
5. 
2 , 
3. 
14. 
2 3 . 
16 , 
17 . 
15 . 
8. 
5. 
0 . 
8 5 . 
1 2 . 
0 . 
0 . 
4 . 
3 3 . 
2 6 . 
16 . 
7. 
4 . 
.2 
. 3 
. 1 
. 3 
.2 
. 0 
.4 
. 0 
.6 
. 9 
.5 
.4 
. 1 
.6 
.8 
.0 
.0 
. 7 
.6 
,6 
,6 
,4 
.4 
,6 
.4 
,4 
3 
5 
1 
5 
0 
6 
1 
9 
0 
7 
9 
6 
9 
6 
9 
9 
1 
7 
6.0 
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VARIABLE NUMBER OF 
VALID 
RESPONSES 
VALUE 
References: 
Pharmaceutical 
Codex 542 
APF 576 
Mar t indale 57 3 
Poisons Regs 575 
HPMC 406 
Merck Manual 4 30 
MIMS Annual 385 
PP Guide 524 
Counselling Aids: 
Audio-Visual 449 
Books 490 
DHP Leaflets 526 
Education: 
Groups 443 
Other 400 
NUMBER OF 
POSITIVE 
RESPONSES 
PERCENT 
490 
570 
566 
570 
297 
294 
204 
449 
16 
1 61 
3 01 
9 
61 
90.4 
99.0 
98.8 
99. 1 
73.2 
68.4 
53.0 
85.7 
3.6 
32.9 
57.2 
2.0 
15.3 
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3.4.3 Dispensing Services 
Replies to the Dispensing Services section of the 
survey were received from 582 community pharmacies in 
Queensland. Information relating to dispensing services, 
collected by Questions 80-152 (Appendix 4) is presented in 
Tables 7 to 9. 
3.4.3.1 Physical Services (Table 7) 
Respondents from 400 pharmacies (69.2%, N=578) 
indicated that they provided a pick-up and delivery service 
for prescriptions. When asked later in the questionnaire about 
provision of a delivery service (Question 166), 455 (82.7%, 
N=550) answered positively. However, the re-test question did 
not mention the pick-up aspect of the service. 
Of the 79 pharmacies involved in private hospital 
dispensing, 57 (72.2% response) estimated the number of 
prescriptions per week. Of this 57, 50.9% dispensed less than 
twenty, 22.8% between twenty and fifty, and 26.3% fifty or 
more prescriptions per week for private hospitals. 
Of the 174 pharmacies involved in nursing home 
dispensing, 121 (69.5% response) estimated the number of 
prescriptions per week. Of this 121, 26.5% dispensed less than 
twenty, 36.4% between twenty and fifty, and 37.2% fifty or 
more prescriptions per week for nursing homes. 
Of the 54 pharmacies involved in medical centre 
dispensing, 32 (59,3% response) estimated the number of 
prescriptions per week. Of this 32, 65.5% dispensed less than 
twenty, 31.3% between twenty and fifty, and only one pharmacy 
fifty or more prescriptions per week for medical centres. 
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Of the 54 pharmacies involved in public hospital 
dispensing, 38 (70.4% response) estimated the number of 
prescriptions per week. Of this 38, 81.6% dispensed less than 
twenty, 15.8% between twenty and fifty, and only one pharmacy 
fifty or more prescriptions per week for public hospitals. 
Of the forty pharmacies involved in dispensing for 
other institutions, 26 (65.0% response) estimated the number 
of prescriptions per week. Of this 26, 26.9% dispensed less 
than twenty, 50.0% between twenty and fifty, and 23.1% fifty 
or more prescriptions per week for other institutions. 
Thirty-seven pharmacies claimed to be normally 
involved in dispensing requiring unusual extemporaneous 
techniques. Techniques listed included preparation of eye 
drops, injectables, dermatological and paediatric products. 
Forty-four pharmacies claimed to be normally 
involved in dispensing requiring unusual ranges of proprietary 
lines, mainly injectables. 
Computers were used for dispensing in 69 
pharmacies. On reposing the question later in the 
questionnaire (Question 161) 68 positive replies were received 
(N=516). Amfac Chemdata and Foundation were the most commonly 
used systems (26.1% each), followed by Vision Management 
(21.8%) and Paulding System 351 (17.4%). Most systems had been 
installed during 1984 (56.5%), with only 11.3% having been in 
use prior to 1982. Additional services nominated as being 
provided since installation of a computer included patient 
medication records (23 respondents) and drug information 
print-outs (22 respondents). 
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Because of the rapidly increasing penetration of 
computers into pharmacy, negative respondents were questioned 
about the future likelihood of computerization of their 
businesses. Valid responses were received from 507 
respondents, 31.4% of whom thought it likely or very likely 
that a computer would be installed within two years, 48.5% 
thought it unlikely or very unlikely, and 20.1% were 
undecided. Of the 159 respondents who considered 
computerization of their businesses likely or very likely 
within two years, 77 (48.4%) felt that installation would be 
within the following twelve months. 
Over ninety percent of respondents claimed to be 
users of ancillary labels. 
While 23 respondents said that the keeping of 
patient medication records was an additional service they had 
been able to provide since installing a computer, 62 (89.9%) 
computer users said that they stored such records on their 
computer system, including five respondents who used a 
combination of computer and card record systems. A total of 
203 respondents (35.5%, N=572) claimed to keep patient 
medication records but, among the 10% describing systems other 
than card or computer systems, there were a number of 
respondents who named prescription books as their recording 
method. Regular use of records stored in this way may be 
doubtful due to difficulties in retrieval of information. The 
question of patient medication records was posed again later 
in the questionnaire (Question 174) and 152 respondents 
(29.7%, N=512) responded positively. 
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NUMBER OF 
POSITIVE 
RESPONSES 
81 
235 
147 
61 
29 
535 
400 
PERCENT 
14.7 
42. 5 
26.6 
11.0 
5.2 
97. 1 
69.2 
TABLE 7 
PHYSICAL DISPENSING SERVICES 
Total number of responses = 582 
Results not tabulated if valid responses below 50% 
VARIABLE NUMBER OF VALUE 
VALID 
RESPONSES 
Prescriptions 553 Below 1000 
per Month 1000-1999 
2000-2999 
3000-3999 
4000 or more 
Waiting Chairs 551 
Delivery Service 578 
After-Hours 
Telephone 580 271 46.7 
Dispensing to: 
Private Hospital 490 79 16.1 
Nursing Home 537 174 32.4 
Medical Centre 459 54 11.8 
Public Hospital 464 54 11.6 
Other Institution 337 40 11.9 
Unusual Extemp-
oraneous Items 573 37 6.5 
Unusual Ready-
Prepared Items 564 44 7.8 
Dispensing 
Computer 580 69 11.9 
Ancillary 572 Never 47 8.2 
Label Use Occasional 122 21.3 
Routine 403 70.5 
Patient Medic- 572 No records 369 64.5 
ation Records Card system 84 14.7 
Computer 57 10.0 
Combination 5 0.9 
Other 57 10.0 
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3.4.3.2 Counsel]ing Services (Table 8) 
A large majority of respondents (83.7%) nominated 
the front counter as the usual site for patient counselling 
within the pharmacy. Although 28 pharmacies had separate 
counselling rooms, only two respondents nominated the room as 
being the usual counselling site. Of 22 pharmacies with a 
specially set up counselling areas, the special area was 
considered to be the usual counselling site in fourteen. 
The most commonly used aids to counselling were 
ancillary labels (87.5%) manufacturers leaflets (71.6%) and 
Department of Health Promotion Leaflets (66.8%). Use of 
computer handouts was mentioned by 43 (62.3%) of computer 
users. Counselling with aids other than those listed was 
claimed by 33 respondents. 
When questioned about the proportion of the 
professional fee which should be designated for counselling, 
higher levels of counselling remuneration were generally 
considered appropriate for ready-prepared items than for 
extemporaneous items. Sixty-four respondents were undecided 
about either. 
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TABLE 8 
COUNSELLING SERVICES 
Total Number of Responses = 582 
Results not tabulated if valid responses below 50% 
VARIABLE NUMBER OF 
VALID 
RESPONSES 
VALUE 
Counselling Room 561 
Counselling Area 533 
Usual Site of 558 
Counselling 
NUMBER OF 
POSITIVE 
RESPONSES 
28 
No counselling 
22 
Room 
Area 
Counte r 
Other 
2 
14 
467 
69 
PERCENT 
5.0 
4. 1 
1 . 1 
0.4 
2 
83 
12 
5 
7 
4 
Counselling with 
Ancillary Labels 538 
Counselling with 
Audio-Visual Aids 352 
471 
1 1 
87. 5 
3. 1 
Counselling with 
Computer Leaflets 366 
Counselling with 
DHP Leaflets 458 
43 
306 
11.8 
66.8 
Counselling with 
Manuf. Leaflets 450 
Proportion of 
Ready-Prep.Fee 
for Counselling 
Proportion of 
Extemp. Fee 
for Counselling 
537 
523 
322 
Less than 10 29 
10-19 82 
20-29 164 
30-39 87 
40-49 36 
5 0 o r m o r e 75 
Undecided 64 
Less than 10 45 
10-19 1 12 
20-29 141 
30-39 71 
40-49 29 
S O o r m o r e 61 
Undecided 64 
71 .6 
5.4 
15.3 
30. 5 
16.2 
6. 7 
14.0 
11.9 
8.6 
21.4 
27.0 
13.6 
5.6 
11.7 
12.2 
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3.4.3.3 Drug Surveillance (Table 9) 
In an attempt to measure the drug surveillance 
activities of community pharmacists, respondents were 
questioned about the frequency of reporting of suspected 
adverse drug reactions from their pharmacies and the extent of 
patient referral and contact with medical practitioners in 
relation to drug interactions, side effects, aspects of 
prescription and nonprescription medications, disease states 
and other professional matters. 
Official reports of adverse drug reactions to ADRAC 
using the "blue form", were low. In the preceding six months, 
28 respondents (5.2%, N=537) had filed a total of 57 reports. 
Only six respondents had submitted more than two reports in 
the six-month period. Reports to medical practitioners were 
more common, with 134 respondents (27.6%, N=486) having done 
so in the preceding six months, a total of about 400 reports. 
Assuming that pharmacists would be referring 
patients and contacting doctors more regularly on matters 
other than adverse drug reactions, they were questioned on 
their activities in this regard during the preceding week 
(Table 9). Apart from matters relating to prescription drugs, 
more issues were dealt with by referring patients to medical 
practitioners than by direct contact with doctors. Respondents 
were also asked to estimate whether activity during that week 
had been normal or more or less than usual in regard to 
patient referrals and doctor contacts. Most respondents felt 
that the activity had been about normal for both patient 
referrals (78.6%, N=494) and doctor contacts (72.6%, N=463). 
Fewer than twenty respondents considered that referrals and 
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contacts had been more frequent than usual during the period. 
Eighteen percent felt that they had made fewer referrals than 
usual, and 23.3% that they had had fewer contacts with doctors 
than usual. When questioned about interprofessional relations 
with medical practitioners, 42 pharmacists (7.4%, N=570) found 
medical practitioners to be co-operative only about half the 
time or less, while 61.9% found them co-operative most of the 
time, and 30.7% always experienced co-operation. 
TABLE 9 
DRUG SURVEILLANCE 
Patient Referral and Doctor Contacts for a One Week Period 
Total Number of Responses = 582 
REPORT TYPE 
Drug Interactions 
Patient (439) 
Doctor (408) 
Side Effects 
Patient (437) 
Doctor (395) 
Prescription Drugs 
Patient (386) 
Doctor (435) 
VALUE POSITIVE RESPONSES and (PERCENT) 
PATIENT DOCTOR 
None 
Once 
Twice 
3 or more 
None 
Once 
Twice 
3 or more 
None 
Once 
Twice 
3 or more 
Nonprescription Drugs None 
Patient (416) Once 
Doctor (371) Twice 
3 or more 
Disease State 
Patient (458) 
Doctor (381) 
Other Matters 
Patient (344) 
Doctor (339) 
None 
Once 
Twice 
3 or more 
None 
Once 
Twice 
3 or more 
396(90.2 
23 (5.2 
14 (3.2 
6 (1.4 
306(70.0 
85(19.5 
32 (7.3 
14 (3.2 
290(75. 1 
38 (9.9 
26 (6.7 
32 (8. 3 
311(74.8 
30 (7.2 
17 (4.1 
58(13.9 
170(37. 1 
51(11.1 
62(13.5 
175(38.2 
299(86.9 
16 (4.7 
9 (2.6 
20 (5.8 
370(90.7) 
20 (4.9) 
14 (3.4) 
4 (1.0) 
337(85.3) 
47(11.9) 
8 (2.0) 
3 (0.8) 
163(37.5) 
80(18.4) 
67(15.4) 
125(28.7) 
340(91 .6) 
18(4.9) 
7 (1.9 
6 (1.6) 
311(81 .6) 
42(11.0) 
14 (3.7) 
14 (3.7) 
243(71 .7) 
37(10.9) 
26 (7.7) 
33 (9.7) 
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3.4.4 Other Health-Related Services (Table 10) 
To identify specialized stock ranges and services, 
respondents were asked if their pharmacies provided specific 
goods and/or services. 
Stock ranges most commonly advertised by providers 
were nutritional supplements (48.3%) and invalid or health 
care aids (42.4%). Sports medicine supplies, asthma pumps, 
blood pressure monitors and blood glucose monitors were also 
advertised by greater than 35% of stockists. Only 10.0% of 
those providing ostomy supplies advertised the fact, perhaps 
because these items may have been supplied by prescription. 
Services most commonly advertised by providers were 
beauty treatment, ear-piercing, and make-up demonstrations 
(59-74%). Among specialized health-related services, the most 
commonly advertised were diabetic centres (47.9%) and blood 
glucose monitoring (42,3%), pregnancy testing (46.0%), and 
hire of invalid or health care aids (45.9%). Services related 
to blood pressure and pulse rate measurement were advertised 
by about one third of providers. Only 24.0% of those providing 
sports medicine services, such as strapping, advertised the 
service. 
Sixty-two respondents (12.6%, N=494) nominated 
other facilities provided by their pharmacies, including 
participation in the methadone programme, and provision of 
hearing tests and appliances. 
Seventy-three respondents (13.9%, N=524) expressed 
the intention of commencing special facilities or services, 
including computerized dispensing, diabetic centres, and 
nutritional supplies and/or services. 
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TABLE 10 
OTHER HEALTH-RELATED SERVICES 
Total number of responses = 582 
Results not tabulated if valid responses below 50% 
VARIABLE 
GOODS 
Asthma Pumps 
Blood Glucose Monitors 
Blood Pressure Monitors 
Health Care Aids (Sale) 
Homeopathic Medicines 
Naturopathic Medicines 
Nutritional Supplements 
Ostomy Aids 
S p o r t s M e d i c i n e Goods 
V e t e r i n a r y M e d i c i n e s 
SERVICES 
A c u p u n c t u r e 
Blood G l u c o s e M o n i t o r i n g 
Blood P r e s s u r e M o n i t o r i n g 
S e l f - O p . B . P . M e a s u r e m e n t 
P u l s e R a t e M e a s u r e m e n t 
B e a u t y T r e a t m e n t 
Make-up D e m o n s t r a t i o n s 
E a r - P i e r c i n g 
D i a b e t i c C e n t r e 
H e a l t h C a r e A i d s ( H i r e ) 
P r e g n a n c y T e s t i n g 
S p o r t s M e d i c i n e S e r v i c e s 
VALID 
RESPONSES 
546 
527 
535 
532 
504 
505 
537 
502 
509 
514 
517 
518 
509 
515 
518 
492 
512 
51 1 
509 
524 
531 
515 
POSITIVE 
RESPONSES 
356 
172 
292 
347 
74 
109 
377 
59 
244 
227 
4 
26 
42 
49 
73 
162 
245 
140 
71 
279 
189 
192 
PERCENT 
65.2 
32.6 
54. 6 
65.2 
14. 7 
21 .6 
70.2 
11.8 
47.9 
44.2 
0.8 
5.0 
8.3 
9. 5 
14. 1 
32.9 
47.9 
27.4 
14.0 
53.2 
35.6 
37. 3 
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3.4.5 Over-the-Counter Medication Services (Table 11) 
Review of the Australian and international 
literature did not reveal any innovative services from 
community pharmacy in relation to the provision of 
nonprescription medications. However, it was evident that 
differing estimates of community pharmacy involvement in 
primary health care services had resulted from studies 
employing various methodologies. Observational methods 
appeared to provide more reliable results than those depending 
on self-reporting or estimation. In this mail survey, 
investigation into the nonprescription drug area of practice 
was therefore restricted to eliciting opinions on the need for 
a class of drugs to be available from pharmacies only 
(Schedules 2 and 3), whether more drugs should be released 
into this category from prescription-only status (Schedule 4 ) , 
and what level of professional fee was being charged for 
supply of drugs in this category (Schedule 3). Considerable 
changes of this nature had occurred in Queensland shortly 
before the survey was conducted. 
Although the vast majority of respondents (98.6%) 
thought that a pharmacy-only class of drugs should continue to 
exist, only 47.7% thought that more drugs should be released 
into this category for pharmacist prescribing, with 15.1% of 
respondents undecided on the issue. 
Despite recommendations from PGA (Qld.Branch) that 
a dispensing fee of $3.60 should be charged on S3 medications, 
only 38.7% of respondents indicated that they were acting on 
this recommendation, with 22.7% not charging any fee despite 
requirements to supervise the sale and label the product. 
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TABLE 11 
OVER-THE-COUNTER MEDICATION SERVICES 
Total number of responses = 582 
Results not tabulated if valid responses below 50% 
VARIABLE 
Need for 
Pharmacy-Only 
Schedule 
NUMBER OF 
VALID 
RESPONSES 
576 
VALUE 
Yes 
No 
Undec ided 
NUMBER OF 
POSITIVE 
RESPONSES 
568 
1 
7 
PERCENT 
98.6 
0.2 
1 .2 
Need More 
Pharmacy-Only 
Medicines 
570 Yes 
No 
Undec ided 
272 
212 
86 
47. 7 
37.2 
15.1 
Fee Charged on 543 
Pharmacy-Only 
Medic ines 
No fee 123 
Less than $1 2 
$1.00-$1.99 94 
$2.00-$2.99 74 
$3.00-$3.99 23 
Guild ($3.60) 210 
$4.00 or more 3 
Var ious 14 
22. 7 
0.4 
17.3 
13.6 
4.2 
38.7 
0.6 
2.6 
3.4.6 Commercial Services (Table 12) 
Results relating to provision of commercial 
services have been included for completeness, even though not 
directly related to the aims of the study. In addition to the 
agencies listed, respondents were also acting as agents for 
various other groups including funeral plans, insurance, dry 
cleaning, hearing aids, post office and ambulance. Other 
services nominated by respondents included photo-copying and 
making appointments for clients with other health workers. 
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TABLE 12 
COMMERCIAL SERVICES 
Total number of responses = 582 
Results not tabulated if valid responses below 50% 
VARIABLE 
Customer Accounts 
Bankcard 
Other Credit Cards 
Tax Cards 
Discounts 
Bank Agency 
Building Society 
Agency 
Credit Union Agency 
Medibank Agency 
Medical Benefits 
Fund Agency 
Payment Agency 
for Gas 
Payment Agency 
for Electricity 
Payment Agency 
for Rates 
Justice of the Peace 
Film Processing Agent 
Passport Photos 
Adult Scales 
Baby Scales 
NUMBER OF 
VALID 
RESPONSES 
572 
571 
538 
573 
541 
479 
479 
452 
499 
NUMBER OF 
POSITIVE 
RESPONSES 
523 
494 
343 
532 
345 
107 
125 
47 
206 
PERCENT 
91 .4 
86.5 
63.8 
92.8 
63.8 
22. 3 
26. 1 
10.4 
41 . 3 
560 
503 
513 
508 
522 
576 
496 
553 
550 
515 
29 
24 
161 
566 
62 
437 
474 
92.0 
1 .4 
5.7 
4. 7 
30.8 
98. 3 
12.5 
79.0 
86.2 
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3.5 DISCUSSION 
3.5.1 Community Pharmacy Services 
Ob iective 1 - To determine the nature and extent of 
services being provided through community pharmacies 
in Queensland. 
Objective 1 has been fulfilled by 3.4.3 to 3.4.6 
and summarized in Tables 7 to 12. Services related to 
dispensing have been presented as physical aspects (Table 7), 
counselling (Table 8) and drug surveillance (Table 9). Other 
health-related services identified were either involved mainly 
with the sale of specialized stock ranges, or combined 
services including monitoring and testing with the stocking of 
such ranges of goods (specialized services) (Table 10). The 
mail survey methodology was considered inappropriate for 
measurement of extent of services related to nonprescription 
medication, but opinions on controversial issues in this field 
at the time were presented in Table 11. Commercial services 
were listed in Table 12. 
The range and extent of innovative specialized 
services being provided by at least five percent of community 
pharmacies in Queensland at the end of 1984 are shown in Table 
13. Pharmacies offering diabetic services were classified by a 
positive response to operation of a "diabetic centre" and/or 
provision of a staff-operated blood glucose monitoring 
service. Pharmacies offering hypertensive services were 
identified by positive response to the provision of a 
staff-operated blood pressure monitoring service. It is 
interesting to note that 70% (408) of the pharmacies were 
involved in one or more of the listed non-traditional service 
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areas. Fifty percent of these were providing one service only, 
35.8% were providing two, 11.0% were providing three, and the 
remaining 3.2% were providing four or five of the listed 
services. 
TABLE 13 
SPECIALIZED SERVICES 
SERVICES No. of 
RESPONSES 
No. PROVIDING 
SERVICE 
% PROVIDING 
SERVICE 
Invalid or Health 
Care Aids Hire 524 
Sports Medicine 
Services 515 
Pregnancy Testing 
in Pharmacy 531 
Diabetic Services 526 
Hyper tens ive 
Services 509 
279 
192 
189 
80 
42 
53.2 
37. 3 
35.6 
15.2 
8. 3 
NOTE: Frequencies below 5% not tabulated 
The 1982 study of pharmacies in NSW and ACT by 
Ortiz et al (43) found that pharmacies dispensed an average of 
520 prescriptions per week, which translates to a figure of 
2253 per month. Patient medication records were kept by 17% of 
pharmacies. Although this figure is lower than that found by 
the 1984 Queensland survey, it may be attributable to the 
increased penetration of computerized dispensing systems 
during the period: 7% recorded in NSW/ACT in 1982 and 12% in 
Queensland in 1984. (Compare Table 7). Ortiz et al (43) found 
that 8% of pharmacies had a counselling area separated from 
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the normal trading environment, and that 26% of respondents 
used aids to assist counselling, including special reference 
books, patient leafets, advisory labels, charts, and 
demonstration units. (Compare Table 8). Services identified in 
pharmacies in NSW and ACT by Ortiz et al (43) in 1982 were 
pregnancy testing (64%), blood pressure testing (11%), pulse 
rate measurement (1.7%), urine testing (0.7%) and blood 
glucose testing (0.6%). (Compare Table 10). Although pregnancy 
testing was offered by a much lower proportion of pharmacies 
in the Queensland study, a higher proportion indicated 
involvement in diabetic services. This may have been due to 
pharmaceutical company participation in the setting up of 
diabetic centres in community pharmacies during this period. 
3.5.2 Pharmacist Characteristics 
Objective 2 - To collect demographic data about 
pharmacists engaged in community pharmacy practice 
in Queensland. 
Objective 2 has been fulfilled by 3.4.1 and 
summarized in Table 4. Demographic details of pharmacists in 
charge were presented in Table 5. 
Interstate comparisons of pharmacist demographics 
were not readily available for the period under study, but 
figures prepared from the data collected by Pharmacy Boards in 
1982 (44) indicated that extrapolation to the Australian 
situation would not be possible. For example, the proportion 
of female registrants varied between States from 29.0% in WA 
to 47.3% in ACT. Respondents to the 1982 surveys employed in 
community pharmacies varied from 63.9% in Tas. to 88.0% in WA, 
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with the proportion of females employed in community pharmacy 
varying from 22.9% in SA to 43.6% in ACT. Age distribution 
also varied between States from 25.5% of employed pharmacists 
in SA aged between 40-49 years to 46.2% in ACT. However, wide 
variations in response rates were also evident, ranging from a 
low of 58.4% of NSW registrants to a high of 88.6% of 
Tasmanian registrants. 
The only comparable Australian study was a survey 
conducted in NSW and ACT in 1982 (43), which received replies 
from 68% of pharmacies. The survey found that the pharmacists 
in charge were 87% male, aged between 21 and 77 years with a 
mean of 44 years, 64% with Ph.C. and 36% with B.Pharm. 
qualifications. Most respondents (79%) worked more than forty 
hours per week. Pharmacists in charge were the sole owners of 
55% of pharmacies, partners in 28%, and employees in 18%. 
Membership of PSA was claimed by 85%, and of PGA by 80%. One 
third of respondents had attended an educational function in 
the preceding twelve months. The AJP was cited as the most 
commonly received journal. (Compare Table 5). 
3.5.3 Pharmacy Characteristics 
Objective 3 - To collect business characteristic 
data about community pharmacies in Queensland. 
Objective 3 has been fulfilled by 3.4.2 and 
summarized in Table 6. 
The 1982 survey by Ortiz et al (43) found that 17% 
of NSW and ACT pharmacies were located in central business 
districts or small country towns, 8% in regional shopping 
centres, 36% in local neighbourhood shops, 36% in suburban 
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shopping strips, and 4% in other locations. Only 33% of 
pharmacies opened for normal trading hours, with the remainder 
open for longer hours. Sixty percent were members of a 
marketing group. The average turnover was in the vicinity of 
$320,000 per annum. The respondent was the only full-time 
pharmacist employed in 69% of pharmacies. (Compare Table 6). 
Interstate variations in community pharmacy 
business characterisics have been reported in the Guild 
Digest, 1986 (39). 
3.5.4 Factors Involved in Provision of Specialized Services 
Objective 4 - To determine the relationships between 
demographic and business factors and the provision of 
innovative specialized services. 
A series of null hypotheses of the general form 
"There is no difference in (variable) between providers and 
nonproviders of (service)." were tested by the chi square 
statistic, using a critical significance level of P=0.05. 
The demographic and business information variables 
listed in Table 14 were correlated against the specialized 
services shown in Table 13. The analysis was intended as a 
screening procedure to facilitate further investigation of 
factors affecting the establishment and operation of 
specialized services. 
Only demographic and business variables 
significantly related to the provision of each specialized 
service have been discussed. 
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TABLE 14 
DEMOGRAPHIC and BUSINESS FACTORS 
DEMOGRAPHIC VARIABLES 
Sex 
Age 
Year and type of pharmacy qualification 
Pharmacist Status ie owner, partner, manager 
Membership of professional organizations 
Attendance at continuing education activities 
BUSINESS VARIABLES 
Site 
Location ie city or country 
*Trading Hours 
Size 
Marketing Group membership 
Turnover 
Prescription proportion 
Availability of reference texts 
*For comparative purposes, trading hours were grouped into 
normal, extended and other, defined as follows: 
Normal Trading Hours - Mon. to Fri. to 6 p.m 
or Mon. to Fri. to 6 p.m. 
and Sat. to 12 noon 
Extended Trading Hours - Regularly extending beyond 
6 p.m. one or more nights 
per week, and/or after 12 
noon Sat., and/or Sun. 
Other Trading Hours - Less than five days per 
week or irregular extended 
hours on call or rostered. 
3.5.4.1 Invalid or Health Care Aids Hire Service 
Sex of the pharmacist was the only demographic 
factor showing significant differences between providers and 
non-providers of a hire service (x =8.25 DF=1 P=0.004). A 
larger proportion of male respondent pharmacists (56%) than 
female (39%) were involved in the provision of this service. 
The reason for this difference has not been elucidated, but it 
is possible that the heavy and cumbersome nature of aids such 
as wheelchairs may be an influencing factor in the decision to 
implement such a service. 
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Significant business factors (Figure 1) in 
provision of an invalid aids hire service were site and size 
of the pharmacy, turnover, proportion of turnover resulting 
from prescription trade, and marketing group membership. 
FIGURE 1 
Business Fac to rs R e l a t e d to Provision of Invalid Aids Hire Serv ices 
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Higher proportions of responding suburban shopping 
centre pharmacies and city or town centre pharmacies were 
involved in hiring (x =12.58 DF=4 P=0.014, Fig 1A). Less 
involvement was seen in regional shopping centres and 
neighbourhood shopping strips. The contribution by pharmacies 
classified as "other" is numerically small, as this group 
comprised less than 10% of the total sample. Definitions of 
sites were provided by the survey instrument (Appendix 4). 
A greater proportion of larger pharmacies (x 
=20.85 DF=8 P=0.008, Fig 1B) was involved. Lack of physical 
space may indeed be a limiting factor in the decision to 
provide such a service. 
A greater proportion of pharmacies with higher 
turnover was providing a hire service (x =20.00 DF=5 
P=0.001, Fig IC). However, the relationship between provision 
of this service and the prescription proportion of the 
business appears to be more complex (x =13.20 DF=6 P=0.040, 
Fig 1D). 
Strong inter-relationships were found to exist 
between business factors. The correlation between size and 
turnover (x =228.16 DF=24 P=0.0001) appeared to be the only 
comparision showing a pattern consistent with the relationship 
to provision of invalid or health care aids hire service. It 
may be postulated, although a causal relationship cannot be 
established, that the convenience of a suburban shopping 
centre pharmacy in terms of distance and off-road parking, 
combined with an area sufficient for storage of required 
stock, and a turnover sufficient to allow investment in the 
required equipment may provide a set of conditions optimal for 
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the development of invalid and health care aids services. 
A greater proportion of merchandising group members 
(59%) was providing the service than of non-members (47%) (x 
=7.80 DF=1 P=0.005). Further investigation of this factor 
showed that the group with major involvement had invested in a 
Home Health Care company the previous year and had offered 
training nights to pharmacy staff in this area of business 
during 1984. 
3.5.4.2 Sports Medicine Services 
Sports medicine services eg strapping, were offered 
by a higher proportion of pharmacists who had attended general 
continuing education programmes during 1984 (42%) than of 
those not attending (32%) (x =5.35 DF=1 P=0.021). Further 
investigation showed that evening lectures were the major type 
of continuing education (CE) involved. The principal CE 
provider in Queensland, PSA (Qld.Branch), had offered evening 
lectures on the topic of Sports Medicine at several centres 
throughout the State during 1984. Although this may appear to 
be an influence in the provision of this service, the 
methodology of the survey was not designed to test such a 
relationship. It may be that pharmacists already involved in 
sports medicine were those motivated to attend lectures on the 
subject, or that innovative practitioners in general are those 
more likely to attend continuing education courses. 
No business factors were found to be significant to 
the provision of this service. 
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3.5.4.3 Pregnancy Testing Service 
Age of the pharmacist (x =11.65 DF=4 P=0.020) 
type of pharmacy qualification (x =15.01 DF=1 P=0.001) and 
year of qualification (x =9.528 DF=3 P=0.023) were 
significantly different demographic features between providers 
and non-providers of a pregnancy testing service. Since 
respondents had predominantly qualified in Queensland, where 
pharmaceutical education underwent a transition from an 
apprenticeship system conferring the qualification of 
Pharmaceutical Chemist (Ph.C.) to a university course 
conferring the degree of Bachelor of Pharmacy (B.Pharm.) in 
the early 1960's, and as the vast majority of students proceed 
directly from school to pharmacy education, strong 
correlations exist among these three factors eg for comparison 
of age and year of qualification, R=0.89. Provision of the 
service was predominantly by young, more recent B.Pharm. 
graduates. Pregnancy testing techniques have been covered in 
the undergraduate course in Queensland since the mid-1970s. 
The development of easily performed, reliable in vitro tests 
may have accelerated the provision of pregnancy testing 
services in community pharmacies. 
Business factors (Figure 2) significantly related 
to the provision of a pregnancy testing service were site, 
location, and opening hours of the pharmacy. 
The service was offered by a higher proportion of 
pharmacies in regional shopping centres than other sites 
(x =13.97 DF=4 P=0.007, Fig 2A) and a higher proportion of 
pharmacies in the Brisbane metropolitan area (47%) than 
pharmacies outside Brisbane (25%) (x =25.93 DF=1 P=0.0001). 
FIGURE 2 
Business Factors Related to Provision of Pregnancy Testing Services 
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2B Business Hours 
A higher proportion of pharmacies with extended 
trading hours (x =21.32 DF=2 P=0.0001, Fig 2B) were 
offering the service. 
Significant relationships were found to exist 
between site and trading hours (x =66.22 DF=8 P=0.0001), 
location and trading hours (x =24.13 DF=2 P=0.0001), and 
site and location (x =28.43 DF=5 P=0.0001). It cannot be 
determined from the current study whether any or all of the 
factors are causal to the provision of pregnacy testing 
facilities. 
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3.5.4.4 Diabetic Services 
Pharmacies offering diabetic services were 
classified by a positive response to operation of a "diabetic 
centre" and/or provision of a staff-operated blood glucose 
monitoring service. 
Diabetic services were offered by a higher 
proportion of male pharmacist providers (17%) than females 
(8%) (x =4.40 DF=1 P=0.036) and by a higher proportion of 
pharmacists in partnership situations (22%) than by sole 
owners (16%) or managers (7%) (x =11.83 DF=2 P=0.003). A 
significant relationship was found between the sex and status 
of the pharmacist (x =123.28 DF=4 P=0.0001) such that 
around 85% of responding pharmacists of owner or partner 
status were male. As well as the influence of ownership, other 
questions which arise for follow-up studies of the factors 
affecting the provision of these services include issues such 
as the likelihood of providers of the service or members of 
their family being diabetic. 
Some pharmacies identifying themselves as "diabetic 
centres" may have been functioning only in a supply capacity 
and not in a service role. A pharmaceutical firm specializing 
in diabetic goods identifies selected pharmacies handling 
their products as Diabetic Self-Care Centres. The survey 
instrument was designed to identify suppliers of diabetic 
goods and/or services for inclusion in follow-up studies. 
Members of the PGA, an organization for pharmacy 
owners, were offering services in greater proportions (18%) 
than non-members (7%) (x = 6.16 DF=1 P=0.013). The Guild 
policy was not actively promoting diabetic services in 1984. 
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Business factors (Figure 3) related to provision of 
diabetic services were pharmacy location, size, turnover, and 
marketing group membership. 
FIGURE 3 
Business Factors Related to Provision of Diabetic Ser vices 
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A higher proportion of pharmacies outside the 
Brisbane metropolitan area (19%) was involved in the provision 
of these services than Brisbane pharmacies (11%) (x =7.49 
DF=1 P=0.006). 
Smaller pharmacies were involved in lower 
proportions (x =19.85 DF=8 P=0.011, Fig 3A), as were 
pharmacies with lower turnovers (x =17.56 DF=5 P=0.004, Fig 
3B). As previously mentioned, size and turnover were found to 
be inter-related (P=0.0001). 
Relationships were also found to be significant 
between size and location (x =18.93 DF=8 P=0.015) and 
between location and turnover (x =28.43 DF=5 P=0.0001) such 
that Brisbane pharmacies were generally smaller than country 
pharmacies, and 61% of pharmacies in Brisbane reported an 
annual turnover below $300 000 compared to 45% of country 
pharmacies. It may be that metropolitan diabetics are more 
likely to obtain their needs through illness support groups 
such as the Diabetic Association of Queensland, or it may be 
that expansion into diabetic services is not a viable exercise 
for the smaller pharmacy, both in terms of physical size and 
turnover. 
Marketing group members were involved in diabetic 
services in a higher proportion (18%) than non-members (12%) 
(x =4.10 DF=1 P=0.043), but the contribution of individual 
groups was found not to vary significantly (P=0.215). 
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3.5.4.5 Hypertensive Services 
Pharmacies offering hypertensive services were 
identified by positive response to the provision of a 
staff-operated blood pressure monitoring service. 
No demographic factors were found to be 
significantly related to the provision of hypertensive 
services. 
Site was the only business factor which varied 
between providers and non-providers (x =9.61 DF=4 P=0.048). 
The service was offered by higher proportions of pharmacies in 
regional shopping centres (16%), and city or town centres 
(12%). Possible interpretation could be that pharmacies in 
these situations have a larger, more varied customer flow 
providing a larger potential pool of candidates for 
screening. 
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3.5.5 Selection of a Specialized Pharmacy Practice Area 
Objective 5 - To select an area for in depth 
investigation of the development of innovative 
specialized practice. 
From the innovative specialized services listed in 
Table 13, diabetic service was chosen for follow-up studies to 
elucidate the precise nature of the service, the extent of 
use, and causal factors in service development. The selection 
was based on the diversity of possible services which could be 
provided to diabetic patients through community pharmacies 
indicated by international literature review, and the variety 
of demographic factors (sex, pharmacist status, PGA 
membership) and business factors (location, size, turnover, 
merchandising group membership) which were shown 
experimentally to differ between providers and nonproviders of 
diabetic services. Also, the identified sample (80 pharmacies) 
was large enough for further study, especially as means were 
available for expanding the sampling frame (Ames list etc). 
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Chapter 4 
SURVEY OF DIABETIC SERVICES 
FROM COMMUNITY PHARMACIES IN 
QUEENSLAND. 1 9 8 €» — 8 7 
4.1 INTRODUCTION 
Provision of diabetic services was chosen as the 
specialized area of practice for further investigation because 
of the size of the identified sample, the variety of 
demographic and business variables significant to its supply, 
and the scope for involvement in various aspects of service. 
Review of the international literature showed that 
reasons given by practitioners for becoming involved in the 
provision of diabetic services included perceiving the needs 
of a large number of diabetics in the local community (1,2) 
and having a diabetic in the family (3,4). Rewards for 
involvement were seen as both professional and financial 
(2,5,6). 
An Australian pharmacist active in the field (7) 
was of the opinion that, while all pharmacies needed to have 
some involvement with diabetic patients, not all were required 
to be specialized outlets. However, these outlets needed to be 
strategically placed deraographically to ensure efficient 
service for patients. 
Suggestions have been made and reports published, 
both in Australia and overseas, regarding potential community 
pharmacy involvement in aspects of diabetic care including 
service provision, supply functions and counselling. 
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4.1.1 Services 
Services suggested or reported have included: 
1. patient and pharmacy staff education via 
leaflets, booklets, and audio-visual means (2,5,6,8-23), 
2. blood or urine glucose screening and/or 
monitoring either on a regular basis or as part of a promotion 
such as Diabetes Week (1,3,5,7,9,12,22-29), 
3. assistance in the case of blood glucose 
monitoring equipment problems (1), 
4. maintenance of patient profiles 
(5,6,8,10,11,30,31). 
A study by Zelnio et al (32) found that both 
patients and medical practitioners reacted favourably to 
pharmacists providing informational services such as 
educational pamphlets, keeping patient profiles, and teaching 
testing techniques. However, their attitude was less 
favourable towards pharmacists performing urine tests, taking 
blood samples, checking injection sites or teaching insulin 
injection techniques. 
4.1.2 Supply 
The establishment of a specific area of the 
pharmacy for storage and display of diabetic goods has been 
advocated and reported (1,4,6,8,9,14,20,22), with some authors 
recommending that such an area should also provide facilities 
for training patients in techniques (5,6,22,29). 
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Among the wide range of diabetic goods suggested 
for stock have been: 
1. prescription-only items such as oral 
hypoglycaemics (5,10,14,33), 
2. a range of insulin types (5,6,9,10,14,33,34), 
3. disposable syringes (1,5-7,14,15,34), glass 
syringes and disposable needles (5,9,34), automatic injectors 
(4,34) and other injection aids including scale magnifiers 
(14,15), devices for destroying needles (15,34) and alcohol 
swabs (5,8,14,29,34), 
4. blood glucose monitors (1,5-7,14,22,34) and 
ancillary items such as blood glucose testing strips 
(5-7,14,22,29,34) and blood letting devices (6,14,22,29,34), 
5. urine testing equipment, strips and tablets 
(5-7,9,10,14,22,29,34,35), 
6. diabetic sweets (1,9) and diabetic foods 
(5,6,14), 
7. sugar substitutes (5,9,29), 
8. identification cards, bracelets and/or tags 
(6,8,10,14,36), 
9. glucagon injection (10,34), 
10. oral glucose (5,10,15,34), 
11. books on diabetic diet and/or diabetes and its 
management (6,9,10,14). 
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4.1.3 Counselling 
Areas in which pharmacists were suggested to be of 
potential assistance in counselling diabetic patients 
included: 
1. storage, administration and other aspects of 
insulin therapy (6,8,10,11,16-18,33-40), 
2. methods of measuring blood glucose, including 
care of monitors, blood sampling techniques, and record 
keeping (1,6, 15, 17-19,20,29,33,37-39), 
3. measuring and recording urine glucose 
(6,10,18,27,33,35-37), 
4. oral hypoglycaemic therapy including dosage and 
drug interactions, and advice about other prescription drugs 
which may affect blood glucose levels (5,6,10,14, 
17,29,31,33,36,39) , 
5. selection of nonprescription medications, 
including advice on sugar content of medicines 
(5,6,9-11 ,14,22,31,36,37,41 ), 
6. aspects of diabetic management including dietary 
advice (10,18,35-38,42), coping with diabetic emergencies 
(6,17,18,33,34,36-38), foot care (6,9,10,14,15,18,31,35,36, 
38,39) and eye care (31,35,43). 
The role of the pharmacist in referral of diabetic 
patients to other health care professionals was also 
emphasized (3,12,14,22,23,28). For effective counselling to 
occur, Cohen (14) stressed the need for knowledgeable staff. A 
pharmacist involved in the field (4) noted that considerable 
time was spent advising patients, and that pharmacists and 
staff could add to their knowledge by taking an interest in 
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the subject, talking and listening to diabetics, and reading. 
Other suggested methods for improving knowledge were attending 
diabetes education programmes (5,6,22), reading diabetes 
journals (22), and joining local Diabetic Associations 
(5,6,22) or Diabetic Educators' Associations (5,6,29). 
4.2 AIMS 
The aims of the study into specialized diabetic 
practice were: 
1. To document the services offered to patients by 
pharmacies involved in the provision of diabetic services. 
2. To document the types of stock held by community 
pharmacies relevant to diabetes. 
3. To estimate the degree of counselling 
involvement which community pharmacists perceive themselves to 
have with diabetic patients. 
4. To document the educational background of 
diabetic service providers. 
5. To document the historical development of 
provision of diabetic services from community pharmacies in 
Queensland. 
6. To determine the motivation for practitioners to 
become involved in provision of diabetic services, 
7. To classify pharmacies involved in specialized 
diabetic practice into levels of service provision. 
8. To describe the services provided at each level 
of specialization. 
9. To describe the characteristics of pharmacists 
and pharmacies at each level of specialization. 
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4.3 METHODOLOGY 
4.3.1 The Sample 
4.3.1.1 Sample Type 
Review of the contemporary literature failed to 
reveal specific surveys of diabetic service provision from 
Australian community pharmacies. Because of the lack of 
comparative information, a census was again selected as the 
appropriate sampling approach. As the population of community 
pharmacies providing diabetic services was estimated to be 
less than 20% of the total population of community pharmacies 
in Queensland, cost and time factors posed few problems. 
4.3.1.2 Sampling Frame 
The group of pharmacies to be surveyed was intended 
to include all pharmacies in Queensland with an interest and 
involvement in diabetic services. Several means of 
identification were employed in order to achieve this aim, and 
pharmacies were included in the sample on the basis of one or 
more of the following: 
1. a positive response to the mail Survey of 
Pharmaceutical Services Provided by Community Pharmacies in 
Queensland. 1984 in the areas of provision of a staff-operated 
blood glucose monitoring service and/or the operation of a 
diabetic centre in the pharmacy, 
2. the appearance of the name of the pharmacy in 
the Ames Self-Care Centres Directory, April 1986, 
3. the appearance of an advertisement regarding 
diabetic services by the pharmacy in the relevent district 
edition of the Yellow Pages, Telecom Australia, 1986, 
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4. the appearance of an advertisement by the 
pharmacy in recent editions of diabetic publications such as 
Diabetes Conquest (Australian Diabetes Foundation), Control 
(Diabetic Association of Queensland) or Diabetes in the News 
(Miles Laboratories, Aust.), 
5. other indications such as ownerwship by a 
pharmacist also owning a pharmacy identified by the previous 
means, known interest by the owner at a previous address, 
referral by a pharmacist from an identified pharmacy, and 
recent letters on diabetic issues to the editors of pharmacy 
publications such as the Australian Journal of Pharmacy and 
the Australian Pharmacist. (These means of identification were 
only recorded if the pharmacy had not already been identified 
by one or more of the previous means.) 
A total of one hundred and forty-two pharmacies 
were identified through these sources, as shown in Table 15. 
TABLE 15 
IDENTIFICATION OF PHARMACIES OFFERING DIABETIC SERVICES 
Sample Size = 142 
SOURCE NUMBER PERCENT 
1984 Survey 74 52.1 
Ames Self-Care 77 54.2 
Yellow Pages 5 3.5 
Advertisements 2 1-4 
NOTE: As pharmacies may have been identified from more than 
one of these sources, percentages sum to greater than 100%. 
Total Other 24 26.9 
Compos ed of: 
Same Owner 5 3,5 
Interested Owner 5 3,5 
Referred 13 9,2 
Letter 1 0-7 
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4.3.2 Survey Type 
It was decided to collect information from 
pharmacies involved in diabetic services by two methods. The 
two methods were applied to the same population to provide 
different information (44). A telephone interview was 
conducted regarding aspects of service provision, followed by 
a mail questionnaire designed to collect information about 
both the businesses and the pharmacists involved. Combining 
various methods for use in a single survey has been advocated, 
the advantages of this approach being that each method could 
complement the other methods used, thereby compensating for 
each other's inadequacies (44-46). 
The main advantages of the telephone interview in 
this specific instance were that it would be likely to result 
in a higher response rate and allow faster collection of 
information than would a mail survey. Also, by conducting the 
telephone interview first, an opportunity would be provided to 
establish rapport with respondents prior to their receiving 
the mail questionnaire, thus being likely to increase the 
response rate to that section also (44,47-50). Other 
advantages of using a telephone interview component are that 
it can be used for questions that are difficult to answer on a 
mail questionnaire, such as open-ended questions, those 
needing to be answered in sequence, or those requiring a 
series of screen questions (44,48). The facility for 
discussion increases the likelihood of receiving complete and 
accurate answers to open-ended questions and decreases the 
chance of misinterpretation of the questions (49,51). While 
these advantages are shared by face-to-face interviews, the 
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telephone method is less expensive (49,51). This consideration 
was of particular concern because of the wide geographic 
distribution of pharmacies in Queensland. The main 
disadvantage of the telephone method is that respondents may 
be less inclined to answer sensitive or personal questions 
(49,51). 
The mail technique allowed respondents the 
flexibility of completing the questionnaire at a convenient 
time, with the opportunity to consult other sources of 
information without incurring the expenses which would be 
involved in a prolonged telephone interview (44,50). Mail 
questionnaires also have the advantages of being able to be 
used for questions which may be difficult to handle by phone, 
such as personal or sensitive items, long questions, items 
needing to be ranked, or questions needing diagrams or 
pictures (44). 
4.3.3 Preliminary Pilot Study 
As with the previous survey, the preliminary pilot 
study was conducted by informal discussions with community 
pharmacists. Pharmacists selected for interview at the 
preliminary stage were those known, either by reputation or by 
advertising, to be involved in the provision of diabetic 
services . 
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4.3.4 Data Management and Analysis 
4.3.4.1 Data Coding 
Numerical codes were used for both numerical and 
categorical data, applying the same rules as were used in the 
previous survey. In addition, for questions using Likert-type 
scales offering gradation of response, '1' was used for the 
most negative response (48). The data coding key was set up as 
a library within the analytical package Statistical Analysis 
System (52) to allow output to be readily checked and 
interpreted (53). 
For the telephone interview section of the survey, 
answers were recorded in full or marked on the survey form and 
codes later written on the right hand side of the 
questionnaire to reduce intermediate coding steps and 
consequent chances of error, and to facilitate data entry 
(48,53,54). 
For the mail survey, where possible, codes were 
included on the questionnaire (53). Codes not built into the 
survey instrument were later written directly onto the right 
hand side of the questionnaire forms. 
Responses to attitudinal questions were recorded 
directly as numerical codes. Open-ended questions were 
assessed and coded by the chief researcher to maintain 
consistency (53). 
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4.3.4.2 Data Entry and Cleaning 
Information was entered into the computer in three 
data bases. Telephone Interview, Mail Survey Pharmacy 
Information and Mail Survey Pharmacist Information. As the 
number of cases was fewer than for the previous survey, data 
was entered once only into the computer and checked manually 
for accuracy against the original survey forms (53). 
On completion of each data base, frequency tables 
were computed and checked for inconsistencies such as 
uniqueness of record identifiers, and values outside the range 
for each variable (53,54). The data coding key was arranged to 
designate miscodes outside the allowable ranges. 
4.3.4.3 Analysis 
Analysis of the results was performed using the 
University of Queensland Prentice Computer Centre mainframe 
IBM 3083 E24 computer with VMS/CMS operating system and the 
Statistical Analysis System, SAS (52). 
Nonpararaetric statistical procedures were employed 
for variables of the nominal type (55-57). Ordinal data, such 
as that collected by Likert scales, were analysed by 
summation, and a mean score for each variable calculated (58). 
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4.4 TELEPHONE INTERVIEW 
4.4.1 Aims 
The aims of the telephone interview were: 
1. To document the services offered to patients by 
pharmacies involved in the provision of diabetic services. 
2. To document the types of stock held by community 
pharmacies relevant to diabetes. 
3. To estimate the degree of counselling 
involvement which community pharmacists perceive themselves to 
have with diabetic patients. 
4.4.2 Respondents 
The respondent was defined as the pharmacist most 
involved in dealing with diabetic customers (Appendix 8). 
4.4.3 Survey Instrument 
The questionnaire (Appendix 8) was composed of six 
sections: an introduction (8 variables); three sections to 
collect information relevant to the stated aims regarding 
Services (20 variables). Supply (24 variables) and Counselling 
(56 variables); Business Information (13 variables); and 
Demographic Details (4 variables). 
4.4.3.1 Length 
It was estimated that the questionnaire would take 
fifteen to twenty minutes to administer. Although this was 
recognized as possibly inhibitory to response, it was hoped 
that this problem would be overcome by the respondents' 
interest in the topic (50). In practice, many interviews 
extended up to thirty minutes. If the duration of the 
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questionnaire or external interruptions posed a problem to 
individual respondents, the design of the survey instrument 
allowed the interview to be suspended after the 'Supply' 
section and resumed at a later time without disruption. 
Dillman (47) stated that, once begun, the length of the 
interview did not seem to affect completion rates. 
4.4.3.2 Appearance 
As the survey instrument was not seen by the 
respondents, appearance was important only to allow 
consistency and ease of administration by the interviewer 
(48). Considerations in this regard included clarity of type, 
using lower case for all sections to be read by the 
interviewer to the respondent, and upper case for interviewer 
instructions included on the survey instrument (48,49). Page 
turns were placed at intervals suitable to the interviewer 
rather than based on the length of the page. In this way, the 
interviewer was not required to turn the page in the middle of 
posing a question, and partially blank pages did not distract 
the respondent (48). In accounting for the needs of the 
respondent, attention was paid more to the sound than the 
appearance of the survey instrument (48). 
4.4.3.3 Confidentiality 
The respondents' individual right to privacy must 
be protected by assurance of confidentiality (59). This 
assurance was offered in the introductory section of the 
survey instrument, immediately after the respondent's consent 
to participate had been received. 
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4.4.3.4 Question Sequence 
Screening questions to determine the eligibility of 
respondents were included at the beginning of the survey 
instrument for time and cost reasons (60). Screens are easy to 
manage in a telephone questionnaire format (47). 
The questions were ordered to maximize respondent 
participation (48). As discussed in relation to the previous 
survey, early questions were general, relevant to the topic 
and easy to answer, and potentially objectionable questions 
such as personal or sensitive demographic details were placed 
towards the end. Dillman (48) has suggested that if 
respondents answer the first few questions, they are likely to 
complete the interview. To facilitate the opening of the 
interview and overcome respondents' doubts about lack of 
knowledge of the topic, the first question was closed-ended 
and simple to answer, followed by an open-ended question to 
allow respondents to express their opinions and establish 
rapport with the interviewer (48, Appendix 8). The order and 
format were designed with a logical flow and to keep the 
attention of the respondent (48,60). Transitional statements 
were included to minimize confusion on the part of respondents 
when changes in topic occurred (47,48,60). Questions were 
ordered according to topic and so that, within that framework, 
questions of the same format were posed together (48). 
4.4.3.5 Question Structure 
Because of the length of the questionnaire, and to 
facilitate coding and analysis, open questions were limited. 
The question types mainly used were closed-ended questions 
seeking attribute information, closed-ended questions offering 
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specific options for answers, and scales assessing 
respondents' attitudes, beliefs, or behaviour (50). The 
Likert-type rating scales used required the respondent to 
place the object being rated one of a series of numerically 
ordered categories (61). Where answer options were provided, 
an explanation of the options was included in the wording of 
the question (48). Care was taken to make the questions easily 
readable by the interviewer (47,48). An attempt was made to 
keep the questions short and simple (47), but where this was 
likely to adversely affect the quality of the response, an 
explanation was included and the question concluded with a 
summary (48, Appendix 8). Response categories offered were 
limited to a maximum of five (48), which was shown to be 
manageable by respondents in the pilot survey. It was 
suggested to respondents that they make a note of the 
descriptions of the numerical response categories offered to 
the Likert-type questions (48). This approach also allowed 
abbreviation of following questions using the same response 
options by posing all questions of a similar type in series in 
a consistent manner (48). 
4.4.4 Pilot Study 
A pilot study was performed by telephone after 
compilation of the survey instrument (48,50,60). Pharmacists 
in thirteen pharmacies, approximately ten percent of the 
identified population, were interviewed to test the survey 
instrument and interview procedures. Feedback was used to make 
adjustments during the pilot phase (48,60). As only minor 
changes were necessary, results from the pilot study were 
included with results from the main survey. 
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4.4.5 Administration 
4.4.5.1 Introduction to the Interview 
While advance letters have been shown to improve 
response to surveys of the general public, surveys of 
specialized populations, such as the one in question, have 
been shown generally to attract such high response rates that 
this approach cannot significantly improve response (48). 
Instead, the introduction to the interview was used to 
introduce the interviewer and the research institution, to 
inform respondents briefly of the topic of the interview and 
of how they were selected for participation, to convince them 
that their participation would be worthwhile, to give an 
indication of the time involved, and to assure them of 
confidentiality (48,60). Consistency of delivery of the 
introduction was maintained to avoid bias (59,60). 
4.4.5.2 Interviewer Training 
Problems of training interviewers (47,48,62) were 
avoided by the designer of the survey instrument conducting 
all interviews. This approach also had the advantage that the 
interviewer was easily able to respond to any questions asked 
by respondents (48). 
4.4.5.3 Timing and Follow-Up 
Interviews were conducted during the period 
December 1986 to January 1987. Because the contact telephone 
numbers were business numbers, calls were made during business 
hours on Monday to Friday. Dillman (48) observed that people 
being surveyed on a work-related topic are more receptive to 
being interviewed during working hours. 
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The cover sheet of the survey instrument was 
designed for keeping a record of calls to the the respondent, 
including the time and date of each call, the outcome of the 
call, and recall information indicating whether the 
interviewer had already spoken with the chosen respondent or 
not (48), A record was also kept of suggested times for 
call-backs. It was decided that unavailable respondents should 
be contacted at least three times (59), but if an interest in 
participation was expressed, a further call or calls were made 
in an attempt to complete the interview. 
4.4.6 Response 
Pharmacists in ninety-one of the one hundred and 
forty-two pharmacies listed considered the pharmacies to be 
actively involved in the provision of services for diabetic 
patients, and were thus suitable for interviewing. Interviews 
were successfully completed with eighty-three pharmacists and 
partially completed with another two pharmacists; three 
expressed willingness to participate in the survey but were 
unable to be interviewed in spite of several call-backs, due 
to time constraints; hearing difficulties prevented the 
participation of another; two did not wish to be interviewed 
further. Willingness to participate was thus expressed by 
pharmacists in 97,8% of eligible pharmacies, ie those 
self-identified as offering diabetic services, with the final 
response rate being 93.4%. Dillman (47) stated that response 
rates of over 90% can be expected from properly conducted 
surveys of specialized groups. 
Four pharmacies on the list had closed; one owner 
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had only recently taken over the pharmacy and was uncertain of 
the depth of involvement. Pharmacists in the remaining 
forty-six pharmacies did not consider themselves or the 
pharmacies to be currently providing any services directed to 
diabetic patients beyond those offered to all clients. 
Pharmacists in nine of these said that the pharmacy had never 
had any special involvement in the area. One had no 
involvement beyond supply of blood glucose monitors, and 
another retailed monitors through a health equipment outlet 
rather than the pharmacy. Twenty-three felt that, despite 
their attempts to provide a service in the past, there 
appeared to be little call for the services in their area, 
four attributing that to the establishment or increased 
activity of local diabetic groups, and one to improved 
diabetic clinic services at the local hospital. Five had 
ceased their involvement due to aspects of Ames Laboratories 
policies, four due to new ownership, two due to new 
managership, and one country pharmacy due to restricted hours 
during which the pharmacist was in attendance at the 
particular branch. 
4.4.7 Validation 
Zelnio (50) stated that most biases due to 
nonresponse tend to disappear when a response rate of 70% or 
more is achieved. Kerlinger (58) recommended that an attempt 
be made to learn something of the characteristics of 
nonrespondents if the response rate is below 80-90%. As 
response to the telephone interview was 93,4%, sample 
validation was considered unnecessary. 
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4.4.8 Results 
4.4.8.1 Demographics 
Of the total sample of 142 pharmacies identified as 
likely to be providing diabetic services in Queensland, 105 
(73.9%) were located within 25Km of a Diabetic Association of 
Queensland Support Group, as listed in Control . October, 1986. 
Fifty-six pharmacies (39.4%) were located in the Brisbane 
metropolitan area. The ownership of fourteen pharmacies (9.9%) 
had changed since the 1984 survey. 
Seventy of the ninety-one active pharmacies (76.9%) 
were located within twenty-five kilometres of a Support Group. 
Within the Brisbane telephone district 85.7% of active 
pharmacies were within twenty-five kilometres of a Support 
Group centre, while in country areas 66.3% were within that 
distance. 
Within the 85 active pharmacies responding to the 
survey, more than one pharmacist was providing diabetic 
services in 37.7%, and assistants were involved in service 
provis ion in 25.3%. 
Other demographic details are shown in Table 16. 
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TABLE 16 
PHARMACIES OFFERING DIABETIC SERVICES 
DEMOGRAPHIC DETAILS 
T o t a l number of r e s p o n s e s = 85 
VARIABLE NUMBER OF 
VALID 
RESPONSES 
VALUE NUMBER OF 
POSITIVE 
RESPONSES 
PERCENT 
P h a r m a c i s t I n f o r m a t i o n 
Sex 85 
Pharmacy 
Q u a l i f i c a t i o n 
P h a r m a c i s t 
S t a t u s 
Average Work ing 
Hour s/Week 
84 
85 
83 
Mai e 
Female 
Ph.C. 
B,Pharm, 
B.Pharm.Hons. 
Other 
Sole owner 
Partner 
Manager 
Assistant 
20-39 
40-49 
50-59 
60 or more 
68 
17 
26 
52 
2 
4 
29 
27 
21 
8 
7 
47 
25 
4 
80.0 
20.0 
30.9 
61 .9 
2.4 
4.8 
34. 1 
31.8 
24. 7 
9.4 
8.4 
5 6. 7 
30. 1 
4.8 
Pharmacy I n f o r m a t i o n 
Other P h a r m a c i s t s 85 
A c t i v e i n D i a b e t i c 
S e r v i c e 
A s s i s t a n t s A c t i v e 83 
in D i a b e t i c 
S e r v i c e 
Hours Open 
pe r Week 
L o c a t i o n 
85 
85 
One 
Two 
T h r e e 
One 
Two 
T h r e e 
F o u r 
L e s s t h a n 50 
50 t o 59 
60 or more 
Br i s b a n e 
C o u n t r y 
25 
6 
1 
16 
2 
"2 
1 
34 
30 
21 
31 
54 
29.4 
7. 1 
1 .2 
19. 3 
2.4 
2.4 
1 .2 
40,0 
35.3 
24.7 
36. 5 
63. 5 
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VARIABLE 
Site 
Turnover 
($ x 1000) 
Prescription 
Proportion (%) 
Prescriptions 
per Month 
Proportion of 
Customers Using 
Diabetic Service 
(Est imated) 
NUMBER OF 
VALID 
RESPONSES 
85 
80 
81 
84 
85 
VALUE NUMBER OF 
POSITIVE 
RESPONSES 
City Centre 
Regional Centre 
Suburban Centre 
Suburban Strip 
Medical Centre 
Private Hospital 
Other 
Less than 200 
200-399 
400-599 
600-799 
800 or more 
Not applic 
Less than 20 
20-39 
40-59 
60-79 
80 or more 
Less than 1000 
1000-1999 
2000-2999 
3000-3999 
4000 or more 
Below 5% 
5-9% 
10-14% 
15-19% 
32 
13 
7 
23 
5 
2 
3 
3 
13 
28 
15 
20 
1 
4 
30 
36 
10 
1 
4 
22 
24 
21 
13 
64 
19 
1 
1 
PERCENT 
37.6 
15.3 
8.2 
27, 1 
5.9 
2 .4 
3. 5 
3.8 
16. 3 
35.0 
18.8 
25.0 
1 .2 
4.9 
37.0 
44.4 
12.4 
1 .2 
4. 8 
26.2 
28.6 
25.0 
15.5 
75. 3 
22. 3 
1 .2 
1 .2 
242 
4.4.8.2 Services 
Practical services provided to diabetic patients 
from community pharmacies were provision of prepared 
information in such forms as leaflets, newspapers, posters, 
audio and video tapes etc by various means, measurement of 
blood and/or urine glucose in a number of circumstances, and 
assistance with maintenance of home blood glucose monitoring 
(Table 17). 
Only six pharmacies (7.1%) did not claim to have 
either leaflets or any other materials available for provision 
of information to diabetic patients, whereas 17 (20,0%) had 
other materials in addition to the common leaflets and 
newspapers. Types of materials volunteered in addition to 
those specifically mentioned in the questionnaire included 
Diabetic Association catalogues, photocopied acticles, and a 
file of items of interest for access by patients. Alternative 
means of distribution of information included direct mailing 
to diabetic patients via a list kept in the pharmacy, and 
delivery of newspapers to diabetics in retirement/nursing 
homes. Information was also circulated to local doctors. 
The twenty-one pharmacists (24.7%) who were 
involved in the provision of diabetic education outside the 
pharmacy setting did so for the Blue Nurses (a home nursing 
service), for staff at the local hospital, at the local 
community health centre, on the local radio station, and for 
the local Diabetic Association branch. Some pharmacists who 
were not involved explained that this function was performed 
in their area by others, such as the Blue Nurses, Community 
Health Service, Diabetic Association, and hospital staff. 
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Reservations about the legal implications of blood 
glucose measurement in the pharmacy were expressed by several 
pharmacists. Some chose not to do so for these reasons, and 
others either measured their own blood glucose when 
demonstrating monitoring techniques, or instructed and 
supervised the patient in performing the test on themselves. A 
number of pharmacists who were involved in diabetes screening 
did so in association with groups such as Lions' Clubs, 
Diabetic Association, Blue Nurses, or a local Aboriginal 
Community Health organization. Pharmacies were not involved 
because of geographic reasons sometimes, such as proximity to 
a medical centre or pathology laboratory. Measurement of blood 
glucose for diagnosed diabetics was usually only performed if 
the patient presented with problem readings, or occasionally 
on referral. Several pharmacists said that the Blue Nurses 
performed this function in their locality. Of the fifty-seven 
pharmacies (67,1%) who performed any type of blood-glucose 
monitoring, only two charged a fee ($1) and none applied a 
charge for measurements associated with demonstration of the 
use of a blood glucose monitor. 
In addition to acting as agents for manufacturers 
when repairs to blood glucose monitors were required, over one 
third of pharmacists attempted some repairs and/or maintenance 
procedures in their pharmacies. They reported that problems 
were often solved by such simple means as cleaning monitors or 
replacing batteries. If patients were to be without their 
monitors during repair, alternatives such as visual monitoring 
using blood glucose measurement strips were suggested, and 
about one fifth of pharmacies lent monitors to customers. 
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Eight pharmacies (9,4%) were involved in the hiring 
of blood glucose monitors. Several pharmacists said that they 
had hired blood glucose monitors from their pharmacies in the 
past, but had ceased to do so because of lack of demand, or 
because they were not looked after properly. 
Only three pharmacies (3.5%) claimed to perform 
urine glucose tests, one specifying that the method was used 
as a crude screen only, and patients referred if any problem 
was suspected. Urine glucose tests were performed routinely in 
some pharmacies in association with pregnancy tests, but 
otherwise pharmacists felt that the better reliability of 
blood glucose tests made them more appropriate. Some 
pharmacists stated that urine ketone tests were more likely to 
be performed in their pharmacies than urine glucose tests. 
TABLE 17 
DIABETIC INFORMATION AND MONITORING SERVICES 
Total number of responses = 85 
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VARIABLE NUMBER OF 
VALID 
RESPONSES 
VALUE NUMBER OF 
POSITIVE 
RESPONSES 
PERCENT 
Information 
Leaflets 85 64 75.3 
Leaflet 
Distribution 
Method 
Other Aids* 
64 
85 
Selected 20 
Givenout 9 
With counselling 3 
Selected/given 18 
Combinations 14 
Diabetic papers 60 
Posters 6 
Tapes/other 12 
No other aids 17 
* Multiple answers cause sum to be > 100% 
Blood/Urine Glucose Measurement 
B , G, Measurement 
as Demonstration 85 57 
B,G, Screening 
on Request 85 12 
B.G, Screening 
as Promotion 85 6 
31 
14 
4 
28 
21 
70 
7 
14 
20 
3 
1 
7 
1 
9 
6 
2 
1 
0 
67, 1 
14, 1 
7, 1 
B , G. Measurement 
for Diabetics 85 
B.G. Operator 
Repair of B.G 
Monitor s 
Alternative 
Monitor ing 
59 
82 
79 
Pharmacis t 
Assistant 
Either 
Customer 
Act as agent 
On premises 
Both 
Other 
Don't know 
Pharmacy loans 
Manufac loans 
Manufac replaces 
Visual method 
More than one 
Other 
Don't know 
27 
4 7 
3 
7 
2 
48 
2 
28 
2 
2 
16 
2 
22 
6 
20 
9 
4 
31.8 
79 
5 
1 1 
3 
20 
2 
27 
7 
25 
1 1 
5 
7 
1 
9 
4 
58. 5 
2.4 
34,2 
2.4 
2.4 
3 
5 
9 
6 
3 
4 
1 
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4.4.8.3 Supply 
Of the 85 active pharmacies responding to the 
survey, 29 (34.1%) stated that they attempted to keep a full 
range of diabetic requirements to meet all the possible needs 
of their diabetic patients. A further 54 (63.5%) stated that 
they kept a reasonable range to cover the most frequent needs, 
and two pharmacies (2.4%) ordered most items only on the 
specific request of customers. Specific items stocked by 
pharmacies active in diabetic services are shown in Table 18, 
An area was specifically allocated to the display 
of diabetic goods in 42 (49.4%) pharmacies. In twenty 
pharmacies, the length of shelving was less than ten feet, in 
eighteen pharmacies it measured between ten and twenty feet, 
and four pharmacies reported displays of twenty feet or more 
in length. Space constraints were cited as a problem by 
several pharmacists, some of whom compromised by using 
periodical displays. 
Because of the cost involved, not all pharmacies 
maintained stocks of a range of insulins. The twenty-eight 
pharmacies (32.9%) not doing so stated that they ordered 
insulin on the request of customers and/or kept supplies for 
specific patients. Several stated that they had fast access to 
supplies if called for. 
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While all pharmacies reported stocking boxes of 
disposable insulin syringes, the quantities kept showed wide 
variation: 
No. of Boxes (lOOs) 
Less than 5 
5 to 9 
10 to 19 
20 to 29 
30 to 49 
50 or more 
No. of Pharmacies 
18 
27 
18 
9 
5 
Percent 
21 
31 
21 , 
10, 
5, 
9, 
.2 
. 8 
.2 
.6 
.9 
,4 
The average number of boxes of 100 disposable syringes usually 
held in stock in any one pharmacy varied from 1 to over 100, 
Forty-five pharmacies (53,0%) had usual stock levels below ten 
boxes, eighteen (21,7%) between ten and nineteen boxes, and 
the remaining twenty-two (25.3%) usually kept twenty or more 
boxes in stock. Low stock levels were explained in some cases 
by patients usually acquiring supplies through the local 
hospital clinic or Diabetic Association. The prices charged 
for a box of 100 syringes, to the nearest dollar, varied from 
$15 to $34. Twenty-one pharmacies (24.7%) were supplying boxes 
of syringes at $18 or less, forty-four (51.8%) at $20 or less, 
and sixty-seven (78.8%) at $25 or less. Three pharmacies 
declined to reveal their usual charge, and the remaining 
fifteen (15.7%) were charging from $26 to $34. One pharmacy 
supplied syringes at cost price to customers collecting 
insulin prescriptions. A significant (P=0.008) negative trend 
was found to exist in the relationship between stock level and 
usual price charged. Pharmacies holding high stocks of 
syringes were more likely to be charging lower prices and 
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those with low stocks higher prices, although the spread of 
prices was much broader in the low stock group. Sixty-six 
pharmacies (79.5% of the 83 giving valid answers) stated that 
they also sold syringes in quantities less than a complete box 
of 100, 
In addition to the pharmacies 
stocked blood glucose monitors, the remaininj 
indicated that they ordered monitors on 
cus tomer s, 
which regularly 
fifteen (17,9%) 
the request of 
Opinions on stocking diabetic foodstuffs, including 
diabetic chocolates and sweets, varied widely. Some pharmacies 
appeared to keep a wide range, sometimes in the health food 
section of larger pharmacies. Others felt that such lines were 
not in accord with current thinking on dietary guidelines for 
diabetic patients, and were therefore not appropriate to 
stock. Changes in dietary recommendations alo appeared to have 
resulted in a lower demand. Many also stated that 
confectionery lines were either difficult to obtain, or tended 
to go out of date on the shelf. 
Lack of suitable items was given by various 
pharmacists as the reason for not stocking identity tags, log 
books, or books about diabetes. 
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TABLE 18 
DIABETIC SUPPLY 
Total number of responses = 85 
VARIABLE NUMBER OF VALID 
RESPONSES 
B.G. T e s t S t r i p s 85 
U.G, T e s t M a t e r i a l s 85 
Ora l H y p o g l y c a e m i c s 85 
I n s u l i n s ( R a n g e ) 85 
Disposable Syringes 85 
Glass Syr inges 85 
B.G. Monitors 84 
Injection Aids 85 
Urine Test Equipment 85 
Blood Test Aids 85 
Foodstuffs 85 
Sweeteners 85 
Identity Tags 85 
Glucagon 8 5 
Glucose Tablets 85 
Log Books 85 
Diet Books 85 
Diabetes Books 85 
POSITIVE 
RESPONSES 
85 
85 
85 
57 
85 
48 
69 
45 
70 
8 5 
48 
85 
69 
56 
83 
77 
74 
45 
PERCENT 
100.0 
100.0 
100.0 
67, 1 
100.0 
56. 5 
82. 1 
52.9 
82.4 
100.0 
56. 5 
100.0 
81 .2 
65.9 
97. 7 
90, 6 
87, 1 
52 .9 
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4.4.8.4 Counselling 
Involvement of pharmacists in counselling of 
diabetics was investigated under the headings of insulin, 
blood glucose monitoring, urine glucose monitoring, oral 
hypoglycaemics, over-the-counter medication, and management. A 
rating scale of 1-5 was used to estimate the extent of 
involvement. The higher the mean score, the greater the 
frequency of counselling by pharmacists in relation to the 
specific topic (Table 19). It was apparent from discussion 
that the degree of counselling for a particular topic varied 
with circumstances, eg a new development would be likely to 
cause high involvement with that topic until most patients had 
been informed, and then decline to its former level. 
Twenty-three (27.4%) of the 84 pharmacists giving 
valid responses said that discussions relating to insulin were 
more often initiated by the pharmacist, twenty-one (25.0%) 
that they were more often initiated by the customer, and 
twenty-seven (32.1%) that they were started about equally from 
each side. The remaining thirteen respondents (15.5%) 
indicated minimal involvement in this area of counselling. 
Reasons given for low involvement were that other sources such 
as medical practitioners, hospital diabetic clinics or Blue 
Nurses were the usual suppliers of information relating to 
insulin therapy. 
Pharmacists' involvement in counselling about blood 
glucose monitoring with patients buying or discussing a 
monitor for the first time was generally of a high degree, and 
comments indicated that considerable staff time was involved 
without direct remuneration. Several pharmacists stated that 
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specifics such as frequency of monitoring and recording of 
results were more often dealt with by other agents such as 
medical practitioners or nurses. 
Eleven pharmacists (12.9%) of the sample of 85 said 
that discussions about blood glucose monitoring with patients 
already doing their own measurements were more often initiated 
by the pharmacist, thirty-one (36.5%) that they were more 
often initiated by the customer, and forty-one (48.2%) that 
they were started about equally from each side. Two pharmacies 
(2,4%) were minimally involved in counselling in this field as 
they were branches of more active pharmacies and tended to 
refer patients with problems in the area of monitoring to the 
major branch. 
Fifteen (17.9%) of the 84 pharmacists giving valid 
responses said that discussions about urine glucose monitoring 
were more often initiated by the pharmacist. A number of these 
commented that their reason for initiating the discussion was 
frequently in order to inform the patients about the 
advantages of blood glucose monitoring. Nineteen pharmacists 
(22.6%) said that these discussions were more often initiated 
by the customer, and seven (8,3%) said that they were started 
about equally from each side. Forty-three pharmacies (51.2%) 
indicated minimal counselling involvement in relation to urine 
glucose monitoring, mainly due to decreasing numbers of 
patients, especially new patients, using this method. 
Fifty-eight (69.9%) of the 83 pharmacists giving 
valid responses said that prescription drug counselling 
discussions were more often initiated by the pharmacist, only 
seven (8.4%) that they were more often initiated by the 
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customer, and seventeen (20.5%) that they were started about 
equally by each side. Only one pharmacist was not involved in 
this area, due to the situation of the pharmacy within a 
private hospital. Methods of counselling specified included 
reference to patients' medication profiles for details of 
previous treatment and compliance, reference to comptiterized 
drug interaction programmes, and use of ancillary labels and 
computer information leaflets as well as verbal counselling. 
Eighteen (21,4%) of the 84 pharmacists giving valid 
responses said that discussions about nonprescription 
medications were more often initiated by the pharmacist, 
thirty-one (36,9%) that they were more often initiated by the 
customer, and thirty-five (41,7%) that they were started about 
equally by either side. All pharmacists replying indicated 
involvement in this area of counselling. One pharmacist 
specified a preference for recommending single ingredient 
products to diabetic patients to minimize problems. 
Eighteen (21.7%) of the 83 pharmacists giving valid 
responses said that discussions related to management of 
diabetes were more often initiated by the pharmacist, 
twenty-six (31.3%) that they were more often initiated by the 
customer, and thirty-four (41.0%) that they were started about 
equally by either side. Five pharmacists (6.0%) indicated 
minimal involvement in counselling of these topics. It was 
again stated that other sources such as medical practitioners, 
hospital diabetic clinics or Blue Nurses were more frequently 
consulted about these matters. One pharmacy had a podiatrist 
and an optometrist operating on site once a month, and another 
employed a pharmacist who was also a trained nutritionist. 
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TABLE 19 
DIABETIC COUNSELLING 
Total number of responses = 85 
VARIABLE NUMBER OF MEAN SCORE STANDARD 
VALID DEVIATION 
RESPONSES 
Insulin 
Storage 84 2,76 1.09 
Drawing Up 84 1.80 0.79 
Mixing 84 1.80 0.82 
Site Selection 84 1.93 1.06 
Site Preparation 84 2.16 1.07 
Dose Adjustment 84 2.04 1.16 
Duration of Action 84 2.32 1.09 
Blood Glucose Monitoring 
Buyers 
Use of Monitor 83 4.99 0.11 
Care of Monitor 82 4,79 0,70 
Sample Collection 82 4.74 0.77 
Freq of Monitoring 82 3,94 1,55 
Recording Results 82 4,15 1.41 
Users 
Use of Monitor 84 3,21 0.97 
Care of Monitor 84 3.19 1.08 
Sample Collection 84 2.41 0.95 
Freq of Monitoring 84 2.43 1.19 
Recording Results 84 2.31 1.12 
Urine Glucose Monitoring 
Sample Collection 84 1.44 0.55 
Testing Procedure 84 1.67 0.81 
Recording Results 84 2.31 0.81 
Oral Hypoglycaemics 
Dose Instructions 84 3.52 1.15 
Compliance 84 3,35 1-19 
Adverse Reactions 84 2.83 0.97 
Drug Interactions 84 3,36 1-1^ 
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VARIABLE NUMBER OF 
VALID 
RESPONSES 
MEAN SCORE STANDARD 
DEVIATION 
Nonprescription Medication 
Sweeteners 
Sugar Free Products 
Cough/Cold 
Foot Care 
85 
85 
85 
84 
2.45 
3. 37 
3.91 
2. 18 
0,91 
0.90 
0.97 
1 .01 
Management 
Insulin Dependent Diabetics 
Dietary Advice 
Symptoms of 
Hypoglycaemia 
Treatment of 
Hypoglycaemia 
Sick Days 
Symptoms of 
Hyperglycaemia 
Action for 
Hyperglycaemia 
Foot Care 
Complications 
83 
83 
83 
83 
83 
83 
83 
83 
Non-Insulin Dependent Diabetics 
Dieta 
Sympt 
Hypog 
Treat 
Hypog 
Sick 
Sympt 
Hyper 
Actio 
Hyper 
Foot 
Compl 
ry Advice 
oms of 
lycaemia 
ment of 
lycaemia 
Days 
oms of 
glycaemia 
n for 
glycaemia 
Care 
ications 
83 
83 
8 3 
83 
83 
83 
83 
8 3 
3.06 
2. 72 
2.45 
2.07 
2. 33 
2.68 
2. 16 
2. 35 
3.02 
2.46 
2.21 
1 ,93 
2,22 
2,59 
2,08 
2.27 
, 13 
, 15 
. 10 
.01 
.01 
. 16 
,02 
. 10 
1.15 
0. 98 
0.92 
0.87 
0.95 
1 , 12 
0, 98 
1.11 
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All of the pharmacists interviewed referred 
diabetic patients to one or more of the listed practitioners 
(Tables 20 & 21), Several stated that referrals to other than 
general medical practitioners were done only through the 
patients' general practitioners. Many country pharmacists were 
unable to refer patients other than to a general practitioner 
because no other expertise was available locally. These 
limitations are reflected by the high referral score for 
general practitioners in comparison with other health 
professionals shown in Table 20. Diabetes educators were 
usually described as specialist nursing staff at hospital 
clinics, or Blue Nurses. Referral to other pharmacists was, 
not unexpectedly, the least used route of referral, but the 
general impression from discussion was that pharmacists using 
this route appeared to be those more highly committed to the 
welfare of their diabetic patients. The overall pattern of 
referrals is shown in Table 21. 
TABLE 20 
REFERRAL SCORES 
VARIABLE NUMBER OF MEAN SCORE STANDARD 
VALID DEVIATION 
RESPONSES 
General Practitioner 85 2.46 0.67 
Specialist 85 1-^7 0.77 
Dietician 85 1-39 0.93 
Podiatrist 85 1-37 0.81 
Diabetes Educator 85 
Other Pharmacist 85 
1.67 0.91 
1.25 0,51 
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TABLE 21 
REFERRAL PATTERNS 
Total number of responses = 85 
VARIABLE NUMBER OF VALUE NUMBER OF PERCENT 
VALID POSITIVE 
RESPONSES RESPONSES 
General Practitioner 85 Frequently 47 55,3 
Some t imes 30 3 5,3 
Never 8 9.4 
Specialist 85 Frequently 10 11.8 
Somet imes 24 28.2 
Never 47 55.3 
Notapplic 4 4,7 
Dietician 85 Frequently 9 10,6 
Sometimes 32 37,6 
Never 27 31.8 
Not applic 17 20.0 
Podiatrist 85 Frequently 7 8.2 
Sometimes 28 32.9 
Never 39 45.9 
Not applic 11 12.9 
Diabetes Educator 85 Frequently 18 21.2 
Sometimes 28 32.9 
Never 32 37.7 
Notapplic 7 8,2 
Other Pharmacist 85 Frequently 1 1.2 
Some t imes 21 24.7 
Never 61 71.8 
Not applic 2 2.3 
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4.4.9 Discussion 
4.4.9.1 Services 
Objective 1 - To document the services offered to 
patients by pharmacies involved in the provision 
of diabetic services. 
Objective 1 has been fulfilled by 4.4.8.2 and 
summarized in Table 17. The services investigated were related 
to provision of written information and to blood and urine 
glucose monitoring (Photographs 1 & 2). 
As no other investigations of Australian community 
pharmacies offering specialized diabetic services appear to 
have been carried out, no figures are available for 
comparison. However, the types of services identified by the 
survey as being offered by Queensland community pharmacies are 
similar to what was expected from the international literature 
review. 
At the time of the survey, about two-thirds of 
pharmacist respondents claimed that blood glucose measurements 
were being performed in their pharmacies. However, subsequent 
amendments to the Health Act 1937-86, known as the Skin 
Penetration Regulations 1987 (63), may have resulted in a 
decrease in numbers. The Regulations require registration of 
establishments carrying out a process of skin penetration, and 
do not exclude pharmacists in the conduct of their profession, 
although exemptions have been made in these terms for most 
other health professionals. 
PHOTOGRAPH 1 
DIABETES INFORMATION LEAFLETS 
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PHOTOGRAPH 2 
BLOOD GLUCOSE MONTTORTNfl 
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4.4.9.2 Supply 
Objective 2 - To document the types of stock held 
by community pharmacies relevant to diabetes. 
Objective 2 has been fulfilled by 4.4.8.3 and 
summarized in Table 18, 
No other studies are available for comparison of 
stock levels, but the types of goods carried are again those 
expected from the literature review (Photograph 3). 
All pharmacies reported keeping ranges of stock of 
blood glucose testing strips, urine glucose testing strips 
and/or tablets, and oral hypoglycaemic drugs. This result was 
to be expected, as all of these items were usually provided on 
prescription at the time of the survey. Although insulin was 
also usually provided on prescription, only two-thirds kept a 
range of insulins, probably due to the limited shelf life and 
high costs involved. However, most appeared to have fast 
access to supplies when required, or arrangements with their 
patients to order repeat supplies prior to needing them. 
PHOTOGRAPH 3 
DIABETIC STOCK DISPLAY 
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4.4.9.3 Counselling 
Objective 3 - To estimate the degree of counselling 
involvement which community pharmacists perceive 
themselves to have with diabetic patients. 
Objective 3 has been fulfilled by 4.4.8.4 and 
summarized in Tables 19 - 21. Counselling topics included 
insulin therapy, blood glucose monitoring, urine glucose 
monitoring, oral hypoglycaemics, nonprescription medications, 
and management (Photographs 4 & 5), as well as referral to 
other health care practitioners. 
Examination of calculated counselling scores shows 
that pharmacists were more involved in some aspects of 
counselling than others. The areas showing greatest 
involvement were blood glucose monitoring, oral hypoglycaemic 
therapy, and nonprescription medication. Diabetes management 
topics showed intermediate involvement. Least involvement was 
shown in regard to insulin therapy and urine glucose 
monitoring. No figures are available for comparison with these 
findings . 
Counselling about blood glucose monitoring was 
greater with patients purchasing a monitor, but substantial 
involvement was still evident with those already using 
monitors. Purchase of a monitor is an occasion obviously 
requiring intensive counselling by the vendor. Transfer of 
information at the time of purchase apparently also leaves 
both parties open to follow-up counselling opportunities. The 
low degree of involvement in counselling about urine gluose 
monitoring was explained by pharmacists as being due to 
progressively fewer patients using these methods of 
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monitoring, and to the fact that those who were doing so had 
been using the methods for a considerable time. 
Provision of prescription and nonprescription 
medication being the traditional realm of the pharmacist, high 
counselling scores associated with oral hypoglycaemics and 
nonprescription products were not unexpected. However, because 
of the complicated administration regimens associated with 
insulin therapy, many pharmacists commented that counselling 
in that area was more often conducted in hospital situations, 
by trained diabetic educators, or by groups such as the Blue 
Nurses than by pharmacists. 
Pharmacists were involved in counselling both 
insulin dependent (IDD) and non-insulin dependent diabetics 
(NIDD) about aspects of management. For all topics, scores 
were slightly lower for non-insulin dependent patients. It may 
be that there is less recognition by pharmacists of the 
consequences of poor control for this group of diabetic 
patients. 
An important feature of counselling is referral of 
patients to other health professionals when appropriate. 
General practitioners were the most frequently named referral 
points. Many country pharmacists had no facilities apart from 
the general practitioner at their disposal. Where they were 
available, other health professionals were suggested in the 
order of diabetes educators, specialist endocrinologists, 
dieticians, and podiatrists. 
PHOTOGRAPH 4 
INSULIN THERAPY COUNSELLING 
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PHOTOGRAPH 5 
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4.5 MAIL SURVEY 
4.5.1 Aims 
4. To document the educational background of 
diabetic service providers, 
5. To document the historical development of 
provision of diabetic services from community pharmacies in 
Queens land. 
6. To determine the motivation for practitioners to 
become involved in provision of diabetic services. 
4.5.2 Survey Instrument 
The survey instrument consisted of three 
questionnaires. Part 1 was designed to collect information 
about the pharmacies providing diabetic services in 
Queensland, A stock list of diabetic items was included to 
assist in the answering of some questions. Parts 2 and 3 were 
designed to collect information about pharmacists involved in 
the provision of those services. 
Factors considered in the preparation of the survey 
instrument used for the Survey of Services from Community 
Pharmacies in Queensland. 1984 were again taken into account. 
Some steps previously taken in order to improve response 
rates, such as reducing the physical length of the 
questionnaire and presenting an attractive appearance, were 
considered less important for this questionnaire because the 
respondents were already known to be likely to co-operate. 
An explanation of the reason for a sample number on 
the questionnaire and an assurance of confidentiality were 
given with each section of the survey instrument. 
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4.5.3 Respondents 
Respondents to Part 1 and Part 2 were defined as 
the pharmacist responsible for deciding to establish or 
continue the provision of diabetic services in each pharmacy. 
An allowance was made that, in the case of the decision maker 
not working regularly in the pharmacy in question, reference 
to the pharmacist providing the service in that pharmacy may 
be needed to complete some questions. Respondents to Part 3 
were defined as all pharmacists regularly involved in the 
provision of diabetic services who had not replied to Parts 1 
and 2 of the survey. 
4.5.4 Pilot Study 
A random sample of approximately ten percent (9 
pharmacies) of the sample was selected using a Random Numbers 
Table (64). Two of those selected were owned by pharmacists 
who owned a second pharmacy involved in provision of diabetic 
services. These pharmacies were also included in the pilot 
sample. It was decided to include pharmacies which had been 
used in the pilot of the telephone survey as well. Of the 
thirteen pharmacies used in that pilot, two were rejected due 
to low levels of involvement, and three had already been 
selected by the random sampling technique. The survey 
instrument was mailed to the nineteen selected pharmacies on 
27th April, 1987, Replies to various sections were received 
from ten pharmacies within the following two weeks and showed 
only minor problems in relation to explaining who was to 
answer which section. Care was taken to clarify details of 
required respondents prior to the main mailing. 
268 
4.5.5 Administration and Collection 
The main survey was mailed to the remainder of the 
eighty-five pharmacies on 11th May, 1987, The mailing included 
a covering letter (Appendix 9 ) , explanatory notes for 
pharmacists owning more than one pharmacy involved in the 
provision of diabetic services (Appendix 10), a copy of Part 1 
of the questionnaire (Appendix 11), a Stock List (Appendix 
12), a copy of Part 2 of the questionnaire (Appendix 13), the 
required number of Part 3 of the questionnaire (Appendix 14) 
as ascertained from the telephone survey, and sufficient 
pre-addressed postage-paid return envelopes to allow privacy 
for all respondents. 
Telephone follow-up of nonresponding pharmacies in 
the Brisbane telephone district was commenced on 25th May, at 
which stage 37 (43.5%) pharmacies had replied. Postcard 
reminders were sent to nonrespondent country pharmacies on 
29th May, by which time 47 (55.3%) had replied. Further 
reminders, and remails were conducted as needed. 
4.5.6 Response 
A final response rate of 95.3% (81 pharmacies) was 
achieved by mid-July, Two nonresponding pharmacies were from 
the Brisbane metropolitan area, and two from outside Brisbane. 
Within the responding pharmacies, responses were received from 
109 pharmacists claiming to be actively involved in the 
provision of diabetic services. 
4.5.7 Validation 
As with the mail survey of diabetic pharmacies, the 
high response negated the need for sample nonresponse 
validation. Item nonresponse was also negligible. 
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4.5.8 Results 
4.5.8.1 Pharmacist Characteristics 
TABLE 22 
PHARMACIST DEMOGRAPHICS 
Total number of responses = 109 
VARIABLE 
Sex 
Year of Birth 
Pharmacy 
Qualification 
Pharmac is t 
Status 
Pharmacis t 
Posi tion 
Average 
Hour s/Week 
NUMBER OF 
VALID 
RESPONSES 
109 
108 
109 
109 
109 
109 
VALUE 
Mai e 
Female 
Before 1930 
1930-1939 
1940-1949 
1950-1959 
1960s 
Ph.C. 
B,Pharm, 
Other 
Sole owner 
Partner 
Manager 
As s i s tant 
In-charge 
Assistant 
Less than 
20-39 
40-49 
50-59 
60 or more 
20 
NUMBER OF 
POSITIVE 
RESPONSES 
85 
24 
1 
2 8 
31 
29 
19 
39 
67 
3 
35 
32 
26 
16 
71 
38 
3 
13 
53 
31 
10 
PERCENT 
78,0 
22.0 
0.9 
26. 0 
28. 7 
26.8 
17.6 
35.8 
61 . 5 
2.7 
32. 1 
29.4 
23,8 
14. 7 
65. 1 
34.9 
1 .8 
11.9 
48. 7 
28.4 
9.2 
NOTE: Of the 109 respondent pharmacists active in the 
provision of diabetic services, 76 (69,7%) had been 
respondents to the previous telephone survey. 
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TABLE 23 
PHARMACIST INFORMATION 
Total number of responses = 109 
VARIABLE NUMBER OF VALID POSITIVE PERCENT 
RESPONSES RESPONSES 
Memberships 
PSA Member 101 75 74.3 
ACPP Member 64 8 12.5 
SHPA Member 60 5 8.3 
DAQ Member 65 18 27,7 
ADEA Member 59 2 3.4 
Reading Habits 
AJP 102 87 85.3 
Aust, Pharmacist 94 71 75.5 
Aust. Prescriber 94 76 80.9 
Current Therapeutics 81 52 64.2 
Patient Management 63 16 25.4 
The Pharmacy Journal 71 30 42.3 
Control 61 14 23.0 
Diabetes Conquest 64 25 39,1 
Diabetes in the News 88 64 72,7 
Education Sources 
Pharmacy Lectures 64 37 57,8 
Pharmacy Materials 71 50 70,4 
Diabetes Lectures 62 23 37,1 
Diabetes Materials 64 37 57,8 
Industry Materials 80 65 81.3 
Books 77 56 72.7 
Journals 94 86 91.5 
4.5.8.2 Pharmacy Characteristics 
TABLE 24 
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PHARMACY DEMOGRAPHICS 
Total number of responses 81 
VARIABLE 
Establi shment 
of Service 
NUMBER OF 
VALID 
RESPONSES 
81 
Role in Service 
Provision 
Year of Takeover 
Type of Reference 
Texts Available 
Estimated Degree 
of Involvement 
Total Area of 
Pharmacy (sq ft) 
Area of Front 
Shop (sq ft) 
PGA Membership 
Marketing Group 
Membe rs hip 
81 
77 
80 
80 
79 
79 
81 
81 
VALUE 
Before 1960 
1960-1979 
1980-1984 
1985/1986 
Don ' t know 
Established 
Continued 
Before 1980 
1980-1984 
1985-1987 
Not applic 
Patient 
Diabetic 
General medical 1 
Var ious 8 
Not specified 5 
NUMBER OF 
POSITIVE 
RESPONSES 
1 
11 
35 
23 
1 1 
61 
20 
3 
5 
8 
61 
17 
6 
PERCENT 
1 .2 
13.6 
43.2 
28,4 
13.6 
75. 3 
24. 7 
3,9 
6, 5 
10,4 
79.2 
21.2 
7.5 
Minor 
Moderate 
Ma jor 
1000 to 1999 
2000 to 2999 
3000 to 4999 
5000 or more 
Amcal 
Chemway 
Greenspot 
Soul Pattinson 
Sunshine 
Tr i-pharm 
Other/multiple 
22 
48 
10 
Less than 1000 22 
1000 to 1999 27 
2000 to 2999 18 
3000 to 4999 10 
5000 or more 2 
Less than 1000 36 
23 
12 
6 
2 
68 
1 .2 
10.0 
6,2 
27. 5 
60.0 
12. 5 
84.0 
1 
3 
6 
9 
8 
1 
13.6 
3.7 
9,9 
7,4 
11.1 
9.9 
13.6 
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4.5.8.3 Service Development 
TABLE 25 
INFLUENCES ON SERVICE PROVISION 
Total number of responses = 81 
VARIABLE 
Interest 
Satisfaction 
Profit 
NUMBER OF 
VALID 
RESPONSES 
81 
80 
80 
Previous Diabetic 
Pharmacy • 7 9 
Diabetic Clinic 
Proximity 80 
Number of Diabetic 
Customers 81 
Need of Diabetic 
Customers 80 
Pharmacist is a 
Diabetic 77 
Diabetic in Family 80 
Diabetic Friend 78 
Diabetic on Staff 79 
Approached by Ames 77 
Approached Ames 76 
PSA Influence 80 
PGA Influence 79 
Group Influence 79 
MEAN SCORE 
3. 58 
3.93 
2.95 
1 .71 
1 .29 
3.48 
3.49 
1 . 19 
1 . 53 
1 .23 
1.11 
2.16 
2 . 57 
1 .55 
1 . 34 
1 . 14 
STANDARD 
DEVIATION 
1 .06 
0, 88 
1 , 10 
1 .41 
0.94 
1 . 14 
1.18 
0.84 
1 . 18 
0. 72 
0.60 
1 . 54 
1 . 70 
0.91 
0. 70 
0. 50 
TABLE 26 
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VARIABLE 
ECONOMIC FACTORS IN SERVICE PROVISION 
Total number of responses = 81 
VALUE NUMBER OF 
VALID 
RESPONSES 
NUMBER OF 
POSITIVE 
RESPONSES 
PERCENT 
Number of Types of 
Insulin Stocked 81 Less than 5 
5-9 
10-14 
15 or more 
18 
27 
18 
18 
22.2 
33.4 
22.2 
22.2 
Value of Insulin ($) 76 Less than 250 18 
250-499 15 
500-749 15 
750-999 9 
1000-1999 12 
2000 or more 7 
23 
19 
19 
1 1 
15 
9 
Value of Diabetic 
Stock ($) 75 Less than 1000 24 
1000-1999 23 
2000-2999 13 
3000-3999 7 
4000 or more 8 
32.0 
30. 7 
17.3 
9. 3 
10.7 
Total Stock 
($ x 1000) 
Value 
72 Less than 50 1 1 
50 to 99 31 
1 0 0 t o 1 9 9 2 5 
2 0 0 o r m o r e 5 
15.3 
43. 1 
34.7 
6.9 
Estimated Diabetic 
Stock Proportion (%) 69 Less than 1.0 13 
1,0 to 1.9 22 
2.0 to 2.9 11 
3.0 to 4. 9 18 
5 . 0 t o 9 . 9 3 
l O . O o r m o r e 2 
18.8 
31 .9 
15.9 
26. 1 
4 
2 
4 
9 
Calculated Diabetic 
Stock Proportion (%) 69 Less than 1.0 18 
1.0 to 1.9 21 
2.0 to 2.9 9 
3.0 to 4.9 18 
5.0 to 9.9 1 
l O . O o r m o r e 2 
26. 1 
30.4 
13.0 
26. 1 
5 
9 
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TABLE 27 
LEVELS OF SUCCESS 
Total number of responses = 81 
VARIABLE NUMBER OF MEAN SCORE STANDARD 
VALID DEVIATION 
RESPONSES 
Financial 79 2.75 0.82 
Professional 79 3.86 0.80 
Customer 
Satisfaction 80 3.90 0.70 
Customer Increase 80 2,86 0,88 
Interprofessional 
Relations 78 2.91 1.03 
TABLE 28 
RESPONDENT INFORMATION 
Total number of responses = 81 
VARIABLE NUMBER OF VALUE 
VALID 
RESPONSES 
Service Provider 81 
Telephone Respondent 81 
Pharmacist Status 81 Sole Owner 
Partner 
Manager 
Ass i stant 
Average 
Hours/Week 81 Less than ! 
20-39 
40-49 
50-59 
60 or more 
NUMBER OF 
POSITIVE 
RESPONSES 
75 
69 
36 
27 
16 
2 
0 5 
5 
30 
31 
10 
PERCENT 
92,6 
85.2 
44.4 
33. 3 
19.8 
2.5 
6. 2 
6, 2 
37.0 
38. 3 
12.3 
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4.5.9 Discussion 
4.5.9.1 Educational Background 
Objective 4 - To document the educational background 
of diabetic service providers. 
Objective 4 has been fulfilled by 4.5.8.1 and 
4.5.8.2 and summarized in Tables 22 - 24. 
Of the 109 pharmacists providing diabetic services 
in 81 pharmacies, only three pharmacists indicated that they 
held pharmacy qualifications higher than Ph.C. or B.Pharm., 
two holding a post-graduate honours degree, B.Pharm.(Hons.), 
and one a Fellowship of the Society of Hospital Pharmacists 
(FSHP). Qualifications beyond the basic requirements for 
registration as a pharmacist were evidently not seen as an 
essential prerequisite to specialization in diabetic 
services. 
Of 101 responding, 75 pharmacists (74.3%) reported 
membership of the Pharmaceutical Society (PSA). Membership of 
other listed professional organizations was incompletely 
answered, but 18 pharmacists reported membership of the 
Diabetic Association of Queensland (DAQ). Only two claimed 
membership of the Australian Diabetes Educators Association 
(ADEA). Of the 81 pharmacies, 68 (84.0%) were members of the 
Pharmacy Guild (PGA). 
Readership of the pharmacy journals Australian 
Journal of Pharmacy. Australian Pharmacist and Australian 
Prescriber was claimed by over 75% of respondents. Ames 
newspaper for diabetics, Diabetes in the News, was also widely 
read. In comparison with the general pharmacist population 
(Table 4), readership levels of other professional journals 
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such as Current Therapeutics and Patient Management was higher 
among pharmacists providing diabetic services. Journal reading 
was cited by over 90% of those responding as being a source 
from which they had built up their expertise in the diabetic 
area. Other major sources (above 70%), in descending order of 
frequency of mentions, were tapes or written information from 
pharmaceutical companies, books on diabetes, and continuing 
education tapes and/or booklets from pharmacy sources. 
Fewer than half of the pharmacies were reported to 
have diabetic reference texts available, and almost half of 
those specified patient-oriented material only. 
4.5.9.2 Historical Development 
Objective 5 - To document the historical development 
of provision of diabetic services from community 
pharmacies in Queensland. 
Objective 5 has been fulfilled by 4.5.8.2 and 
4,5,8.3 and summarized in Tables 24 & 25. 
A proliferation of pharmacies involved in provision 
of diabetic services appears to have occurred since 1980. Only 
twelve pharmacies (14.8%) were claimed to have been in 
operation prior to 1980. Respondents in eleven pharmacies 
(13.6%) did not know when the service had been established. 
The introduction of U-100 insulins into the PBS in 
1980 may have been one catalyst for increasing interest in 
this area of practice, as this event required the provision of 
extra information to diabetic patients (65). Comment was also 
made at the time that diabetics could be expected to play an 
ever increasing role in self-management with the introduction 
of blood glucose monitoring techniques, and would require 
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assistance from interested pharmacists with monitoring and 
home treatment of diabetic emergencies (34). 
Also in the period since 1980, pharmaceutical 
companies have been active in encouraging the development of 
diabetic centres in community pharmacies (15,19,20,66). The 
Ames Division of Miles Laboratories was particularly involved 
in promoting the provision of advice on the use of blood 
glucose monitors at the point of sale, and reported the 
existence of about 100 diabetic care centres under their 
auspices in pharmacies in Australia in 1983 (66) and 200 by 
1984 (19). The scheme was subsequently further expanded 
(19,20,23). 
The survey showed that 35 pharmacies (43.2%) active 
in the provision of diabetic services in Queensland had 
commenced their activities in the period 1980-1984, and 23 
(28.4%) subsequent to that date. Respondents were the 
initiators of diabetic service provision in 61 pharmacies 
(75.3%), and the remainder had decided to continue already 
established services. Half of these had taken control of the 
businesses prior to 1985 and half after that date. 
4.5.9.3 Motivation 
Objective 6 - To determine the motivation for 
practitioners to become involved in provision of 
diabetic services. 
Objective 6 has been fulfilled by 4.5.8.3 and 
summarized in Table 25. 
The pharmacists responsible for establishing or 
continuing diabetic services within the 81 pharmacies cited 
professional and altruistic reasons as the major influences on 
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their decision to do so. In descending order, they saw the 
provision of diabetic services as a way to increase their 
professional satisfaction, they had a personal interest in the 
subject, they had a number of diabetic customers, and they 
perceived their diabetic customers to be in need of help. The 
prospect of profitability and the influence of Ames were also 
strong factors in service provision. Interestingly, nineteen 
pharmacists reported that an approach by Ames had had a large 
or major effect on their decision to provide a service, 
whereas twenty-six said that they had approached Ames about 
establishing diabetic centres and rated this as having a large 
or major effect on their decision to do so. 
Although other factors were less important to the 
overall picture of influence, several showed stong effects 
within the limited groups to which they were applicable. For 
example, ten of the nineteen pharmacists who had set up 
diabetic services in other pharmacies saw this as a major 
influence on the decision to do so in the pharmacy in 
question. Four of the nine pharmacies mentioning proximity to 
a diabetic clinic cited it as a major influence. All four 
pharmacists who said that they were diabetics felt that the 
fact had a large or major influence in their involvement in 
the provision of diabetic services in their pharmacies, as did 
nine of the sixteen who had diabetics in their families. 
External influences from professional organizations 
or marketing groups appeared to be of minor importance, but 
this may have been due to little encouragement having been 
provided from these sources rather than to that which was 
provided having little effect. 
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4.6 COMBINED DIABETIC SURVEY 
4.6.1 Aims 
7. To classify pharmacies involved in specialized 
diabetic practice into levels of service provision. 
8. To describe the differences in services provided 
at each level of specialization. 
9. To describe the differences in characteristics 
of pharmacies and pharmacists at each level of 
specialization. 
4.6.2 Classification into Service Levels 
4.6.2.1 Introduction to Cluster Analysis 
Cluster analysis was selected an appropriate 
statistical technique for grouping pharmacies with similar 
levels of service provision, the program used for analysis 
being the SAS CLUSTER procedure (67). 
Cluster analysis has been described by Tull and 
Hawkins (68) as a technique to separate objects into groups 
such that the groups are relatively homogeneous. The technique 
can be applied to nominal, ordinal, interval or ratio data, 
depending on the method employed. 
Churchill (69) defined cluster analysis as a body 
of techniques concerned with developing natural groupings of 
objects based on the relationships of the "p" variables 
describing the objects. He further explained that the 
technique assigns objects to groups so that there will be as 
much similarity within groups and as much difference among 
groups as possible (70). 
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Aldenderfer and Blashfield (71) stated that a 
clustering method is a multivariate statistical procedure that 
starts with a data set containing information about a sample 
of entities and attempts to reorganize these entities into 
relatively homogeneous groups. They also cautioned that most 
clustering methods are relatively simple procedures providing, 
at best, plausible algorithms for creation of clusters, that 
different methods will generate different clusters from the 
same data set, and that, although the strategy is to seek a 
structure, its method of operation imposes a structure. 
Zelnio and Simmons (72) similarly defined the 
purpose of the procedure as identifying groups or clusters so 
that there is homogeneity within and heterogeneity between 
clusters. The clusters are formed based on the similarity of 
relevant measurements. Zelnio and Simmons (72) suggested that 
a possible application of the technique in pharmacy research 
may be clustering of pharmacists based on the level of service 
provided. 
Four suggested stages have been listed for the 
operation of cluster analysis (70,71): 
1. selection and coding of attributes 
(variables) with which to measure the 
entities in the sample, 
2. estimation of similarity (resemblance) 
among the entities, 
3. use of a clustering method to create 
groups of similar entities, 
4. validation of the resulting cluster solution. 
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4.6.2.2 Selecting and Coding Attributes 
The literature does not provide definite guidance 
with regard to selecting attributes (70,72,73), but it has 
been advised that a large number of attributes should be used, 
that they should be of equal importance (unweighted) when 
generating estimates of similarity, and should be standardized 
to avoid the influence of scale of measurement (70,72). 
Aldenderfer and Blashfield (73) advised that, ideally, the 
attributes should be selected on the basis of a stated theory 
used to support the classification, but noted that this 
approach was seldom possible in practice as such theories were 
often implicit. The attributes may be measured on continuous 
or categorical scales, and, if categorical, may be dichotomous 
or multichotomous (70). 
The variables selected as attributes for clustering 
were independent variables or groupings of variables relating 
to diabetic service provision in the three previously 
discussed areas of services, supply and counselling. Where 
attributes were described by more than one variable, data were 
receded in binary form with participation ('1') or 
nonparticipation ('0') in regard to the attribute being based 
on a combined score of 50% or more of the possible total for 
the variables concerned for 'participation', and less than 50% 
for 'nonparticipation'. 
The attributes used for analysis were related to 
services provided (Table 29), supply of diabetic goods (Table 
30), and diabetic counselling topics (Table 31). 
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TABLE 29 
SERVICE ATTRIBUTES 
INFORMATION (Appendix 8, p4) 
Availability of information leaflets. 
Method of distribution of leaflets. 
Availability of diabetic newspapers. 
Availability of diabetic posters etc., 
Other educational materials including 
audio/video tapes in the pharmacy. 
Provision of diabetic education 
outside the pharmacy setting. 
GLUCOSE MONITORING (Appendix 8, p5) 
When demonstrating monitors. 
As a screening service on demand. 
As a screening promotion. 
For diagnosed diabetics. 
Repair of monitors. 
Help with alternative monitoring. 
Hire of monitors, 
Urine glucose measurement. 
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TABLE 30 
SUPPLY ATTRIBUTES 
REGULAR STOCK RANGE (Appendix 8, pp6-7) 
* Blood glucose testing strips, 
* Urine glucose testing strips/tablets, 
* Oral hypoglycaemics, 
Insulins, 
* Disposable insulin syringes. 
Glass syr inges, 
Blood glucose monitors. 
Injection aids (automatic injectors, 
scale magnifiers, devices for 
destroying needles etc.). 
Urine testing equipment (testing sets, 
test tubes etc . ) , 
* Blood testing aids (blood letting 
devices, calibration aids etc.). 
Dietetic foodstuffs including diabetic 
chocolates/sweets, 
* Artificial sweeteners. 
Identification bracelets/tags. 
Glucagon injection. 
Glucose tablets , 
Log books, 
Books on diabetic diet/recipes. 
Books on diabetes and its management. 
* These attributes were subsequently discarded from the 
analysis as all pharmacies scored positively on supply of 
these items. 
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TABLE 31 
COUNSELLING ATTRIBUTES 
Insulin Therapy (Appendix 8, p7) 
based on counselling in relation to use of 
insulin. 
Blood Glucose Monitoring - Purchasers (Appendix 8, p8) 
based on counselling in relation to blood 
glucose monitoring with customers buying or 
discussing a monitor for the first time. 
Blood Glucose Monitoring - Users (Appendix 8, p8) 
based on counselling in relation to blood 
glucose monitoring with customers who are 
already doing blood glucose monitoring. 
Urine Glucose Monitoring (Appendix 8, p8) 
based on counselling in relation to urine 
glucose monitoring. 
Oral Hypoglycaemic Therapy (Appendix 8, p8) 
based on counselling in relation to taking 
oral hypoglycaemic medications. 
Nonprescription Medications (Appendix 8, p9) 
based on counselling in relation to choice 
and use of OTC products. 
Management of Insulin Dependent Diabetes (Appendix 8, p9) 
based on counselling of insulin dependent 
patients in relation to diabetic management. 
Management of Non-Insulin Dependent Diabetes (App.8, p9) 
based of counselling of non-insulin dependent 
patients in relation to diabetic management. 
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4.6.2.3 Estimation of Similarity 
There are four types of similarity measures 
available (73): 
1. correlation coefficients, 
2. distance measures, 
3. association coefficients, 
4. probabilistic similarity coefficients. 
The first two types have been most commonly employed in social 
science research. 
When nominal or ordinal data are being used, 
various matching coefficients have been proposed (70,72). The 
coefficients generally measure the number of characteristics 
on which two entities are matched in relation to the number of 
comparisons being made (72). 
The SAS CLUSTER procedure uses distance measures of 
similar ity (67). 
4.6.2.4 Clustering 
Seven major types of clustering methods have been 
listed (74): 
1. hierarchical agglomerative, 
2. hierarchical divisive, 
3. iterative partitioning, 
4. density search, 
5. factor analytic, 
6. clumping, 
7. graph theoretic. 
The most commonly used methods in the social sciences have 
been hierarchical agglomerative, iterative partitioning, and 
factor analytic. 
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The SAS CLUSTER procedure (67) produces 
hierarchical agglomerative clusters. With this method, each 
entity begins in a cluster by itself; the two closest 
clusters, as calculated by the similarity measure chosen, are 
merged to form a new cluster; clusters (or entities) are 
sequentially merged until only one cluster remains (67,72,74). 
Once a measure of similarity has been chosen, a method of 
comparison must be considered (72). The general methods of 
comparison are linkage (eg single linkage, complete linkage, 
average linkage) nodal, and factor analytic (70,72,74). 
Hierarchical clustering methods employ linkage methods of 
comparison (70), The algorithms available in SAS CLUSTER are 
the centroid method. Ward's minimum variance method, and the 
average linkage method (67). 
Ward's minimum variance method was chosen because 
of its tendency to join clusters with a small number of 
observations (67). In Ward's method, the distance between two 
clusters is the sum of squares between two clusters summed 
over all the variables. At each cluster generation, the 
within-cluster sum of squares is minimized over all partitions 
obtainable by merging two clusters from the previous 
generation (67) ie the method is designed to optimize the 
variance within clusters (74). The method tends to produce 
tight hyperspherical clusters of approximately the same size, 
and is sensitive to outliers (67,74). 
When the clustering procedure has been executed, a 
decision must be made as to the optimal number of clusters 
formed (74). However, Alderderfer and Blashfield (74) have 
remarked that this decision is usually far from clear cut due 
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to the lack of suitable null hypotheses and to the 
complexities of multivariate sampling distributions. The 
approaches usually adopted in social science research are 
heuristic procedures (74). 
A dendrogram is a "tree" diagram which indicates 
the the groups of entities forming at various similarity 
(distance) levels (70). A common heuristic procedure involves 
subjective inspection of different levels of the dendrogram 
(74). Aldenderfer and Blashfield (74) have pointed out that 
this approach may be biased by the needs and opinions of the 
researcher. A second heuristic approach is to plot the number 
of clusters implied by the dendrogram against the fusion or 
amalgamation coefficient (the numerical value at which various 
entities merge to form a cluster). In the SAS CLUSTER 
procedure, the value used in the Semipartial R-Squared 
(squared semi-partial correlation) which is the sum of the 
squares between the clusters just joined divided by the 
corrected total sum of squares. A flattening of the graph 
would indicate that further mergers of clusters would provide 
no more information (74). Another subjective method is to 
examine the values of the fusion coefficients for a 
significant jump in value which would imply the merger of two 
relatively dissimilar clusters. The number of clusters prior 
to the jump would thus be the most likely solution (74). 
Aldenderfer and Blashfield (74) have cautioned that it is 
often difficult to isolate the "correct" jump in fusion 
values. 
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4.6.2.5 Validation 
Evaluation of a cluster analysis solution should 
focus on whether or not the clusters are of sufficient 
homogeneity and whether or not the solution accurately 
describes the original data (70,72). Some measure of average 
similarity is useful in regard to testing homogeneity of 
clusters (70). The solution can be evaluated by gauging its 
predictive validity with respect to variables not used in 
defining the clusters (72). A common approach is to determine 
the extent to which cluster membership is associated with some 
attribute of interest (72). 
Other commonly used methods of validation include 
significance tests on the attributes used to create the 
clusters; replication of the clustering, either by means of 
holdout sample or by use of a different clustering method; or 
comparison of cophonetic values (true levels at which entities 
are linked) with input similarity values for each pair of 
entities (72,75). Cophenetic correlation is restricted to use 
with hierarchical agglomerative clustering methods (75). 
Aldenderfer and Blashfield (75) have commented that: 
1. significance tests on the attributes used to 
create the clusters are misleading, if not useless, due to 
inappropriate statistical application, 
2. while failure of a replication would be reason 
for rejecting a clustering solution, success of a replication 
does not guarantee validity of a solution, and 
3. cophonetic correlation is generally a misleading 
indicator of the quality of a cluster solution. 
289 
It was decided, therefore, to test the validity of 
the clustering solution by significance tests on external 
variables, ie variables not used in creation of the clusters. 
The variables chosen for validation were those considered 
likely to be dependent on the provision of diabetic services: 
Stock Policy - based on whether the pharmacy policy 
in relation to stocking items for supply to diabetic patients 
was to keep a full range of requirements to meet all possible 
needs, or to keep a reasonable range and/or order stock to 
supply requirements (Appendix 8, p5), 
Pis play - based on whether or not there was an area 
in the pharmacy specifically allocated to the display of 
diabetic goods, and the length of display (Appendix 8 p6). 
Syringe Stock - based on the number of boxes of 
disposable insulin syringes (100s) normally kept in stock 
(Appendix 8, p6), 
Diabetic Customer Proportion - based on the 
estimated proportion of customers who are diabetic and/or 
would require diabetic services (Appendix 8, p11). 
Insulin Range - based on the number of types of 
insulin regularly kept in stock (Appendix 11, p4). 
Estimated Diabetic Stock Proportion - the estimated 
proportion of total stock value invested in diabetic stock 
(Appendix 11, p4), 
Calculated Diabetic Stock Proportion - the 
proportion of total stock value invested in diabetic stock, 
calculated from the estimated total value of current diabetic 
stock and the current total stock value including diabetic 
stock (Appendix 11 pp4 and 6 ) , 
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Degree of Involvement - the respondent's subjective 
opinion of whether the involvement in provision of diabetic 
services was minor, moderate or major (Appendix 11, p4), 
Kendall's rank correlation coefficient, tau-b, was 
used to test the validity of the cluster solution, Kendall's 
tau is a nonparametric measure of association which is 
appropriate for analysis of rank-order data (76), In using tau 
to measure the association between two ordinal variables, the 
cases are first placed in the natural order of rank according 
to one of the variables. It may then be determined how many 
pairs of ranks of the second variable are in their natural 
order with respect to each other for each case. The tau 
coefficient is based on the number of concordant and 
discordant pairs of observations (77), ie it is a function of 
the number of interchanges between neighbours required to 
transform one ranking into another (76). Tau-b incorporates a 
correction for tied pairs (77) and was therefore the 
appropriate measure to use in this case, where the cluster 
variable consisted of two values only. 
Tau-b was used to test the set of null hypotheses 
that "there is no relationship between cluster membership and 
each of the dependent variables listed". When the sample size 
is greater than 10, as in this case, tau can be considered 
normally distributed with a mean, u (u=0), and a standard 
deviation, o. The significance of tau (T) can be determined by 
reference to a table of normal deviates, z, (78) where: 
z = (T-u)/o 
An alpha level of 0,05 was selected for rejection of the null 
hypotheses, 
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4.6.3 Results 
4.6.3.1 Cluster Solution 
Visual inspection of the dendrogram produced by SAS 
CLUSTER Ward's method suggested a two cluster solution as 
being the most likely (Figure 4 ) . This solution is evident at 
a semipartial R-squared value of 0.1. At a similarity level of 
0,05, three clusters were evident, at 0.04, four clusters, and 
at 0,03, six clusters. 
A plot of the number of clusters against the 
semipartial R-squared values for cluster formation showed the 
curve to be essentially flat at the two cluster solution, 
again implying this to be the most likely grouping (Graph 2). 
Changes in the value of the semipartial R-squared 
were inspected to detect significant 'jumps' in value. Prior 
to the formation of six clusters, jumps were all less than 
0,002 (Table 32), Small jumps were seen between the six- and 
five-cluster solutions and between the four- and three-cluster 
solutions, indicating that six clusters or four clusters may 
possibly be appropriate solutions. However the much larger 
jump between the two- and one-cluster solutions led to the 
acceptance of the two cluster solution as being most likely. 
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FIGURE 4 
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GRAPH 2 
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TABLE 32 
CLUSTER SOLUTION 
Number of 
Clusters 
6 
5 
4 
3 
2 
1 
Semi part ial 
R-Squared 
0.0256 
0.0317 
0. 0334 
0.0467 
0.0511 
0.1084 
Change 
in Value 
0.0001 
0,0061 
0,0017 
0.0133 
0.0044 
0.0573 
4.6.3.2 Cluster Validation 
Kendall's rank correlation coefficient, Tau-B, was 
used to determine whether the cluster solution imposed by SAS 
CLUSTER Ward's method was valid for selected variables 
external to the creation of the clusters. 
Results of these analyses are shown in Table 33. 
Using P=0.05 as the critical probability (alpha level) for 
rejection of the null hypotheses, relationships are evident 
between cluster membership and stock policy, diabetic customer 
proportion, and perceived degree of involvement in diabetic 
services. Using a one-tailed test, significance would also be 
observed for display size and calculated diabetic stock 
proportion. These relationships provide confirmatory evidence 
for the cluster solution. 
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Variable 
Stock Policy 
Display 
Syringe Stock 
Diabetic Customers 
Insulin Stock 
Estim. Diabetic Stock 
Calc. Diabetic Stock 
Degree of Involvement 
TABLE 33 
VALIDATION OF CLUSTER SOLUTION 
Kendall's Tau-B z 
0.382 
0. 161 
0,133 
0,361 
0.087 
0.213 
0. 123 
0. 238 
3.82 
1 .66 
1 .40 
3.68 
0.09 
1 .03 
1 .26 
2. 38 
Probability 
<0.0002 
0.097 
0. 162 
0.0002 
0.928 
0. 303 
0.107 
0.017 
4.6.3.3 Differences in Service Provision Between Clusters 
Because the variables relating to diabetic service 
provision in the areas of service, supply and counselling were 
used in the formation of the clusters, it is not appropriate 
to test for significant differences in those variables between 
the clusters. Instead, Cramer's Contingency Coefficient 
(Cramer's V) was used to measure the degree of separation of 
pharmacies into the two clusters. Cramer's V, a measure of 
association for nominal data, does not depend on the order in 
which the categories are listed, and is a measure based on the 
chi-square statistic (79). Its value ranges from 0 in the case 
of independence to 1 in the case of perfect association (79). 
Therefore, variables with a higher value of Cramer's V, 
greater than 0.2 with one degree of freedom, were identified 
as characterizing differences between clusters (Table 34). 
Variables tested were those listed in Tables 29-31. Only those 
variables exhibiting differences are shown in Table 34. 
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TABLE 34 
SERVICES DIFFERING BETWEEN CLUSTERS 
Service Cramer's V 
Services: INFORMATION 
Other educational materials 
including audio/video 
tapes in the pharmacy 0.331 
GLUCOSE MONITORING 
When demonstrating monitors 0.244 
For diagnosed diabetics 0.326 
Help with alternative monitoring 0.254 
Hire of monitors -0.208 
Supply: Glass syringes 0.198 
Log books 0.203 
Counselling: Insulin Therapy 0.521 
Blood Glucose Monitoring (Users) 0.434 
Urine Glucose Monitoring 0.291 
Nonprescription Medications 0.243 
Management of IDD 0.904 
Management of NIDD 0.803 
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4.6.3.4 Differences in Pharmacist Characteristics 
Chi-square tests were used with nominal variables 
and Kendall's tau-b with ordinal variables to identify which 
characteristics of the pharmacists providing diabetic services 
differed significantly between the clusters of pharmacies. 
Null hypotheses of the general form "there is no difference in 
(variable) between clusters" were tested using P=0.05 as the 
critical probability (alpha level) for rejection. Variables 
tested were those listed in Table 35. Due to the small numbers 
of positive responses, chi-square was not a valid test for the 
membership variables ACPP, SHPA and ADEA as expected counts 
were less than 5 for 20% or more of the cells. Inspection of 
Cramer's V for these variables revealed low values for ACPP 
and SHPA membership, suggesting that differences between 
clusters were unlikely. However, for ADEA membership, Cramer's 
V = 0.253 with DF = 1, suggesting that there was possibly a 
relationship between ADEA membership and pharmacy cluster. 
4.6.3.5 Differences in Pharmacy Characteristics 
Chi-square and Kendall's tau-b were similarly used 
to determine pharmacy characteristics differing significantly 
between the clusters. Null hypotheses of the general form 
"there is no difference in (variable) between clusters" were 
tested, again using the 5% level of significance. Chi-square 
was not a valid test for 'Pharmacy Site', as more than 20% of 
cells had expected counts of less than 5. However, a low value 
of Cramer's V indicated that a significant relationship was 
unlikely. Variables tested were those listed in Table 36. 
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TABLE 35 
PHARMACIST CHARACTERISTICS DIFFERING BETWEEN CLUSTERS 
DEMOGRAPHICS 
Variable DF Chi-Square 
Qualification 1 0.73 
Sex 1 1.01 
Pharmacist status 3 3,93 
Variable Kendall's Tau-B z 
Working hours/week 0.076 0.88 
Probability 
NS 
NS 
NS 
Probability 
NS 
MEMBERSHIPS 
Variable 
PSA membership 
DAQ 
DF Chi-Square 
1 3.52 
1 3. 56 
Probability 
NS 
NS 
JOURNAL READING 
AJP 
Aus t,Pharmac i s t 
Aus t,Prescr iber 
Curr,Therapeutics 
Patient Management 
Pharm,J, 
Control 
Conquest 
Diabetes in the News 
1 1 
1 0 
t 0 
1 3 
1 1 
1 0 
1 5 
1 4 
1 1 
38 
21 
008 
1 1 
65 
82 
85 
32 
68 
NS 
NS 
NS 
NS 
NS 
NS 
0.016 
0.038 
NS 
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CONTINUING EDUCATION 
Variable DF 
Pharmacy l e c t u r e s 
Pharmacy m a t e r i a l s 
D i a b e t e s l e c t u r e s 
D i a b e t e s m a t e r i a l s 
I n d u s t r y m a t e r i a l s 
Books on d i a b e t e s 
J o u r n a l r e a d i n g 
Chi-Square 
2 
0 
10 
8 
7 
1 1 
1 
58 
. 50 
.28 
.87 
.90 
.47 
,80 
P r o b a b i l i t y 
NS 
NS 
0, 001 
0.003 
0.005 
0.001 
NS 
MOTIVATION 
V a r i a b l e K e n d a l l ' s 
Tau-B 
I n t e r e s t i n d i a b e t e s 0 . 3 0 8 
P r o f . s a t i s f a c t i o n 0 . 2 5 2 
P r o f i t a b l e 0.035 
Previous experience -0.109 
Clinic Proximity 0.096 
Diabetic customers 0.079 
Customers needed help 0.226 
Diabetic pharmacist 0.093 
Diabetic in family 0.180 
Diabetic friend 0.126 
Diabetic staff member 0.094 
Approached by Ames -0.034 
Approached Ames -0.028 
PSA influence -0.061 
PGA influence -0.060 
Merch. group infl, 0.038 
Probability 
3.28 
2, 55 
0. 34 
1 . 02 
0.86 
0.78 
2. 38 
0.82 
1 .67 
1 , 14 
0. 86 
0. 32 
0,26 
0. 57 
0. 55 
0.33 
0.001 
0.011 
NS 
NS 
NS 
NS 
0.017 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
TABLE 36 
PHARMACY CHARACTERISTICS DIFFERING BETWEEN CLUSTERS 
Variable DF Chi-Square Probability 
Location 1 1.37 NS 
PGA Membership 1 0,13 NS 
Merch,group 1 0.11 NS 
Variable Kendall's Tau-B 
Trading Hours 0.056 
Turnover -0.135 
Script Proportion -0.062 
Scripts/Month -0.062 
Year of Establishment 0.060 
Insulin Stock Value -0.035 
Diabetic Stock Value 0.150 
No.Reference Texts 0.072 
Pharmacy Size 0.097 
Front Shop Area 0.097 
Total Stock Value 0.011 
z 
0.60 
1 . 39 
0.61 
0.62 
0.63 
0. 37 
1 .60 
0.67 
1 ,02 
1 ,04 
0.11 
Probability 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
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4.6.4 Discussion 
4.6.4.1 Classification of Pharmacies 
Objective 7 - To classify pharmacies involved 
in specialized diabetic practice into levels of 
service provision. 
Objective 7 has been fulfilled by 4.6.3.1 and 4.3,6,2. 
Using attributes related to diabetic service 
provision, the most likely pattern imposed upon the group of 
specialized pharmacies by Ward's clustering method was a two 
cluster solution. The clusters could therefore be considered 
to comprise pharmacies providing diabletic services at a lower 
or higher level respectively. 
4.6.4.2 Service Levels 
Objective 8 - To describe the differences in 
services provided at each level of specialization. 
Objective 8 has been fulfilled by 4.6.3.3 and summarized in 
Table 34. 
The service attributes which did not differ 
significantly between the lower and higher level providers 
were general means of providing information, diabetic 
screening, assistance with repair of monitors, and urine 
glucose testing. It was expected that less usual means of 
providing information, such as audio and/or video tapes, may 
have been in use only among higher level service providers, 
but somewhat surprising that there was no difference observed 
in provision of information outside the pharmacy setting by 
pharmacists in either group. Although there were differences 
in blood glucose monitoring services between lower and higher 
level service providers, concordance with regard to screening 
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for diabetes may be attributable to the fact that external 
agents were often involved in screening programmes, and were 
frequently the instigators. Although both groups were equally 
involved in assisting clients with repair of blood glucose 
monitors, higher level providers were more involved in 
offering alternative means of monitoring while repairs were 
being carried out, such as lending a monitor or advising on 
visual testing. Lower level providers were more likely to have 
monitors for hire. Generally minor involvement in urine 
glucose measurement precluded observation of differences 
between clusters. 
Differences in supply attributes did not contribute 
greatly to the cluster separation, as even those which were 
possibly significant were of marginal importance only. 
Various aspects of counselling appeared to be the 
major factors distinguishing between clusters, with six of the 
eight sets of topics showing significant differences. No 
differences were found in counselling about blood glucose 
monitors with customers buying or discussing a monitor for the 
first time. High counselling scores were evident for this 
activity in both clusters, presumably due to customers need 
for information about how to use the monitors at the time of 
purchase. Counselling patients about oral hypoglycaemic 
therapy also did not differ between lower and higher level 
service providers. This may be because counselling on oral 
prescription medications is increasingly being considered an 
integral part of the dispensing process and oral 
hypoglycaemics were receiving the same counselling attention 
from pharmacists as were other drug groups. Topics exhibiting 
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differences between clusters were those which either required 
specialized knowledge about aspects of diabetes eg insulin 
therapy, management of IDD and NIDD; or required pharmacists 
to recognize special needs of diabetic patients eg successful 
continuation of blood glucose monitoring, advantages of blood 
glucose monitoring over urine glucose monitoring, and 
selection of appropriate nonprescription medications. 
4.6.4.3 Demographics 
Objective 9 - To describe the differences in 
characteristics of pharmacists and pharmacies at 
each level of specialization. 
Objective 9 has been fulfilled by 4.6,3,4 and 4.6.3,5 and 
summarized in Tables 35-36, 
Demographic characteristics of pharmacists 
providing diabetic services did not differ between pharmacy 
clusters. Although significance was not proved statistically, 
greater proportions of pharmacists in higher service level 
pharmacies claimed membership of some professional 
organizations. The trend was observed for membership of PSA (P 
= 0,061, Cramer's V = 0.189), DAQ (P = 0.059, Cramer's V = 
0.238) and ADEA (Cramer's V = 0.250). Differences in journal 
reading habits of pharmacists between the two clusters were 
observed for Control and Conquest . both of which would be 
received by members of DAQ. Use of easily accessible means of 
acquiring expertise in the area of diabetes, such as 
continuing education meetings or materials from pharmacy 
professional organizations and journal reading, was consistent 
between groups. However, greater proportions of pharmacists in 
higher service level pharmacies took recourse to meetings or 
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materials from diabetic organizations, information from 
pharmaceutical companies, and books on diabetes to improve 
their knowledge. Use of these sources would require greater 
motivation and effort from pharmacists. 
Some differences in motivation of pharmacists 
deciding to establish or continue diabetic services were 
observed between clusters, with greater proportions of 
pharmacists in higher service level pharmacies citing such 
altruistic reasons as personal interest in diabetes, a desire 
to increase professional satisfaction , and recognition of 
their diabetic customers' need for help. 
No significant differences were found in the 
business characteristics of pharmacies between clusters, 
4.7 FUTURE APPLICATIONS OF THE METHODOLOGY 
Objective 10 - To develop a methodology suitable 
for application to future studies. 
The methodology employed in this thesis to 
investigate the provision of services from community pharmacy 
comprised three major steps. 
The initial "Survey of Services from Community 
Pharmacy in Queensland, 1984" identified and quantified 
services associated with the dispensing process, primary 
health care, and specialized health-related areas. It also 
allowed identification of the pharmacies involved. From this 
information, diabetic service was selected as a case study for 
futher investigation into the development of specialized 
services in community pharmacy. 
The combined mail and telephone "Survey of Diabetic 
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Services from Community Pharmacies in Queensland, 1986-87" was 
designed to elicit information about the diabetic services 
being provided, and the pharmacies and pharmacists providing 
the services. Although the sample detected by the first survey 
was expanded by other means prior to the second survey, 
sampling problems were still apparent. In the initial survey, 
practitioners identified themselves as being providers of a 
particular service. In the second survey, interviews were not 
completed with pharmacists who did not consider themselves to 
be providing diabetic services beyond those expected in the 
average pharmacy, as many of the questions would have been 
irrelevant and the financial and temporal costs difficult to 
justify. While this self-se1ection aspect of the sampling may 
have resulted in bias, the absence of researched information 
about specialized diabetic services meant that no accurate 
measure could be applied at that stage to justify inclusion or 
exclusion of pharmacies from the sample. 
Cluster analysis was used to determine parameters 
for identifying specialists. The purpose of dividing 
specialized diabetic pharmacies into groups on the basis of 
service provision was twofold. Firstly, the parameters 
separating the groups may be used as criteria for future 
identification of pharmacies as high level diabetic service 
providers. Secondly, the information could be used to make 
recommendations to assist practitioners wishing to become 
involved in the provision of diabetic services eg specialized 
diabetic practice could perhaps be initiated by offering 
services similar to those of lower service level providers and 
later expanded to include services offered by the higher level 
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providers. Higher level service providers were here 
distinguished by offering monitoring services, and by 
providing information in novel ways and about aspects of 
health care beyond those related to prescription medications 
and the sale of goods related to the condition. Validation of 
the clustering procedure also showed that higher level 
providers had a comprehensive stock policy, estimated their 
diabetic customer ratio to be greater than the diabetic ratio 
of the general population, and placed a high estimate on their 
degree of involvement in the provision of diabetic services. 
The methodology employed could be used with minor 
modifications to investigate other areas of specialized 
practice related to specific disease states. Sample 
determination for other areas may be even more limited than 
for diabetic pharmacies due to a lack of sources of 
identification. However, using the principles established by 
the survey of diabetic pharmacies, decisions to exclude from 
or include in the sample could be based on provision of 
monitoring/screening services, counselling topics addressed, 
and business characteristics such as stock policy for goods 
related to the specific disease state, estimated proportion of 
customers suffering from the disease state, and the 
pharmacist's estimate of the degree of involvement by the 
pharmacy in relation to that disease state. The methodology 
could also easily be applied to a wider geographic sample, 
allowing extrapolation to the national community pharmacy 
arena, and possibly international comparisons. 
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Chapter 5 
COMMUNITY PHARMACY PRACTICE IN QUEENSLAND -
PAST. PRESENT AND FUTURE 
5.1 THE PAST 
The roots of pharmacy practice in Australia can be 
found in the English system. The result of this background was 
that early pharmacists in Australia had the freedom to deal in 
medicaments, and their ready accessibility to the public meant 
that they were also involved in the provision of advice to the 
public in regard to health matters. However, because the 
giving of advice was considered to be part of the practice of 
medicine, they were unable to charge a fee for consultation. 
The image of the pharmacist was that of a trader earning a 
living from sale of goods rather than that of a professional 
rewarded by fee for service. 
Later in the nineteenth century, the role of the 
pharmacist was described as giving advice on the treatment of 
common ailments from their symptoms, prescribing medical 
treatments for minor ailments, compounding and supplying the 
required medicines, and providing antidotes for poisoning and 
first aid for injuries (1). Their functions were seen not 
merely to involve compounding and supply of medicines, but 
also prescribing and counselling. Pharmacists did not have a 
monopoly on dispensing of doctors prescriptions at this time. 
The advent of patent medicines for self treatment threatened 
both the pharmacists' advisory and compounding roles. 
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During the first half of the twentieth century, 
pharmacists continued to be engaged in compounding and 
dispensing activities and the provision of health advice 
without a fee. The beginnings of pharmacists' involvement in 
community health education activities were seen. Restrictions 
began to be imposed to allow the supply of some medicinal 
compounds on doctors' prescriptions only. A distinction 
between the duties of doctors and pharmacists was made, so 
that doctors became the prescribers and pharmacists the 
dispensers. As the variety of patent medicines increased, the 
front shop area of pharmacies became more and more 
commercially orientated and professional activites such as 
compounding were moved to the seclusion of the dispensary. 
The explosion of sophisticated new pharmaceuticals 
onto the market following the Second World War caused a marked 
decrease in extemporaneous dispensing in the decades 
following. Although the advent of the Pharmaceutical Benefits 
Scheme (PBS) resulted in more prescriptions being written, a 
growing proportion of them involved only simple counting or 
pouring techniques for their supply. The commercial aspects of 
supply became the major function of dispensing. Despite 
advances in the quality of pharmaceutical education, the 
professional role of the pharmacist in the 1950s and 1960s was 
increasingly overshadowed by the business role in the eyes of 
both the public and the profession. 
The emphasis in the role of the pharmacist changed 
during the 1970s and 1980s from chiefly that of a preparer and 
supplier of medicines to place increasing importance on that 
of advisor in the optimal choice and use of prescription and 
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nonprescription medication. Changes in the nature of community 
pharmacy practice occurred in response to the clinical needs 
of patients. Involvement with individuals and their drug 
therapy was necessitated by recognition of the potential for 
adverse reactions and drug interactions with the complex array 
of new drug entities. It was acknowledged that patients needed 
not only to be prescribed the correct medicine, but also to be 
provided with the information to allow them to use it 
correctly. Patients began to demand the knowledge to enable 
them to participate in health care. Aspects of clinical 
involvement by pharmacists included the keeping of patient 
medication records; provision of drug information to patients 
by methods such as verbal counselling, ancillary labels and 
information leaflets; and the provision of drug information to 
doctors and other health professionals. 
The expansion of knowledge, coupled with the 
demands of consumers to accept responsibility for their own 
health, created a need for expansion of the variety and 
quality of expertise of pharmacists in health maintenance. 
While there has been official acceptance of the principle of 
specialization and recognition of specialists in pharmacy in 
the United States (at least in hospital pharmacy), a more 
tentative approach has been adopted in Australia, especially 
in relation to specialization within community practice. 
Despite this reticence on the part of officialdom, some 
practitioners have diversified their role into specialized 
areas of health related services, including such activities as 
screening and monitoring of disease states, in addition to 
supply of medication and medication management advice. 
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5.2 THE PRESENT 
By the mid-1980s, the role of the pharmacist in 
Australia was officially recognized as involving the 
preparation and supply of medications and the provision of 
systems and information to optimize their use; and the 
provision of primary health care services, including supply of 
therapeutic goods, advice on the management of minor ailments, 
recognition and referral of more serious conditions, disease 
prevention and health promotion education (2). 
The "Survey of Services from Community Pharmacies 
in Queensland, 1984" set out to ascertain the nature and 
extent of the activities of community pharmacists in 
Queensland, and to allow identification of pharmacists 
involved in innovative areas of practice. The findings of the 
survey, summarized below, confirmed that pharmacists were 
performing duties related to the dispensing of prescription 
medications and to the provision of primary health care, and 
that many were offering other health-related services of a 
specialized nature. 
5.2.1 Dispensing Services 
The steps involved in the dispensing process have 
been described as prescription review, supply, counselling and 
monitoring. 
Community pharmacists in Queensland were involved 
in dispensing for private hospitals (16.1%), nursing homes 
(32.4%), medical centres (11.8%), public hospitals (11.6%) and 
other institutions (11.9%) in addition to the general public. 
A few pharmacies claimed to be normally involved in dispensing 
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requiring unusual extemporaneous techniques (6.5%) or unusual 
ranges of proprietary items (7.8%). 
Computers were used for dispensing purposes in 
11.9% of pharmacies responding, and a further 31.4% considered 
it likely or very likely that a computer would be installed 
within two years. The major additional services nominated as 
being provided consequent on computerization were patient 
medication records and drug information print-outs. Computers 
were also said to be useful for providing reminders of 
appropriate ancillary labels and for detection of drug 
interactions. 
Ancillary labels were claimed to be in use by 91.8% 
of respondents, 70.5% on a routine basis. Patient medication 
records were claimed to be kept by 35.5% of respondents, 10.9% 
involving the use of computers. 
The front counter was nominated by 83.7% of 
respondents as the usual site for counselling to occur in the 
pharmacy. Although 5.0% of pharmacies had a separate 
counselling room, this was rarely considered to be the usual 
counselling site. In contrast, a specific counselling area 
within the main pharmacy, nominated by 4.1% of respondents, 
was stated to be the usual place for counselling by about two 
thirds of them. Only 1.1% of respondents claimed not to be 
involved in counselling. Counselling aids used were ancillary 
labels (87.5%), manufacturers leaflets (71.6%), and Division 
of Health Promotion (DHP) leaflets (66.8%). Also, 62.3% of 
computer users employed computer generated leaflets. While the 
Pharmaceutical Benefits Scheme (PBS) at the time appeared to 
regard pharmacists chiefly as suppliers, there seemed to be 
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general acceptance among pharmacists of the principle of 
designating a recognizable proportion of the dispensing fee 
for counselling. 
Investigation of the drug surveillance activities 
of community pharmacists indicated that 5.2% had reported 
adverse drug reactions to ADRAC and 27.6% to medical 
practitioners during the preceding six months. Patients had 
been referred to medical practitioners because of suspected 
drug interactions from 9.8% of pharmacies during the preceding 
week, as a result of side effects from 30.0%, and about other 
clinical matters relating to prescription medication from 
24.9% of pharmacies. In the same period, doctors had been 
contacted about drug interactions by 9.3% of pharmacies, side 
effects by 14.7%, and other prescription matters by 62.5%. 
5.2.2 Primary Health Care Services 
The primary health care activities of community 
pharmacists have been defined as responding to symptoms and 
providing advice on self-medication. The outcome of a primary 
health care consultation may be sale of a nonprescription 
medication, advice on other means of management, or referral 
to another health practitioner. Primary health care may also 
be considered to include disease prevention and health 
promotion, screening for health problems, and encouragement of 
the principle of self-care. 
Queensland pharmacists were overwhelmingly (98.6%) 
of the opinion that a pharmacy-only class of drugs should 
continue to exist; only 47.7% were in favour of the release of 
more drugs into this category from prescription-only status. 
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A reluctance was shown to the charging of a 
professional fee on supply of S3 medications, with only 38.7% 
applying fees at the recommended level and 22.7% charging no 
fee in spite of legislated professional obligations associated 
with the sale of these items. 
Investigation of drug surveillance in areas other 
than those directly related to prescriptions showed that 
patients had been referred to medical practitioners about 
nonprescription medications from 25.2% of pharmacies during 
the preceding week, about disease states from 62.9%, and about 
other matters from 13.1% of pharmacies. In the same period, 
doctors had been contacted about nonprescription medications 
by 8.4% of pharmacies, disease states by 18.4%, and other 
matters by 18.3%. 
5.2.3 Specialized Health Related Services 
Specialized services being provided through 
community pharmacies in Queensland were identified and 
quantified by the survey, and service providers identified for 
follow-up study purposes. 
Specialized services have been established to cater 
for the needs of specific demographic groups within the 
community, to provide support to sufferers of specific disease 
states, and to advise on specific product ranges. 
While developments in one State of Australia cannot 
be extrapolated to the national or international scene, 
literature reviewed indicated that entrepreneurial, innovative 
community pharmacists elsewhere in the western world have also 
taken up the challenge of extending their professional 
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practices to the provision of similar services. 
The findings were that asthma pumps, blood glucose 
monitors, blood pressure monitors, and extensive ranges of 
invalid or health care aids, nutritional supplements, sports 
medicine goods, and veterinary medicines were each stocked by 
at least 30% of pharmacies. 
The major health related services offered were hire 
of invalid or health care aids (53.2%), sports medicine 
services (37.3%), pregnancy testing (35.6%), diabetic services 
(15.2%), and hypertensive services (8.3%). Seventy percent of 
the pharmacies responding were involved in provision of the 
listed innovative services, 50.0% offering one service, 35.8% 
two services, and the remaining 14.2% three or more. 
The hypotheses tested allowed identification of 
significant demographic and business variables associated with 
each service. This analysis was used as a screening procedure 
to facilitate further investigation of the factors affecting 
the establishment and operation of specialized health-related 
services . 
For the purposes of this further investigation, 
provision of diabetic services was selected as a case study. 
This area of innovative practice was selected for follow-up 
examination because of the diversity of services which could 
be offered to diabetic patients through community pharmacies, 
the variety of demographic and business factors highlighted by 
the screening analysis as differing between providers and 
nonproviders, the size of the identified sample, and the ease 
of expanding that sample through other means of 
identification. 
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5.2.4 Specialized Diabetic Services 
5.2.4.1 Services Provided 
The "Survey of Diabetic Services from Community 
Pharmacies in Queensland, 1986-86" was aimed firstly at 
documenting the details of diabetic services being offered by 
the community pharmacies involved. Activities, summarized 
below, were broadly divided into three groups: services, 
supply and counselling. 
Services were related mainly to provision of 
information to diabetic patients and aspects of blood glucose 
monitoring. Over seventy percent of pharmacies were involved 
in provision of information via leaflets (75.3%), and via 
diabetic newspapers (70.6%). About one quarter of the chief 
pharmacist providers in active pharmacies were involved in 
provision of diabetic education services outside the pharmacy 
setting. At the time of the survey, about two-thirds of 
respondents claimed that blood glucose measurements were being 
performed in their pharmacies. 
All pharmacies reported keeping ranges of stock of 
blood glucose testing strips, urine glucose testing strips 
and/or tablets, and oral hypoglycaemic drugs. Although only 
two-thirds kept a range of insulins, the remainder either kept 
limited stocks or had arrangements with their patients to 
order repeat supplies prior to needing them. Two-thirds 
regularly stocked glucagon injection. Disposable insulin 
syringes, blood testing aids and artificial sweeteners were 
stocked by all pharmacies. High proportions of pharmacies 
(over 80% for each) reported keeping stocks of blood glucose 
monitors, urine testing equipment, identity bracelets and/or 
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tags, glucose tablets, log books, and books on diabetic diet. 
Although many had urine testing equipment and/or glass 
syringes in stock, the comment was frequently made that they 
had not sold any of the items for some time. Only about half 
of the pharmacies kept injection aids such as automatic 
injectors, scale magnifiers, or devices for destroying 
needles. These items, being of a specialized nature, may only 
warrant stocking by more specialized outlets. Slightly more 
than half of the pharmacies stocked diabetic foodstuffs, 
chocolates or sweets. 
Pharmacists were involved in counselling diabetic 
patients about such diverse topics as insulin therapy, blood 
glucose monitoring, urine glucose monitoring, oral 
hypoglycaemic therapy, nonprescription medicines, and diabetic 
management. The areas of major involvement were counselling 
purchasers of blood glucose monitors about their use, and 
counselling NIDD patients about oral hypoglycaemic drug 
therapy. Areas of least involvement were counselling IDD 
patients about insulin therapy, and counselling about urine 
glucose monitoring. 
5.2.4.2 Factors Relating to Involvement 
Analysis of the "Survey of Services Provided From 
Community Pharmacies in Queensland, 1984", used as a screening 
procedure, indicated that there were significant differences 
in the sex ratios and work status of providers and 
nonproviders of diabetic services. However, chi square 
analyses performed using the expanded sample of diabetic 
service providers to test the hypotheses "that there were no 
significant difference between providers and nonproviders of 
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diabetic services" showed no significant differences in sex 
ratio or work status at the P = 0.05 level. 
Pharmacists involved did not generally have 
qualifications beyond the basic requirements of Ph.C. or 
B.Pharm. They tended to be members of PSA (74.3%) and the 
owners of the pharmacies involved tended to be members of PGA 
(84.0%). Eighteen pharmacists reported membership of DAQ. 
However, providers did not recognize support from professional 
organizations as motivation for the provision of diabetic 
services. Over 70% of pharmacists reported regular readership 
of Australian Journal of Pharmacy. Australian Pharmacist. 
Australian Prescriber. and Diabetes in the News. Journal 
reading was identified as a major source of information about 
diabetes (91.5%), as were information from pharmaceutical 
companies, books on diabetes, and CE information from pharmacy 
sources (each over 70%). Only about a quarter of the 
pharmacies appeared to have specific diabetes reference texts 
available . 
Presence of Diabetic Association Support Group did 
not appear to inhibit the development of diabetic services in 
community pharmacies, as 76.9% were within 25Km of a Support 
Group. In the Brisbane area, this was the case for 87.5% of 
pharmacies, while 66.3% of country pharmacies providing 
diabetic services were within 25Km of a Support Group. There 
was a significant difference in the distribution of pharmacies 
providing diabetic services between the Brisbane area and the 
country, with greater proportions of country pharmacies 
offering the services. As many country centres lacked some of 
the facilities available in Brisbane and other larger 
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provincial centres (such as Diabetic Support Groups, hospital 
diabetic clinics, or health professionals other than general 
practitioners and pharmacists) pharmacists may have been 
filling a breach. Pharmacy site also became significant on 
examination of the expanded sample, although it had not 
appeared to be so previously. As the trend was for higher 
proportions of city centre and regional shopping centre 
pharmacies to be providing diabetic services, this may be 
explained as a function of the higher proportion of pharmacies 
in country areas being providers, since many pharmacies in 
country towns have been classified as being sited in the city 
centre. The physical size of the pharmacy and the annual 
turnover were also significantly different between providers 
and nonproviders, with greater proportions of larger 
pharmacies with higher turnovers being providers. Higher 
proportions of merchandising group members were providers of 
diabetic services, but the groups were not recognized by 
providers as having encouraged the development of diabetic 
services . 
Professional and altruistic reasons were the major 
general influences on the decision to establish or continue a 
diabetic service in a community pharmacy. Pharmacists saw the 
service as a way to increase professional satisfaction, had a 
personal interest in diabetes, had a number of diabetic 
customers, and recognized the need of their diabetic customers 
for assistance. The prospect of making a profit, and the 
support of Ames were also important factors, but to a lesser 
degree. Some individuals cited specific highly motivational 
factors including already having set up a diabetic service in 
324 
another pharmacy, geographic factors such as proximity to a 
diabetic clinic, and being a diabetic or having a diabetic in 
the family. Support from external sources such as professional 
organizations or merchandising groups was apparently minor. 
The great majority of pharmacies providing diabetic 
services (at least 70%) had begun their involvement since 
1980, probably due to the advent of blood glucose monitoring 
and the sale of monitors through pharmacies. 
In summary, the provision of specialized diabetic 
services from community pharmacies in Queensland has been the 
result of the efforts of motivated practitioners, with only 
minor influence from external sources. 
5.2.4.3 Levels of Service Provision 
Grouping of pharmacies specializing in diabetic 
services, based on the services they provided, resulted in the 
formation of two clusters providing lower and higher levels of 
service. The distinguishing features between the two groups 
were that higher service level providers were more likely to 
be providing information to patients by less conventional 
means, such as audio and video tapes; more likely to be 
offering blood glucose monitoring services, beyond screening; 
more likely to assist clients with alternative means of blood 
glucose monitoring while monitors were being repaired; and 
more involved in counselling in aspects of diabetic care apart 
from oral hypoglycaemic therapy, and blood glucose monitoring 
on initial purchase of a monitor. 
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5.3 THE FUTURE 
A look at the history, and a knowledge of the 
current status of community pharmacy practice in Queensland 
logically invite questions about its future development. 
What is the future of community pharmacy practice in 
Queensland? 
Community pharmacists have long had an active role 
in assisting people with the treatment and management of minor 
ailments. Their ready accessibility to the public has been 
responsible in the past for the development of the 
pharmacist's role in provision of primary health care. 
Recent years have seen the expansion of personal 
health care into areas of health maintenance, including self 
management of chronic conditions formerly considered to be the 
responsibility of medical practitioners. Many types of 
patients previously confined to hospital, particularly the 
increasing proportion of elderly people in the community, are 
now being treated at home. These changes have been made 
possible partly through advances in technology. Pharmacies, 
again in part because of their ready accessibility, have 
become the logical retail outlets for technological 
developments such as blood pressure and blood glucose monitors 
and for health-related equipment such as invalid aids. 
While the obvious role of the pharmacist has been 
to provide assistance in the management of medication, sale of 
health-related equipment has also involved them in assisting 
patients with the practical use of such equipment and the 
application of technology to the management of their 
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conditions. Advances in technology have also facilitated the 
development of screening services in community pharmacies 
aimed at detecting, and in some cases monitoring conditions 
such as diabetes, hypertension, high cholesterol levels, and 
pregnancy. 
The fact that nearly three quarters of the 
pharmacies responding to the initial survey were involved in 
the provision of some form of health care not traditionally 
associated with pharmacy, suggests that community pharmacies 
are responding to and fulfilling a public need for such 
services . 
Patients and home-care givers appear to require the 
support and assistance of readily accessible health care 
practitioners to enable them to fulfil the new self care roles 
expected of them. However, modern advances in medical 
treatment are associated with increasing complexity of 
information, technology, and drug therapy. It is therefore 
becoming increasingly difficult for community pharmacists to 
be experts in all areas. The diversity and complexity of 
possible service areas, coupled with the apparent needs of the 
public, would seem likely to provide a climate in which 
specialization would flourish. 
Should specialization be encouraged? 
Specialization has been officially recognized 
overseas, largely in relation to aspects of hospital pharmacy 
practice. At present it appears, at least in Queensland, that 
the specialization trend in community pharmacy is advancing in 
response to public needs at the instigation of motivated 
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practitioners with little influence or support from 
professional bodies or other external sources. The evidence 
suggests that, if the climate is right, some form of 
specialized practice is likely to continue to develop. 
Not unexpectedly, opposition to specialization in 
community pharmacy has been encountered from both within and 
outside the profession. For example, in a recent statement on 
the role of the pharmacist, the Australian Medical Association 
(AMA) expressed the opinion that chemical or physical testing 
should not be performed by non-medically trained personnel 
because misdiagnosis would be likely in the absence of 
clinical expertise required for adequate interpretation of 
test results (3). 
However, if the trend towards specialization in 
community pharmacy does continue to develop in response to 
perceived needs, it is essential that recognized specialist 
practitioners be established and maintained at a high level of 
competence. To ensure both adequate patient care and 
professional credibility, accreditation will be required as a 
guarantee of specialty practice standards. 
How should specialization be encouraged? 
If specialization within community pharmacy is 
recognized as economically viable, professionally rewarding 
and positively contributing to the health care of the 
community, encouragement of the development of specialization 
could conceivably come from a number of sources. At present, 
providers seem to be motivating and training themselves to 
varying degrees. While this has resulted in the provision of 
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useful services to the public, the variability in expertise 
offers little protection to the consumer, as no distinction is 
obvious regarding the quality of the practitioners involved. 
This problem could be addressed by combining the enthusiasm of 
innovative practitioners with guidance and support from other 
sources: the profession itself, educational institutions, the 
government, and disease state support groups. 
In the United States, recognition of specialty 
practice in hospital pharmacy has come from within the 
profession, with APhA setting up criteria and approving 
acceptance as specialists of practitioners fulfilling pre-set 
education and practice requirements. In Australia, PSA, as 
guardian of the professional aspects of pharmacy practice, 
would be a logical organization to guide the development of 
specialization. Because of the importance of education in the 
achievement of adequate standards by specialist practitioners, 
this may be even more appropriately done through the 
Australian College of Pharmacy Practice (ACPP). 
The educational expertise of Universities and 
Institutes of Technology granting pharmacy degrees would also 
make them logical sources of the training needed for 
specialization. This could be achieved variously, eg by 
electives within the under-graduate system, by formal 
post-graduate courses, or by structured continuing education 
courses for practising pharmacists. 
As the Commonwealth Government is the major payer 
of medical costs in Australia, it would be in its interest to 
support specialization within pharmacy practice if it were 
shown that improved patient care and consequent reduction in 
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medical costs would result. That the Government supports 
medical specialization is evidenced by the current medical fee 
structure. 
If specialization in pharmacy practice were to be 
based on a disease state/anatomical classification as is 
medical specialization, support may also be forthcoming from 
specific disease support groups such as the National Heart 
Foundation, Diabetes Australia, the Ileostomy Welfare 
Association and the Arthritis Foundation. 
Involvement by the Commonwealth Government and by 
support organizations, however, was not forthcoming to 
diabetic pharmacies over recent months. In August 1986, the 
Government announced a budget decision to pay an annual grant 
to the Australian Diabetes Foundation (ADF - now Diabetes 
Australia) to enable it to provide diabetics with essential 
supplies including diagnostic testing agents, insulin syringes 
and needles (4). The decision was made as a result of 
submissions to the Government by the ADF, seeking to reduce 
the personal costs to diabetics. The intention was to 
introduce the scheme on 1st April, 1987. In the intervening 
period, PSA and PGA conducted negotiations with ADF to involve 
community pharmacies as convenient distribution points in 
return for a handling fee (5). As a result of these 
negotiations, PSA expressed confidence that pharmacies would 
be involved in the scheme and that co-operation between PSA 
and ADF would involve recognition by accreditation and special 
identification of pharmacists who fulfilled certain 
educational, professional and other commitments in the area of 
diabetes care (6,7). However, an announcement by the 
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Australian Minister for Health, the Hon.Neal Blewett, in May 
1987 (8) made it clear that the scheme, rescheduled to begin 
on 1st September 1987, would operate only through ADF and its 
State Associations, effectively ignoring the past and 
potential role of community pharmacists in diabetic supply and 
management (9,10). The collapse of co-operation and the 
by-passing of pharmacy appeared to be the result of Government 
financial restraints, but the probable long-term financial 
benefits to the health budget resulting from frequent contact 
by diabetic patients with readily accessible specialist 
pharmacists does not appear to have been considered. 
The most reliable driving force for the development 
of specialties in community pharmacy practice thus would 
appear to be the profession itself. The evidence that 
community pharmacists are moving into specialized areas of 
practice of their own volition needs to be addressed by the 
professional bodies and the potential future of this trend 
evaluated. Too often in the past, the profession and its 
representative bodies have been reactive rather than 
pro-active in the face of change. 
What should the functions of specialist pharmacists be? 
At this early stage in the development of 
specialization in community pharmacy practice, the role of 
involved practitioners is to provide goods, information, 
counselling, and if appropriate, screening and/or monitoring 
relevant to a specific patient group or a specific disease 
state . 
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The specialist pharmacist of the future would fill 
a logical place within the specialist medical team, assisting 
with drug information and clinical decision making with regard 
to drug therapy. The variety of drugs available and the extent 
of information required for their safe and effective use are 
making it increasingly difficult for pharmacists to maintain a 
depth of knowledge in all areas. As has occurred in other 
health professions, specialization would appear to be the 
answer to this problem. 
In addition, technological developments in the 
future may provide more detailed data on patients' medication 
status, which would be appropriately reviewed by the 
specialist pharmacist who could then be consulted by the 
physician regarding changes in therapy. An example of this 
type of technology has been seen in the field of diabetes with 
the Memory Glucometer, a programmed blood glucose monitor 
which retains the patient's blood glucose readings over a 
period of time. These readings can later be processed by 
computer, either on site or by modem, to produce profiles of 
blood glucose control for the period in question from which 
informed decisions can be made regarding adjustment of insulin 
dosage, or other management strategies. Pharmacokinetic 
evaluation of therapy for epileptics and asthmatics has also 
been reported. The other function likely to expand with 
improved technology is that of preliminary screening for 
disease. Simplified procedures have already made this a 
practicality in the community pharmacy environment for 
hypertension, diabetes, and pregnancy. 
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Because there were no differences observed in the 
supply functions of lower and higher level diabetic service 
providers, it could be postulated that, at a later stage in 
the development of specialization, the supply element may be 
separated from the service provision, with specialists acting 
in a consultative capacity only. Payment would need to be on 
the basis of a fee for service. The beginnings of this trend 
have been seen in office-based practice settings in the United 
States. 
Such a move would not be without its critics, 
notably other health professionals who may see their roles 
being usurped. In the area of diabetes, competition would 
certainly come from groups such as the Australian Diabetes 
Educators' Association (ADEA) who are in the process of 
establishing an accreditation course for diabetic educators. 
5.4 A BLUEPRINT FOR THE ESTABLISHMENT OF SPECIALIZED SERVICES 
Objective 11 - To suggest a plan to aid the 
controlled development of specialized services 
in community pharmacy practice. 
What are the advantages of controlled development of 
specialization in community pharmacy practice? 
Pharmacists are already active in the provision of 
specialized health related services through community 
pharmacies. This type of service offers advantages to the 
public in terms of health care by its ready availability, to 
the government by reduction in health care costs, and to the 
pharmacist in terms of professional satisfaction. 
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The advantage of controlling the development of 
specialized services is the ability to ensure the quality of 
services being provided, through education of the pharmacist 
providers. Accreditation of providers would allow the public 
to identify practitioners with appropriate qualifications in 
specific fields. 
Which pharmacies will be suitable for the establishment of a 
specialized service? 
Any pharmacy may be an appropriate outlet for a 
specialized service. There were no differences in business 
characteristics observed between low and high level providers 
of diabetic services, indicating that these attributes are not 
determinants of the success of such a venture. A pharmacist 
interested in establishing a specialized service should assess 
the needs of the community which the business serves eg it 
would be unwise to set up a paediatric specialty practice in 
an area with a predominantly elderly population, even if the 
pharmacist is interested in that area of practice. 
Which pharmacists will be suitable as specialists? 
Any pharmacist is a likely candidate for 
development into a specialist. There were no differences in 
the sex, qualifications, status in the pharmacy, or working 
hours of pharmacists providing low or high level diabetic 
services. The main attribute required is motivation, and the 
main motivation a desire for professional satisfaction. 
Associated with this are an interest in the subject, and a 
recognition of the need by customers for the service. 
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Membership of professional groups was common 
amongst practitioners offering diabetic services, but did not 
differ greatly between low and high level providers. Because 
numbers of practitioners have set up specialized health 
related services through their own efforts, it seems likely 
that more pharmacists, who may not have had the 
entreprenuerial drive to "go it alone", could be motivated to 
do so with the support of professional organizations. 
How can pharmacists be trained as specialists? 
Journal reading was common among providers of 
diabetic services, the only differences between low and high 
level providers being that a greater proportion of higher 
level providers regularly read specific diabetic journals. 
Attendance at continuing education events was also common, 
with a greater proportion of higher level providers seeking 
education offered from diabetic sources. This may be in 
response to a need not currently catered for by pharmacy 
sources. 
Pharmacy organizations, in conjunction with 
pharmacy educators, could establish courses to fit 
practitioners to specialize in various areas. Education will 
need to cover topics related to the physiology and management 
of the disease state, and the target population of the service 
in addition to medication aspects. 
What types of services should be provided initially? 
A complete stock range relevant to the chosen 
specialty should be invested in as early as is economically 
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feasible, so that patients will be well served when requiring 
products. A wide stock range also provides opportunity for 
setting up a display area devoted to the specialty service, 
which will then be easily identified by customers. Only minor 
differences were noted between lower and higher level 
providers in the variety of stock held. 
Written information in the form of leaflets, books, 
papers and reference texts can be included in the specific 
display section. Low and high level providers of diabetic 
services did not differ in this respect. 
Pharmacists should be capable of counselling 
patients on the use of prescription medications and choice and 
use of suitable nonprescription medications. The pharmacist 
offering a specialized service must be provided with the means 
to readily update his knowledge in these areas. It is 
important that the pharmacist recognizes the need for 
counselling in regard to continuing therapy with prescription 
medication, in order to encourage compliance and to detect any 
problems arising. Counselling is vital in assisting patients 
with choice of nonprescription medications, as they may be 
unaware of restrictions on the use of some readily available 
ingredients in certain circumstances eg sympathomimetic use by 
hypertensive and diabetic patients. 
In those specialty areas which involve sale or hire 
of equipment, the pharmacist should advise the patient in 
detail on the use of such equipment eg blood pressure and 
blood glucose monitors, invalid aids. The pharmacist must be 
trained in use of equipment, and fitting of aids. 
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For some disease states, the technology is 
available to permit screening in the pharmacy. There were no 
differences in provision of diabetes screening services 
between low and high level service providers. When offering 
screening, the availability of the service should be announced 
to customers by a discreet sign which also advises of times of 
availability and any charges for the service. The pharmacist 
must be trained in screening procedures. 
What types of services can be developed later? 
Information can be provided to patients in novel 
ways, such as by the use of audio or video tapes in the 
pharmacy, or through lectures or discussion groups outside the 
pharmacy setting. 
Greater proportions of higher level providers of 
diabetic services were offering blood glucose monitoring than 
were low level providers. Although the procedure itself does 
not differ, monitoring brings with it a commitment to 
assisting the patient with decision making consequent on the 
results of monitoring. The pharmacist requires an in depth 
knowledge of management of the disease state for this task. 
Interprofessional co-operation should be sought at this stage 
(if not before) so that the pharmacist may act as a member of 
the health care team. 
Patients accepting responsibilty for management of 
conditions may wish to consult the specialist pharmacist for 
help with decision making, even though performing their own 
monitoring. Surveillance of monitoring techniques is another 
task which could be performed by the specialist pharmacist. 
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What steps need to be taken for establishment of a specialized 
service 
1. Market research the business. 
2. Motivate the pharmacist. 
3. Educate the pharmacist. 
4. Stock the pharmacy. 
5. Pharmacist provides goods and information. 
6. Set up a screening service (when applicable). 
7. Seek cooperation of other health professionals 
8. Set up a monitoring service. 
9. Pharmacist participates as a member of the 
health care team in disease state management. 
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APPENDIX 1 
PRESS RELEASE - March, 1984 
PROGRESSIVE PHARMACISTS REQUIRED 
Research is currently being undertaken at the 
Pharmacy Department, University of Queensland, to determine 
the range and extent of services being provided by community 
pharmacy, and to predict future trends. It is apparent that a 
number of pharmacies offer extensions of those services 
usually considered to be available through pharmacy eg in the 
areas of nutrition, sports medicine, family planning, 
veterinary pharmacy, patient education and drug information. 
Still others offer specialized services beyond the normally 
accepted range eg blood pressure and/or diabetic monitoring 
and related services, health care equipment hire, patient 
medication records, nursing home services etc. 
The research team is interested in contacting 
pharmacists who have established, or are considering 
establishing, extra services in these or any other areas, to 
assist in their investigations. If you are one of these 
progressive pharmacists, or are aware of a pharmacy in your 
area which offers expanded services, please contact Mrs. Kay 
Stewart, Pharmacy Department, University of Queensland, 
St,Lucia, 4066 or telephone 377-2107 (9am - 5pm) or 379-9395 
(after hours). Name and address (eg pharmacy label) will be 
sufficient to enable us to return your contact, although an 
indication of the services being offered would also be 
helpful , 
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APPENDIX 2 
PRESS RELEASE - September, 1984 
COMMUNITY PHARMACY SURVEY 
Research is currently in progress at the Pharmacy 
Department, University of Queensland, to determine the range 
and extent of services being provided to the public by 
community pharmacy. 
As part of that research, all pharmacies in 
Queensland will shortly be receiving a questionnaire on this 
topic in the mail. 
The results of the survey will be of considerable 
assistance in planning for the educational and professional 
development of pharmacy in this State. 
I am appealing to all pharmacy owners or managers 
to respond to the questionnaire, as its usefulness to policy 
makers depends on your input. The times you spend will be a 
valuable contribution to moulding the future of our 
profess ion. 
Thanking you in anticipation of your co-operation, 
Kay Stewart, B.Pharm. (Hons.), 
Tutorial Fellow, 
University of Queensland. 
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APPENDIX 3 
COVERING LETTER - October, 1984 
TELEPHONE. <07) 377 .3191 
3 7 7 - 2 0 1 7 
^ntijj>rsttg of (l^meixQlrnxb 
PHARMACY DEPARTMENT 
STEELE BUILDING 
ST. LUCIA. QUEENSLAND. AUSTRALIA. 4067 
E. J . T R I G C S . 
B.PHARM., PH.D. (LONDON) . M.P.S. 
PNOFCSSOR IN PHARMACY 
October, 1984 
Dear Colleague, 
As part of a Doctor of Philosophy Degree, I am undertaking a survey 
of services provided by community pharmacy. 
The enclosed questionnaire has been sent to all pharmacies in 
Queensland. The information collected will help University staff 
and those organizing professional and business programmes to plan 
for the future. The Pharmaceutical Society of Australia (Qld. 
Branch) and the Pharmacy Guild of Australia (Qld. Branch) have 
been consulted in the preparation of this questionnaire. 
Your responses will contribute to the development of our profession. 
Enclosed is a pre-paid envelope addressed personally to me. The 
information will therefore remain strictly confidential. 
May I thank you in anticipation of your co-operation. 
Yours sincerely. 
KAY STEWART, B.Pharm.(Hons) 
NOTE:This letter has been photo-reduced for binding purposes 
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APPENDIX 4 
SURVEY INSTRUMENT - O c t o b e r 1984 
W SURVEY OF SERVICES PROVIDED BY 
COMMUNITY PHARMACIES IN QUEENSLAND. 
1984 
This questionnaire is to be compleled by the pharmacist usually in charge of the day to day operation of the pharmacy. 
Please ask EVERY OTHER FULL-TIME registered pharmacist and pre-registration trainee to complete the Pharmacist 
Information using the separate enclosed form. Material obtained will be used to provide aggregate statistics only. Individual 
answers will remain completely confidential. If you do not wish to answer a question, omit it and go on to the next ques-
tion. 
Please circle the appropriate number, or answer specific qucstior>s at requested. 
m 
13) 
Pharmacist Information 
Sex 
(4) Year of Birth 
F 
2 
19_ 
Qualifications Year of State of Qualification 
(Pharmaceutical Qualification |or country if outside 
and other] Australia) 
(21) Do you think that renewal of registration for community prac-
tice should be — [circle ONE number only) 
Automatic, as at present 1 
Dependent on proof of continuing education activity 2 
Dependent on proof of competence by assessment . . 3 
A combination of 2 and 3 4 
Other (please describe) 5 
|5) Ph.C. 
(6) B.Pharm. 
(7-8) Other (please specify] 
(9) 
(10) 
111) 
(12) 
(13) 
(14) 
(15-16) 
On average, how many hours per week do you work in THIS 
pharmacy? 
hours 
How long have you been working FULL-TIME in THIS phar-
macy to the nearest whole year? 
years 
Are you — (circle ONE number only) 
The sole owner 1 
A partner 2 
An employed manager 3 
An assistant pharmacist 4 
A pre-registration trainee 5 
Are you a member of the following organisations? (circle appro-
priate number for EACH organisation] 
YES NO 
Pharmaceutical Society of Australia (Qld.Branch) 1 2 
Pharmacy Guild of Australia (Qld.Branch] 1 2 
Australian College of Pharmacy Practice 1 2 
Other professional organisations, including non-
pharmaceutical, (please specify) 
How many continuing education programmes have you at-
tended THIS YEAR in each of the following categories? (if 
none, write 0) 
Number 
this year 
Evening lectures 
Week-end seminars 
Conferences 
(17) 
118) 
(19) 
|20) Have you any comments on the provision of continuing educa-
tion programmes? (e.g. availability, frequency, relevance) 
YES NO 
If YES: 
Undecided 6 
Do you currently READ — (circle appropriate number for 
EACH publication) 
YES NO 
(22) Australian Journal of Pharmacy 1 2 
(23) The Australian Pharmacist 1 2 
(24) Introspect 1 2 
(25) Pharmacy Review 1 2 
(25) Pharmacy Trade 1 2 
(27) Australian Prescriber 1 2 
(28) ADRAC Bulletins .• . . . 1 2 
(29) Current Therapeutics 1 2 
(30) Patient Management 1 2 
(31) Drug Intelligence and Clinical Pharmacy 1 2 
(32-34) Other professional journals, including non-pharmaceuti-
cal, (please specify) i. 
(35) 
(36) 
(37) 
(38) 
(39) 
Are you PERSONALLY involved in the provision of 
health or drug education lectures through - (circle appro-
priate number for EACH group] 
^ YES NO 
Hospitals 1 2 
Specific Illness Support Groups 1 2 
Community Organisations 1 2 
Schools 1 2 
Other (please specify) 1 2 
(40) Would you PERSONALLY be willing to be involved in the 
above nclivilics? ^ ^ ^ ^ 
I 2 
(41) Do you PERSONALLY have any special interest areas relating 
to pharmacy practice? (e.g. nutrition, diabetes, acupuncture etc.) 
YES NO 
1 2 
(42-45) If YES, please list: 
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Fliarmacy Information 
Please answer the following questions about THIS pharmacy. 
(46) Which duscriplioii bust fits the location of this pharmacy? 
(please read the COMPLETE list before circling the most ap-
propriate number) 
City or Town Centre 1 
(central business district] 
Regional Shopping Centre 2 
(a large multi-shop complex) 
Suburban Shopping Centre 3 
(a collection of shops under one 
r<M>r, wllli (irf-roiul piirking) 
Neighbourhood Shopping Strip 4 
(a collection of shops excluding 
Regional or Suburban Shopping Centres) 
Other (please describe) 5 
(47) Postcode of business address 
(48) Please list the normal trading hours of this pharmacy. 
OPEN CLOSE 
Monday 
Tuesday 
Wednesday 
Thursday 
Friday 
Saturday 
Sunday 
I'ultlic I lolitljiys 
(49) Approximately how long has this business been operating 
under its PRESENT ownership? 
years 
[50] Approximately how long has this business been operating 
under ANY ownership? 
years 
(51) Size of premises, excluding store rooms. 
SQ. FT or SQ. M 
Dispensary area 
Front shop area 
OR Total area 
[52] Merchandising group membership, (circle appropriate number] 
Not a group member 1 
Amcal 2 
Greenspol 3 
Pharmacare 4 
Soul Pattinson 5 
Sunshine 6 
Tri-pharm 7 
Other (please specify) 8 
[53] Please indicate range in which the pharmacy's 1983-84 annual 
turnover falls, [circle appropriate number) 
Less than J200 000 1 
J200 000 to J299 999 2 
J300 000 to J399 999 3 
J400 000 to J499 999 4 
$500 000 to J599 999 5 
J600 000 to 5799 999 6 
J800 000 to J999 999 7 
J l 000 000 or more 8 
Don't know 9 
(54) Approxiinalcly what proportion of this business is prescription 
n u m ' b e r r ^'^^^' *" ' ' ' '"vate? (circle appropriate 
Less than 25% j 
25 to 34% 2 
35 to 44% 3 
45 to 54% 4 
.';.'; to MH r, 
65 to 74% 5 
75% or more 7 
Don't know g 
(55) Does this pharmacy currently employ a pre-registration trainee? 
YliS NO 
1 2 
(56) If YES, how many hours per week do they work? 
hours 
How many registered pharmacists, including yourself, work in 
this pharmacy — 
NUMBER 
|S7) 40 or more hours per week ^ _ _ _ 
(58} 20 to 39 hours per week , 
(59) Less than 20 hours per week 
How many shop assistants work in this pharmacy — 
NUMBER 
(GO) 4 0 or n iuro , h o u r s p e r wuck 
(61) 20 to 39 hours per week 
(62) Less than 20 hours per week 
Are the following reference books currently on hand in this 
pharmacy? (circle appropriate number for EACH book) 
YES NO 
(63) Pharmaceutical Codex, 1973 or i979 1 2 
(64) A. P. F., 12th or 13th Ed 1 2 
(65) Martindale, 27th or 28th Ed 1 2 
[66] The Poison's Regulations of 1973, Qld 1 2 
(67) Handbook for Patient Medication 
Counselling (Warden-Flood) 1 2 
(68) , Merck Manual of Diagnosis and Therapy 1 2 
(69) MIMS Annual, 1983 or 1984 1 2 
[70] Prescription Proprietaries Guide. 1984 1 2 
(71-74) Please list any other books which are regularly consulted in this 
pharmacy. 
Does this pharmacy provide health or drug education ON 
THE PREMISES by -
YES NO 
(75) Audio-Visual programmes 1 2 
(76) Books 1 2 
(77) Division of Health Promotion leaflets 1 2 
(78) Group lectures, discussions 1 2 
(79) Other (please specify] 1 2 
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Dispensing Services 
(80-81) Do you think the present professional fees payable for NHS 
items arc — (circle appropriate number for BACH type] 
READY PRE- EXTEMPOR-
PARED ITEM ANEOUS ITEM 
Too Low 1 1 
About Right 2 2 
Too High 3 3 
Undecided 4 4 
[82-83] In what range do you think the professional fees should be? 
(circle appropriate number for EACH type) 
READY PRE- EXTEMPOR-
PARED ITEM ANEOUS ITEM 
Below $2.00 1 1 
$2.00 to $2.49 2 2 
$2.50 to $2.99 3 3 
$3.00 to $3.49 4 4 
$3.50 to $3.99 5 5 
$4.00 or more 6 6 
Umlecidcd 7 7 
If $4.00 or more please stale approximate amount.$ « 
(84-85) What proportion of the professional fee do you think should be 
for counselling? (circle appropriate number for EACH type) 
READY PRE- EXTEMPOR-
PARED ITEM ANEOUS ITEM 
Under 10% 1 J 
10-19% 2 2 
20-29% 3 3 
30-39% 4 4 
40-49% ' 5 5 
50% or more 6 6 
Undecided 7 7 
Comment: 
(86) Should the system of renumeration for NHS dispensing be in 
the form of — (circle ONE number only) 
Mark-up on goods only 1 
Mark-up and professional fee [current system] . . . 2 
Mainly by professional fee, but maintaining 
a small mark-up 3 
Professional fee only 4 
Other (please ticscribc] , , . , . . 5 
Undecided 6 
(87-88) In principle, should the professional fee for private prescriptions 
be — (circle appropriate number for EACH type] 
READY PRE- EXTEMPOR-
PARED ITEM ANEOUS ITEM 
Less than NHS fee 1 1 
Same as NHS fee 2 2 
More than NHS fee 3 3 
Undecided 4 4 
Comment: 
(89) On average, how many prescriptions per month does this phar-
rnacy dispense, including NHS, Repat. and Private prescrip-
tions? (circle appropriate number) 
Less than 1000 1 
1000-1999 2 
2000-2999 3 
3000-3999 4 
4000 or more 5 
Don't know 6 
(90) Are chairs available for customers waiting for prescriptions? 
YES NO 
1 2 
(91) Does this phormacy provide a pick-up and delivery service for 
prescriptions (opart from service to institutions]? 
YES NO 
1 2 
[92] Does this pharmacy have a telephone number available for 24 
hour service? 
YES NO 
1 2 
(93-102) Does this pharmacy regularly supply prescription items to -
(circle appropriate number for EACH institution) 
APPROX 
YES NO NUMBERAVEEK 
Private Hospitals 1 2 
Nursing Homes l 2 
Medical Centres 1 2 
Public Hospitals 1 2 
Other (please specify) 1 2 
(103) Does this pharmacy offer services to any of these institutions 
other than the supply of medication? 
NOT 
YES NO APPLICABLE 
1 2 3 
(104-105) If YES, please list: 
[106] Is this pharmacy normally involved in dispensing requiring 
UNUSUAL EXTEMPORANEOUS techniques? 
YES NO 
1 2 
[107-108] If YES, please list: 
(109) Is this pliurniacy normally involved in dispensing requiring 
UNUSUAL ranges of PROPRIETARY lines? 
YES NO 
1 2 
(110-111) If YES, plcn-sc list: 
(112) Does this pharmacy use a computer in dispensing? 
YES NO 
1 2 
If NO, Go to 120. 
[113] If YES, from whom was the SYSTEM obtained? (circle appro-
priate number) 
Amfac Chemdata 1 
Paulding / System 351 2 
Foundation 3 
Vision Management 4 
Other (please specify) 5 
(114) What brand of COMPUTER HARDWARE does your system 
use? [circle appropriate number] 
IBM PC 1 
NEC 2 
System 351 (Alios) 3 
Televideo 4 
Other [please specify) 5 
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(115) When was the system installed? MONTH YEAR (128) 
What additional services have you been able to provide since 
installing the computer? 
(116-119) Please list: 
[120] What is the likelihood of a computer being installed in this 
pharmacy within the next two years? (circle appropriate 
number] 
Already have a computer 1 
Very likely 2 
Likely 3 
Undecided 4 
Unlikely 5 
Very unlikely 6 
(121) If you have answered 'Very likely' or 'Likely', how soon would 
you '»pect a computer to be installed? 
Within three months 1 
Between 3 and 6 months ; 2 
Between 6 and 12 months 3 
After one year 4 
Not applicable 5 
(122) Does this pharmacy use ancillary labels? (circle ONE number 
only] 
Never 1 
Occasionally 2 
Routinely 3 
[123] Any comments? 
(124) Does this pharmacy keep any patient medication records? (circle 
ONE number only) 
No records 1 
Card system 2 
Computer system 3 
A combination of 2 and 3 4 
Other [please specify) 5 
[125] Any comments? 
Docs this pharmacy have — y r s NO 
(126) A SEPARATE counselling room 1 2 
(127) A SPECIALLY SET-UP counselling 
area within the pharmacy 1 2 
(129) 
(130) 
(131) 
(132) 
(133) 
(134) 
Where does patient counselling USUALLY occur in 
pharmacy? [circle ONE number only) 
No counselling activities 1 
Separate room 2 
Specially set up area 3 
At front counter 4 
Elsewhere [please describe) 5 
Are any of the following counselling aids used in this 
pharmacy? (circle appropriate number for EACH aid) 
YES NO 
Ancillary labels 1 2 
Audio-visual programmes 1 2 
Computer handouts 1 2 
Division of Health Promotion leaflets 1 2 
Manufacturers leaflets 1 2 
Other [please describe) 
this 
In the last SIX MONTHS, how many reports of suspected ad-
verse drug reactions have been made from this pharmacy? (If 
none, write 0] 
NUMBER 
(135) 
(136) 
[137] 
To the Adverse Drugs Reactions Committee . 
[ADRAC blue form] 
To medical practitioners 
To other . 
Please specify 
(138-149) In the last WEEK, approximately HOW MANY TIMES have 
patients been referred to medical practitioners, or medical prac-
titioners contacted directly from this pharmacy on the following 
matters? [Fill in approx. number for EACH column. If none, 
write 0) 
PATIENT DOCTOR 
REFERRALS CONTACTS 
Drug interaction 
Adverse drug reaction/side effect . . 
Other matters relating to prescrjption 
[excluding clerical m a t t e r s ) . . . . . . 
Matters relating to OTC medication 
Matters relating to disease state . . . 
Other professional matters 
[150-151] In THIS pharmacy, would you consider this to be — (circle 
appropriate number for EACH column) 
PATIENT DOCTOR 
REFERRALS CONTACTS 
More often than usual 1 • 
About normal 2 . 
Less often than usual 3 . 
(152) When contacting medical practitioners on professional matters, 
do you find them to be co-operative? (circle ONE number only) 
All llic lime ' 
Most of the time 2 
About half the time 3 
Some of the time * 
Rarely or never 5 
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Other Health Related Services 
Does this pharmacy provide any of the following GOODS and/or SERVICES, and if so, how are they ADVERTISED? (Please circle ALL 
appropriate numbers for EACH item listed. If goods / services NOT PROVIDED, please circle 1) 
GOODS/SERVICES ^„ PROVIDED ADVERTISING 
PROVIDED Birr NOT ,», S T O R . LETTER LOCAL YELLOW ORCANIZ- TO „ . , 
ADVERTISED 'NSTORE gQ^ DROP PAPER PAGES ATIONS DOCTORS OTHERS 
(153) Acupuncture 1 2 3 4 5 6 7 6 9 
(154) Asthma Pumps 1 2 3 4 5 6 7 8 9 
(155) Blood Glucose Monitoring Equipment for sale 1 2 3 4 5 6 7 8 9 
[156] Staff-Operated Blood Glucose Monitoring Service . . . . 1 2 3 4 5 6 7 8 9 
[157] Blood Pressure Monitoring Equipment for sale 1 2 3 4 5 6 7 8 9 
(158) Staff-Operated Blood Pressure Monitoring Service . . . . 1 2 3 4 5 6 7 8 9 
(159) Patient-Operated Blood Pressure " " . . . . 1 2 3 4 5 6 7 8 9 
(160) Pulse Rate Measurement 1 2 3 4 5 6 7 8 9 
(161) Computerized Dispensing 1 2 3 4 5 6 7 8 9 
Cosmetic Services (other than supply of goods) 
(162) Beauty Treatment 1 2 3 f 5 6 7 8 9 
(163) Make-Up Demonstrations 1 2 3 4 5 6 7 8 9 
(164) • Ear Piercing 1 2 3 4 5 6 7 8 9 
(165) Other [please specify] 1 2 3 4 5 6 7 8 9 
[166] Delivery Service 1 2 3 4 5 6 7 8 9 
(167) Diabetic Centre 1 2 3 4 5 6 7 8 9 
[168] Invalid or Health Care Aids for sale 1 2 3 4 5 6 7 8 9 
[169] Invalid or Health Care Aids for hire 1 2 3 4 5 6 7 8 9 
(170) Homeopathic Medicines 1 2 3 4 5 6 7 8 9 
[171] Naturopathic Medicines 1 2 3 4 5 6 7 8 9 
(172) Nutritional Supplements (extensive range) 1 2 3 4 5 6 7 8 9 
[173] Ostomy Aids 1 2 3 4 5 6 7 8 9 
(174] Patient Medication Records 1 2 3 4 5 6 7 8 9 
(175) Pregnancy Testing in Pharmacy 1 2 3 4 5 6 7 8 9 
(176) Sports Medicine Goods (extensive range) 1 2 3 4 5 6 7 8 9 
(177) Sports Medicine Services (eg. strapping] 1 2 3 4 5 6 7 8 9 
[178] Veterinary Medicines [extensive range] 1 2 3 4 5 6 7 8 9 
[179] Does this pharmacy provide ANY OTHER special facilities or [185] Do you think there should be corporate advertising to promote 
services? pharmacy services to the public? 
YES NO 
1 YES NO UNDECIDED 
1 2 3 
[180] If YES, please list:. 
(18:) Does this pharmacy anticipate COMMENCING any special fa-
cilities or services? 
YES NO 
(186) Please comment: 
1 2 
[182] If YES, please list: [Ig7| Would this BUSINESS be willing to contribute financially to 
such a scheme? 
YES NO UNDECIDED 
(183) Is this pharmacy anticipating growth in any specific facilities or 1 2 3 
services? 
YES NO (188) Would you PERSONALLY be willing to contribute financially 
J 2 '0 5"'^ '' ' scheme? 
YES NO UNDECIDED 
(184) I'YES, please list: 1 2 3 
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O.T.C. Services Commercial Services 
(189) Do you think there should continue to be provision for a class 
of drugs available for purchase from pharmacy only? 
(190) 
1192) 
YES NO UNDECIDED 
1 2 3 
Give reasons: 
(191) Do you think more drugs should be released to this category 
from 347 
YES NO UNDECIDED 
Give reasons: 
(193) What professional fee does this pharmacy charge on S3's at 
present? 
[194] Please give details of any variations from this fee 
(195) Please give reasons for deciding upon the above charge/charges. 
(196) Please comment on the current labelling regulations for S3's 
[e.g. suitability, practicality) 
Are the following commercial service: offered by this phar-
macy? (circle appropriate number for EACH service) 
YES NO 
(197) Customer Monthly Accounts i 2 
(198) Bankcard j 2 
(199) Other Credit Cards 1 2 
(200) Customer Taxation Records 1 2 
(201) Discount for special groups 1 2 
(202) Agency for Bank j 2 
(203) Building Society 1 2 
(204) Credit Union 1 2 
(205) Medibank Private j 2 
(206) Medical BenefiU Fund 1 2 
(207-208) Other (please specify) 
(209) Payment Centre for Gas 1 2 
(210) Electricity j 2 
[211] Council Rates 1 2 
(212-214) Other (please specify) 
(215) Justice of the Peace 1 2 
(216) Film Processing 1 2 
(217) Passport Photos 1 2 
(218) Weighing Scales - Adult 1 2 
[219] -Baby 1 2 
[220] Other (please specify) 
Thank you for completing this questionnaire. 
As we wish to learn from the experience of pharmacies providing certain services, this 
survey form carries an identification code number on the top left-hand corner of the first 
page. This number should ONLY be removed if you desire complete anonymity. Re-
member, ALL replies remain strictly confidential. 
NOTE: This form has been photo-reduced for binding purposes 
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APPENDIX 5 
111 
ADDITIONAL PHARMACIST SUPPLEMENT - O c t o b e r 1984 
SURVEY OF SERVICES PROVIDED BY 
COMMUNITY PHARIVIACIES IN QUEENSLAND. 
1984 
SUPPLEMENT: ADDITIONAL PHARMACIST 
This supplementary questionnaire is to be completed by each full-time REGISTERED PHARMACIST and PRE-REGIS-
TRATION TRAINEE employed in this pharmacy, other than the pharmacist usually in charge of the day to day operation 
of the pharmacy. Material obtained will be used to provide aggregate statistics only. Individual answers will remain com-
pletely confidential. If you do not vsrish to answer a question, omit it and go on to the next question. 
Please circle the appropriate number, or answer specific questions as requested. 
12) 
|3| 
Pharmacist Information 
Sex 
(4) Year of Birth 
F 
2 
19_ 
Qualifications Year of State of Qualification 
(Pharmaceutical Qualification (or country if outside 
and other) Australia) 
(21) Do you think that renewal of registration for community 
practice should be — (circle ONE number only) 
Automatic, as at present 1 
Dependent on proof of continuing education activity 2 
Dependent on proof of competence by assessment . . 3 
A combination of 2 and 3 4 
Other [please describe] 5 
(5) Ph.C. 
[6] • B.Pharm. 
(7-8) Other (please specify) 
19) 
(10) 
On average, how many hours per week do you work in THIS 
pharmacy? 
hours 
How long have you been working FULL-TIME in THIS phar-
macy to Uie nearest whole year? 
years 
(12) 
113] 
( 1 * 1 
(15-16) 
Are you — (circle ONE number only) 
The sole owner 1 
A partner 2 
An employed manager 3 
An assistant pharmacist 4 
A pre-registration trainee 5 
Are you a member of the following organisations? (circle 
appropriate number for EACH organisation] 
YES NO 
Pharmaceutical Society of Australia [Qld.Branch) 1 2 
Pharmacy Guild of Australia [Qld.Branch) 1 2 
Australian College of Pharmacy Practice 1 2 
Other professional organisations, including non-pharma-
ceutical, [please specify) 
How many continuing education programmes have you attend-
ed THIS YEAR in each of the follovring categories? [if none, 
write 0] 
Number 
this year 
(17) Evening lectures 
(18) Week-end seminars 
(19) Conferences 
(20) Have you any comments on the provision of continuing educa-
tion programmes? [e.g. availability, frequency, relevance] 
YES NO 
1 
If YES: . 
Undecided 6 
Do you currently READ 
EACH publication) 
(drcle appropriate number for 
YES NO 
(22) Australian Journal of Pharmacy 1 2 
(23) The Australian Pharmacist 1 2 
[24] Introspect 1 2 
(25) Pharmacy Review 1 2 
[26] Pharmacy Trade 1 2 
(27) Australian Prescriber i . 1 2 
[28] ADRAC BuUetins 1 2 
(29) Current Therapeutics 1 2 
(30) Patient Management 1 2 
(31) Drug Intelligence and Clinical Pharmacy 1 2 
(32-34) Other professional journals, including non-pharmaceuti-
cal, (please specify] 
[35] 
(36) 
(37) 
(38) 
(39) 
Are you PERSONALLY involved in the provision of health or 
drug education lectures through — (circle appropriate number 
for EACH group) 
^ ^ YES NO 
Hospitals 1 
Specific Illness Support Groups 1 
Community Organisations 1 
Schools 1 
Other [please specify) 1 
[40] Would you PERSONALLY be willing to be involved in the 
above activities? ^ES NO 
1 2 
(41) Do you PERSONALLY have any special interest areas relating 
to pharmocy practice? [e.g. nutrition, diabetes, acupuncture etc.] 
YES NO 
1 2 
(42-45) If YES, please list: 
NOTE: This form has been pho to - r educed for b ind ing purposes 
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APPENDIX 6 
REMINDER CARD - November 1984 
Department of Pharmacy 
University of Queensland 
ST. LUCIA, 4067 
October, 1984 
Dear Colleague, 
You may recall a questionnaire entitled "Survey of Services 
Provided by Community Pharmacies in Queensland, 1984" which 
was sent to you earlier this month. 
At the time of posting this reminder, a reply had not been re-
ceived from your pharmacy. I would be most grateful if the 
survey could be completed and returned as soon as possible. 
May I thank you in anticipation of your co-operation. 
Yours sincerely. 
KAY STEWART, B.Pharm.(Hons), M.P.S, 
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APPENDIX 7 
COVERING LETTER FOR RFIMATT 
TELEPHONt. I 0 7 ) 3 7 7 . 3 1 9 1 
3 7 7 - Z 0 I 7 
^nttTBrsti^ ai (^mBxidnnb 
PHARMACY DEPARTMENT 
STEELE BUILDING 
ST. LUCIA, QUEENSLAND. AUSTRALIA. 4067 
E. J. TRIGGS, 
B.PHARM.. r H . O . I L O N D O N ) . M.P.S. 
PROFESSOR IN PHARMACY * 
November, 1984 
Dear Colleague, 
You may recal l a questionnaire e n t i t l e d "Survey of Services Provided 
by Community Pharmacies in Queensland, 1984" which was sent to you 
las t month. 
At the time of w r i t i n g th is l e t t e r , I am not aware of having 
received 3 response from your pharmacy. I f you have not rep l ied , 
I would be grateful i f the pharmacist usually in charge of the 
day to day operation of th is pharmacy could complete and return 
the survey form. A second copy is enclosed for your convenience. 
As previously, a pre-paid envelope is enclosed, addressed person-
a l l y to me. The information w i l l therefore remain s t r i c t l y con-
f i den t ia l . 
Your reply w i l l be an important cont r ibut ion to th is research 
and to the development of our profession. 
Thanking you for your co-operat ion. 
Yours s incerely. 
KAY STEWART, B.Pharm.(Hons) 
NOTErThis letter has been photo-reduced for binding purposes. 
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APPENDIX 8 
TELEPHONE SURVEY INSTRUMENT 
DTABETIC SERVICES FROM COMMUNITY PHARMACY IN QUEENSLAND. 1986 
November , 1986 
Sample Number: 
Pharmacy Name: 
Phone : 
S t r e e t : 
C i t y : 
Owner: 
R e s p o n d e n t : 
DATE TIME RESULT CODE FOR RECALLS 
R e s u l t A b b r e v . 
NA No Answer 
RNA Desired respondent not 
available 
REF Refused interview 
IC Interview completed 
PIC Partially completed 
WN Wrong Number 
DIS Disconnected 
NI Not Involved 
Recall Code 
A Respondent not chosen 
B Respondent chosen only 
C Respondent spoken with 
LISTEN FOR PHARMACY NAME TO BE IDENTIFIED. 
IF NOT STATED: Hello. Is this Pharmacy? 
IF NOT: The number I have is • 
IF WRONG NUMBER: I am sorry to have bothered you 
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WHEN PHARMACY IDENTITY HAS BEEN CONFIRMED: 
(Hello.) This is Kay Stewart from the Pharmacy 
Practice Group of the University of Queensland 
Pharmacy Department. Could I please speak to the 
pharmacist in charge? 
WHEN PHARMACIST IN CHARGE IS ON THE LINE: 
(Hello. This is Kay Stewart from the Pharmacy 
Practice Group of the University of Queensland 
Pharmacy Department.) We are doing a study of 
pharmacies involved in the provision of diabetic 
services throughout Queensland, which has been 
sponsored by the Queensland Pharmacy Research 
Trust. This pharmacy has been included: (MARK) 
as a result of a previous survey we conducted 
in 1984, in which this pharmacy expressed some 
interest in the diabetic area, 
OR because its name appears on the current Ames 
list of Self-Care Centres 
OR because of its advertisement in the Yellow 
Pages 
OR because of its advertisement in Diabetes 
Conques t etc. 
OR OTHER REASON: 
Does this pharmacy currently have a special 
interest in diabetics? 
IF NO, GO TO PAGE 3. 
IF YES: I need to speak with the pharmacist most 
involved with dealing with diabetic customers. 
Would that be you? 
IF NO: Who would be the best person for me to 
speak to? 
NAME: 
IF NOT AVAILABLE: When would it be 
convenient for me to call? 
DATE: 
TIME: 
FILL IN CODE FOR RECALL. 
IF YES: I will need about fifteen to twenty 
minutes of your time. 
IF NOT CONVENIENT: When could I call back? 
FILL IN CODE FOR RECALL. 
DATE: 
TIME: 
Whom should I ask for? 
NAME: 
IF INTERVIEW AGREED TO, GO TO PAGE 4. 
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ASK QUESTIONS IN THIS SECTION ONLY IF PHARMACY NOT 
CONSIDERED TO BE CURRENTLY ACTIVE IN THE DIABETIC 
AREA. 
IF NO: But the pharmacy has had some involvement 
in providing services for diabetics in the past? 
IF NO: DELETE FROM SAMPLE. 
In that case I will not take up any more of 
your time. Thank you for speaking with me. 
IF YES: Has there been a change of policy or 
circumstances since then? REFER TO REASONS FOR 
INCLUSION IN SAMPLE. 
RECORD REASONS: 
IF NOT KNOWN: Whom could I speak 
that decision? 
to about 
NAME: 
Where could I contact them? 
PHONE: 
When would you suggest I call? 
DATE: 
TIME: 
FILL IN CODE FOR RECALL. 
Do you know of any pharmacies currently offering 
diabetic services? 
IF YES: LIST: 
As this pharmacy does not appear to be especially 
involved with diabetic services, I will not take 
up any more of your time. Thank you very much for 
speaking with me. 
WAS THIS PHARMACY IDENTIFIED BY THE 1984 SURVEY? 
HAS THERE BEEN A CHANGE OF OWNERSHIP SINCE THEN? 
3 54 
ASK QUESTIONS IN THIS SECTION ONLY IF PHARMACY 
CURRENTLY INVOLVED IN PROVISION OF DIABETIC 
SERVICES. 
The purpose of this survey is to collect 
information about the services which community 
pharmacies offer to diabetic customers. All of 
your answers will be kept in the strictest 
confidence and used only to prepare aggregate 
statistics with the details collected from other 
pharmacies, so that no individual information will 
be divulged which could be traced to a particular 
source. If you cannot or do not wish to answer a 
question, please do not hesitate to say so. 
Firstly, I would like to ask you some questions 
about diabetic services in your pharmacy. 
SERVICES 
Do you have educational leaflets on various 
aspects of diabetes available for your customers? 
IF YES: How are they usually distributed? ALLOW TO 
LIST. 
by self-select ion 
handed out by staff 
in conjunction with counselling 
other (RECORD). 
Do you have any other counselling or educational 
aids available? 
IF YES: What sort of things are they? ALLOW TO 
LIST; PROMPT. 
newspapers/news letters 
posters/charts 
audio tapes 
videotapes 
other (RECORD). 
How are they usually used? PROMPT. 
NOTE METHOD FOR EACH TYPE. 
taken by customers 
bought by customers 
hired by customers 
handed out by staff 
in conjunction with counselling 
used in pharmacy 
other (RECORD). 
Are you ever involved in providing education for 
diabetics outside the pharmacy setting <? 
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BLOOD GLUCOSE MONITORING 
Does this pharmacy measure blood glucose levels on 
the premises in any of the following 
circumstances : 
when demonstrating monitors 
as a screening service on demand 
as a screening promotion eg diabetes week 
for diagnosed diabetics? 
IF YES: Who usually does it? 
Is there a charge for any of these 
services? 
IF YES: RECORD CHARGE FOR EACH TYPE. 
Does this pharmacy offer a service for the repair 
of blood glucose monitoring machines: 
as an agent for the makers 
or on the premises? 
What alternatives are available to the patient to 
continue monitoring while repairs are being 
carried out? ALLOW TO ANSWER. 
pharmacy loans a monitor 
pharmacy hires a monitor 
manufacturer loans a monitor 
manufacturer replaces monitor 
other (RECORD). 
Does this pharmacy hire monitoring equipment in 
other circumstances? 
URINE GLUCOSE MONITORING 
Does this pharmacy ever measure urine glucose 
levels on the premises? 
IF YES: Under what circumstances? 
SUPPLY 
I am also interested in the role of pharmacists in 
supplying both the prescription and 
non-prescription needs of diabetics. Which of the 
following statements best describes the policy of 
this pharmacy in relation to stocking items in 
general, not just insulin, for supply to 
diabetics? 
Do you attempt to keep a full range of 
diabetic requirements to meet all possible needs? 
Do you stock a reasonable range to cover the 
most frequent requirements of diabetics? 
or Do you order items only on the specific 
request of customers? 
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Is there an area in the pharmacy specifically 
allocated to the display of diabetic goods? 
IF YES: What length of shelf space does it 
occupy? 
PRESCRIPTION ITEMS 
Which of the following groups of products do you 
keep a range of in stock regularly: 
blood glucose testing strips 
urine glucose testing strips/tab Iets 
oral hypoglycaemics? 
What is your policy specifically on stocking 
insulins: 
ie do you keep a range in stock 
or do you keep or order supplies for specific 
cus tomer s only? 
SYRINGES 
Do you keep disposable insulin syringes in stock? 
On average, and disregarding the proposed changes 
to syringe distribution, how many boxes of 100 
would you normally keep in stock? 
What price do you usually charge for a box of 100 
syringes? 
What price do you usually charge for single 
syringes? 
Do you keep glass syringes in stock? 
BLOOD GLUCOSE MONITORING EQUIPMENT 
Do you keep blood glucose monitors: 
in stock regularly 
or order them only on customer request? 
ANCILLARY ITEMS 
Which of the following diabetic items do you stock 
regularly? 
Injection Aids eg automatic injectors, scale 
magnifiers, devices for destroying needles etc. 
Urine Testing Equipment eg test sets, test 
tubes etc. 
Blood Testing Aids eg blood letting devices, 
calibration aids etc. 
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Dietetic foodstuffs including diabetic 
chocolates/sweets 
Artificial sweeteners 
Identification bracelets/ tags etc. 
Glucagon Injection 
Glucose Tablets 
Log Books 
Books on diabetic diet/recipes 
Books on diabetes and its management 
COUNSELLING 
Next I would like to read you a list of potential 
opportunities for counselling diabetics. Could you 
please tell me to what extent you discuss the 
following topics with your diabetic customers? I 
would like you to attempt to rate the topics on a 
scale of 1 to 5, with 1 meaning that you never 
discuss the topic, and 5 meaning that you have 
considerable involvement in that area. If you have 
a pencil handy (PAUSE) you may find it helpful to 
jot down an idea of the 1 to 5 scale: 1 = Never, 2 
= Rarely, 3 = Sometimes, 4 = Frequently, 5 = 
Always or very frequently. 
INSULIN 
With your insulin dependent diabetic customers, 
how often do you discuss the following subjects, 
using the rating scale of 1 to 5? 
Storage of insulin. 
Administration of insulin: 
drawing up technique 
mixing order and/or technique 
selection of injection site 
preparation of injection site. 
Adjustment of insulin dosage. 
Length of action of insulin types. 
Are discussions related to insulin more often 
started by you or the customer or either one? 
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BLOOD GLUCOSE MONITORING 
The topics related to blood glucose monitoring are 
most easily answered by dividing customers into 
two groups, those buying or discussing a monitor 
for the first time, and those already doing blood 
glucose monitoring. For each of those groups 
separately, how often would you discuss the 
following topics? For each topic, I will need an 
answer on the 1 to 5 scale for buyers and also for 
users. 
How to use a blood glucose monitoring machine. 
Care and maintenance of machine. 
Taking blood samples. 
Frequency of monitoring. 
Recording results. 
Are discussions about blood glucose monitoring 
usually started by you or the customer, or by 
either? 
URINE GLUCOSE MONITORING 
With patients who monitor their urine glucose, how 
often do you need to discuss: 
Collection of urine samples. 
How to perform the test/read the results. 
Recording the results. 
Are these discussions usually started by you or 
the customer or either one? 
ORAL HYPOGLYCAEMICS 
With patients taking oral hypoglycaemics, how 
often do you tell them about: 
Dose level and frequency. (EXPLAIN) 
Importance of compliance. 
Side effects/adverse reactions. 
Precautions eg food/drug interactions. 
Aie these drug counselling discussions usually 
started by you or the customer, or by either? 
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O.T.C.PRODUCTS 
A number of groups of over-the-counter products 
are of particular concern to diabetic customers. 
How often do you advise these customers about: 
Choice of artificial sweeteners. 
Availability of sugar-free products. 
Selection of appropriate cough/cold medications. 
Selection of foot care products. 
Are discussions of O.T.C. products usually as a 
result of: 
customer enquiries about a problem, 
or your volunteering advice about a 
product they have selected, 
or either of those possibilities? 
MANAGEMENT 
Questions related to diabetic management may be 
best answered for insulin dependent and 
non-insulin dependent diabetics separately, as 
some aspects may be seen as more relevant to one 
or the other group. How frequently do you discuss 
the following management topics with your insulin 
dependent diabetics and your non-insulin 
dependents? Estimate on the 1 to 5 scale for each 
group separately. 
Dietary guidelines. 
Symptoms of hypoglycaemia. 
How to manage a hypoglycaemic attack. 
How to cope with sick days. 
Symptoms of hyperglycaemia. 
Action to take with high blood or 
urine glucose levels. 
Foot care. 
Other complications eg sight problems. 
Are discussions related to management usually 
started by you or the customer, or by either? 
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REFERRAL 
In response to discussions with patients in the 
pharmacy, how often, as in Never, Sometimes, 
Frequently, do you refer patients to the following 
health-care professionals: 
Never, sometimes or frequently to a 
general practitioner 
specialist diabetologist/endocrinologist 
dietician/nutritionist 
podiatrist/chiropodist 
diabetes clinic/educator 
another pharmacist. 
BUSINESS INFORMATION 
For comparative purposes, I need to know some 
details about the pharmacy and about yourself as 
the pharmacist providing diabetic services. All of 
these details will remain completely confidential. 
Please skip any questions which you cannot or do 
not wish to answer. Firstly, some infoimation 
about the pharmacy. 
Are any members of staff other than yourself 
regularly involved with diabetic customers? 
IF YES: How many other pharmacists are involved? 
On average, how many hours per week does 
each of them work in the pharmacy? 
LIST: 
Are any other staff members eg shop 
assistants especially involved with the diabetic 
services we have been discussing? 
IF YES: How many? 
On average, how many hours per week 
does each of them work in the pharmacy? 
LIST: 
What are the normal trading hours of this 
pharmacy? RECORD: 
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POSTCODE 
Which description best fits the situation of 
pharmacy: 
City or Town Centre 
(central business district) 
Regional Shopping Centre 
(a large multi-shop complex) 
Suburban Shopping Centre 
(a collection of shops under one 
roof, with off road parking) 
Neighbourhood Shopping Strip 
(a collection of suburban shops 
excluding regional or suburban 
centres) 
Other (please describe). 
this 
In what 
1985-86? 
range did the turnover fall for the year 
Below $200 000 
$200 000 to $399 999 
$400 000 to $599 999 
$600 000 to $799 999 
$800 000 or more 
Approximately what proportion of the 
prescription trade? 
business is 
Less than 20% 
20 to 39% 
40 to 59% 
60 to 79% 
80% or more 
Using average figures prior to the November 1st 
changes, approximately how many total 
prescriptions per month 
dispense? 
does this pharmacy 
Less than 1000 
1000 - 1999 
2000 - 2999 
3000 - 3999 
4000 or more 
What proportion of your customers would you 
estimate to be diabetic, and/or to involve you in 
the diabetic services we have been discussing? 
Less than 5% 
5 to 9% 
10 to 14% 
15 to 19% 
20% or more 
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DEMOGRAPHIC DETAILS 
And finally some details about yourself. 
MALE/FEMALE 
What is your position in the pharmacy: 
the sole owner 
a partner 
an employed manager 
an assistant pharmacist? 
On average, how many hours per week do you work in 
the pharmacy? 
What pharmacy qualification do you hold? 
Do you know of any other pharmacies currently 
offering diabetic services? 
LIST: 
As an extension to this survey on 
diabetic services, in the near future I will be 
sending a mail survey to find out why pharmacies 
became involved in this field and their opinions 
on future development. Parts of this questionnaire 
would best be answered by the person responsible 
for making the decision to establish or continue 
the service in this pharmacy. How should I address 
the questionnaire so that the most appropriate 
person would receive it? 
NAME: 
ADDRESS: 
NOTES: 
The questionnaire from each pharmacy 
will be marked with a code number so that 
information from the same sources can be linked, 
but the code will not be used as a means of 
identifying individual pharmacies. 
That covers all the questions I need to 
ask. Thank you very much for sparing the time to 
speak with me. The results of this survey will be 
published, but if there is anything in particular 
that you would like to know about, please do not 
hesitate to contact me at the Pharmacy Department. 
Thanks again for your help. Good-bye. 
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APPENDIX 9 
COVERING LETTER - May 1987 
May 12, 1987 
Dear 
The Queensland Pharmacy Research Trust has sponsored a study 
into the provision of diabetic services through community 
pharmacies in Queensland. In the climate of uncertainty 
regarding the disttibution of syringes and blood testing 
mateiials, it is important that information about current 
pharmacy diabetic services is available to assist in policy 
formulation. 
The first part of the study was conducted by telephone during 
December 1986 and January 1987, to collect information about 
the types of diabetic services being offered. This mail survey 
has been designed to collect information about the factor s 
involved in the provision of these services. It is being sent 
to all pharmacies which responded to the telephone survey. 
Because the two surveys form part of a single study, it is 
important that this mail questionnaire be answered for all 
pharmacies which participated in the telephone interview, to 
allow as complete a picture as posible to emerge. 
The mail questionnaire consists of three sections. 
Please find enclosed: 
1. copies of Part 1. 
2. copies of Part 2. 
3. copies of a Diabetic Stock List. 
4. copies of Part 3. 
You may be assured of complete confidentiality. 
I would be happy to answer any questions that you might have 
about this questionnaire, or the overall study. Please do not 
hesitate to write, or telephone (07) 377 4294, 
Your prompt response is important to the success and 
usefulness of this study. Thank you for your assistance. 
Yours sincerely. 
Kay Stewart, B.Pharm.(Hons.),M.P.S. 
Pharmacy Practice Group 
Please see attached sheet for explanatory notes. YES/NO 
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APPENDIX 10 
MAIL SURVEY OF DIABETIC PHARMACIES 
EXPLANATORY NOTES 
Par t 1. : You have been sent copies of Part 1. for 
EACH pharmacy in which you have a decision making position. 
The questionnaires have been numbered as follows: 
NUMBER PHARMACY 
Please ensure that you use the CORRECT FORM for the 
information for EACH specific pharmacy. 
Part 2.: You need only answer Part 2. ONCE, even if 
you have replied to Part 1. on behalf of more than one 
pharmacy. 
Part 3. seeks demographic information about OTHER 
pharmacists involved in the PROVISION of the diabetic services 
in your pharmacies. Copies of this section have been: 
enclosed for you to distribute 
sent directly to the pharmacies. 
A Stock List of diabetic items has been provided to 
assist with the answering of some questions. Sufficient copies 
have been included for all the pharmacies you are associated 
with, to allow staff from each pharmacy to assist you with 
those ques tions. 
Please contact me by mail or telephone, (07) 377 4292, if you 
require further copies of any section. 
DO NOT RETURN THIS PAGE WITH YOUR COMPLETED QUESTIONNAIRES. 
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APPENDIX 11 
MAIL SURVEY OF DIABETIC PHARMACIES 
DIABETIC SERVICES FROM COMMUNITY PHARMACY IN QUEENSLAND. 1987 
Sample Number: 
(This number will not be used to identify the pharmacy 
returning this questionnaire, but only to link information 
with that collected in the earlier telephone survey.) 
The purpose of this survey is to collect information about 
factors involved in the provision of diabetic services from 
community pharmacies. All of your answers will be kept in the 
strictest confidence and used only to prepare aggregate 
statistics with the details collected from other pharmacies. 
If do not wish to answer a particular question, please omit it 
and go on to the next question, 
PART 1 DIABETIC SERVICES 
This section of the questionnaire should be answered by the 
PHARMACIST RESPONSIBLE FOR DECIDING TO ESTABLISH OR CONTINUE 
THE PROVISION OF DIABETIC SERVICES in this pharmacy. If you do 
not work regularly in this pharmacy, some questions may 
require reference to the pharmacist PROVIDING the service, 
1. Are you personally REGULARLY involved in the provision of 
diabetic services in this pharmacy? 
a. Yes. 
b. No, 
2. Are you the pharmacist who responded to the recent 
telephone survey on diabetic services? 
a. Yes, 
b. No, 
3. When was the service established in this pharmacy? 
a, Year 
OR b. Don't know, 
4. Did YOU: (Please tick one only.) 
a.Establish the diabetic service? 
OR b,Continue an already established service? 
5. If you have ticked 2,b, when did you take over? 
Year 
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6,-21, How much influence (on a scale of 1-5) did each of the 
following factors have upon your decision to establish or 
continue a diabetic service in THIS pharmacy? Read all the 
questions on pages 2,and 3, before attempting to answer, 
(Please circle the number corresponding to the most 
appropriate answer for each statement.) 
NONE 
AT ALL 
A SMALL 
AMOUNT 
A MODERATE 
AMOUNT 
A LARGE 
AMOUNT 
MAJOR 
FACTOR 
I had an 
interest in 
diabetes. 
I saw it as 
a way to increase 
professional 
satisfaction. 
I saw it as 
profitable, 
I had set up 
diabetic services 
in another of my 
pharmac ies. 
The pharmacy is 
located near a 
diabetic clinic. 
I had a number 
of diabetic 
cus tomer s. 
My diabetic 
customers 
needed help. 1 
l a m a diabet ic. 1 
2 
2 
4 
4 
A member of my 
family is/was a 
diabetic. 
A close frlend 
is/was a 
diabetic. 
A member of my 
staff is/was a 
diabetic. 
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NONE A SMALL A MODERATE 
AT ALL AMOUNT AMOUNT 
A LARGE MAJOR 
AMOUNT FACTOR 
Ames approached 
me to become a 
Self Care Centre. 
I approached 
Ames to become a 
Self Care Centre. 
I was influenced 
by the Pharmaceut 
ical Society. 
I was influenced 
by the Pharmacy 
Guild. 
I was influenced 
by a marketing 
group. 1 5 
If any other factors influenced your decision to establish or 
continue a diabetic service in this pharmacy, please list them 
below and rate them on the 1-5 scale. 
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22. How many types of insulin do you REGULARLY KEEP in stock? 
(Refer to enclosed stock list.) 
types 
23. What is the approximate value of your USUAL holdings 
of insulins? 
$ 
24. Could you please estimate the total CURRENT value of your 
diabet ic stock? 
25 
$ 
(The enclosed list of diabetic goods may be 
of help in estimating your stock value.) 
Does this pharmacy have any diabetic reference texts? 
a.Ye s . 
b. No, 
26. If YES, please list the diabetic reference texts 
available in the pharmacy: 
27. Could you please estimate what PROPORTION of your total 
stock value is invested in diabetic stock? 
28. Do you consider the involvement of this pharmacy in 
diabetic services to be: (Tick one answer only.) 
a. Minor? 
b. Moderate? 
c. Major ? 
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29.-33. How successful (on a scale of 1-5) do you consider the 
diabetic area of your business to be in each of the following 
aspects? (Please circle the number corresponding to the most 
appropriate answer.) 
NOT AT ALL NOT VERY MODERATELY A GOOD A GREAT 
SUCCESSFUL SUCCESSFUL SUCCESSFUL SUCCESS SUCCESS 
Financially. 
Professional 
satisfaction 
Customer 
satisfaction 
Increase in 
customers . 
1 
1 
Inter-profession-
al relationships. 1 
BUSINESS DETAILS 
34. What is your position in this pharmacy? (Tick one only.) 
a. The sole owner. 
b. A partner . 
c. An employed manager. 
d. Other. (Please describe.) 
35. On average, how many hours a week do you work in this 
pharmacy? 
Hours/week 
36, What is the total area of the pharmacy, excluding 
store rooms ? 
Sq, ft 
37, What is the area of the front shop' 
Sq. ft 
3 70 
38. Could you please estimate CURRENT TOTAL stock value 
(INCLUDING diabetic stock)? 
39. Is the owner of this pharmacy a member of the 
Pharmacy Guild of Australia? 
a. Yes. 
b. No. 
40. Is this pharmacy associated with any marketing groups? 
a, Yes, 
b. No. 
41. IF YES: Which groups? (Tick all appropriate answers.) 
Amcal 
Chemway 
Greens pot 
Pharmacar e 
Soul Pattinson 
Sunshine 
Tri-pharm 
Other (Please state.) 
Thank you for your co-operation in completing this section 
(Part 1.) of the questionnaire. Please complete Part 2, 
(DEMOGRAPHICS), Even if you have completed Part 1. for more 
than one pharmacy, you need only fill in Part 2. ONCE. 
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APPENDIX 12 
STOCK LIST 
INSULINS 
CSL-NOVO Insulin 2 (lOOu/ml) 
Insulin (300u/ml) 
Rapitard MC 
Protaphane HM 
Isotard MC 
Protaphane MC 
Actraphane HM 
Actraphane MC 
Actrapid HM 
Actrapid MC 
Protamine Zinc Insulin MC 
Monotard HM 
Lente MC 
Monotard MC 
Semilente MC 
Ultratard HM 
Ultralente MC 
BW-Nordi sk Insulatard Nordisk 
Initard Nordisk 
Mixtard Nordisk 
Velosulin Nordisk 
Eli Lilly Humulin N 
Humulin R 
Weddel Hypurin Isophane 
Hypurin Neutral 
GLUCOSE TESTING MATERIALS 
BLOOD - Ames-BG 
BM-Test-BG 
BM-Test-Glycemie 20-800 
Glucostix 
Visidex 
URINE - Clinistix 
Clinitest Tablets 
Diastix 
Keto-Diastix 
TesTape 
ORAL HYPOGLYCAEMICS 
Daonil 
Diabex 
Diabinese 
Diaformin 
Diamicron 
Diatol 
Euglucon 
Glucophage 
Promide 
Rastinon 500mg 
Rastinon 1g 
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SYRINGES 
Becton Dickinson 0.5ml 
Becton Dickinson 1ml 
Te rumo 
Other disposables 
Glass syr inges 
Needles 
BLOOD GLUCOSE MONITORING EQUIPMENT 
Ames Glucometer I 
Ames Glucometer II 
Diatron Easytest 
Glucochek II 
Hypocount MX 
Omni scan 
Reflolux II 
INJECTION AIDS 
Automatic injectors 
Click-count syringes 
Scale magnifiers 
Devices for destroying needles 
URINE TESTING EQUIPMENT 
Testing sets 
Test tubes 
Dropper s 
BLOOD TESTING AIDS 
Visual reading kits 
Blood letting kits 
Blood letting devices e,g, Autolet 
Lancets 
Platforms 
Calibration aids 
FOODSTUFFS 
Diabetic chocolates 
Diabetic sweets 
Dietetic jams 
Dietetic drinks 
Dietetic fruits etc. 
Artificial sweeteners 
MISCELLANEOUS 
Identification bracelets/tags etc 
Glucagon Injection 
Glucose tablets 
Swabs 
Log books 
Books on diabetic diet/recipes 
Books on diabetes and its management 
Other items 
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APPENDIX 13 
CHIEF PHARMACIST MAIL SURVEY INSTRUMENT 
DIABETIC SERVICES FROM COMMUNITY PHARMACY IN QUEENSLAND. 1987 
This section of the questionnaire should be answered by the 
PHARMACIST who responded to Part 1. of this survey, ie the 
pharmacist responsible for deciding to establish or continue 
the provision of diabetic services. 
Sample Number: 
If you have answered Part 1, of this mail survey for more than 
one pharmacy, please indicate sample numbers of ALL pharmacies 
for which you have replied. You need only answer Part 2. 
ONCE. 
(Numbers will not be used to identify the pharmacy/pharmacies 
returning this questionnaire, but only to link this 
information with that collected in the earlier telephone 
survey,) 
PART 2. DEMOGRAPHICS 
42. What basic pharmacy qualification do you hold? 
(Tick one only,) 
a. Ph.C, 
b. B.Pharm. 
c. Other. (Please describe,) 
43. Do you hold any further professional qualifications in 
either the pharmacy or diabetic field? (Please list.) 
44. Year of birth? 
45. Sex? 
a . Male 
b. Female 
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46.-51, Which pharmacy and/oi diabetic organizations are 
you a member of? 
Pharmaceutical Society of Australia? 
Australian College of Pharmacy Practice? 
Society of Hospital P'cists of Australia? 
Diabetic Association of Queensland? 
Australian Diabetic Educators' Assoc.? 
Other diabetic groups? (Please list.) 
YES NO 
52,-bl. Which of the following journals do you read 
regularly? 
Australian Journal of Pharmacy? 
Australian Pharmacist? 
Australian Prescriber? 
Current Therapeutics? 
Patient Management? 
The Pharmaceutical Journal? 
Diabetes Control? 
Conquest (DAQ)? 
Diabetes in the News? 
Other journals providing infoimation 
in the diabetic field? (Please list,) 
YES NO 
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62,-69, How did you build up youi expertise in the 
diabetic area? 
a. Pharmacy organized continuing 
education lectures, seminars 
or conferences. 
b. Continuing education tapes/ 
booklets from pharmacy sources. 
c. Diabetic group organized 
lectures, seminars or 
conferences , 
d. Tapes or booklets from 
diabetic organizations. 
e. Tapes or written information 
from pharmaceutical companies, 
f. Books on diabetes. 
g. Journal reading, 
h. Other methods, (Please describe,) 
YES NO 
Thank you for your co-operation in completing this section of 
the questionnaire. 
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APPENDIX 14 
ADDITIONAL PHARMACIST MAIL SURVEY INSTRUMENT 
DIABETIC SERVICES FROM COMMUNITY PHARMACY IN QUEENSLAND. 1987 
Sample Number: 
(This number will not be used to identify the pharmacy 
answering this questionnaire, but only to link information 
with that collected in the earlier telephone survey.) 
The purpose of this survey is to collect information about 
factors involved in the provision of diabetic services from 
community pharmacies. All of your answers will be kept in the 
strictest confidence and used only to prepare aggregate 
statistics with the details collected from other pharmacies. 
If do not wish to answer a particular question, please omit it 
and go on to the next question. 
PART 3. DEMOGRAPHICS 
This section is to be answered by all PHARMACISTS REGULARLY 
INVOLVED IN THE PROVISION OF DIABETIC SERVICES in this 
pharmacy, who have not answered Parts 1, and 2. of this mail 
survey. 
1(2), Are you the pharmacist who responded to the recent 
telephone survey on diabetic services? 
a. Yes. 
b. No, 
2(34), What is your position in the pharmacy?(Tick one only,) 
a. The sole owner, 
b. A partner. 
c. An employed manager, 
d. Other. (Please describe.) 
3(35), On average, how many hours a week do you work 
in this pharmacy? 
Hours/week 
4(42), What basic pharmacy qualification do you hold? 
(Tick one only, ) 
a. Ph.C. 
b. B,Pharm. 
c. Other. (Please describe,) 
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5(43), Do you hold any further professional qualifications in 
either the pharmacy or diabetic field? (Please list,) 
6(44), Year of birth? 
7(45), Sex' 
a, Male 
b, Female 
8-13(46,-51), Which pharmacy and/or diabetic organizations 
are you a member of? 
YES NO 
Pharmaceutical Society of Australia? 
Australian College of Pharmacy Practice? 
Society of Hospital P'cists of Australia? 
Diabetic Association of Queensland? 
Australian Diabetic Educators' Assoc? 
Other diabetic groups? (Please list,) 
14-23(52-61) Which of the following journals do you read 
regularly? 
Australian Journal of Pharmacy? 
Australian Pharmacist? 
Australian Prescriber? 
Current Therapeutics? 
Patient Management? 
The Pharmaceutical Journal? 
YES NO 
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YES NO 
Diabetes Control? 
Conquest (DAQ)? 
Diabetes in the News? 
Other journals providing information 
in the diabetic field? (Please list.) 
24-31(62.-69). How did you build up your expertise in the 
diabetic area? 
a. Pharmacy organized continuing 
education lectures, seminars 
or conferences. 
b. Continuing education tapes/ 
booklets from pharmacy sources. 
c. Diabetic group organized 
lectures, seminars or 
conferences. 
d. Tapes or booklets from 
diabetic organizations. 
e. Tapes or written information 
from pharmaceuticaJ, companies. 
f. Books on diabetes. 
g. Journal reading. 
h. Other methods. (Please describe.) 
YES NO 
Thank you for your co-operation in completing this section of 
the questionnaire. 
